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SUMMARY
Topical application of phorbol ester tumour promoter 
evoked the stimulated generation of hydrogen peroxide in the 
mouse skin _in viv o , probably resulting from its action on an 
associated non-target population of infiltrating inflammatory 
cells. This formation was demonstrated indirectly by hydrogen 
peroxide dependent 3-amino-1 ,2,4-triazole catalase complex 
formation and confirms the hypothesis and findings of Goldstein 
et al. (1983).
In the assay model discussed, n-alkanes representing the 
range Cg-C-j^ caused stimulated production of hydrogen peroxide 
but in mouse skin already containing inflammatory cells. It is 
proposed that the known tumour-promoting activity of dodecane 
and tetradecane is free radical mediated, and that this 
activity is expressed when these alkanes cause an inflammatory 
state such as occurs upon repeated dermal application. Free 
radical generation and possible tumour-promoting activity of 
lower alkanes is latent, due to lower irritancy and high 
volatilization, unless these alkanes are encountered in 
combination with an irritant.
Skin explant studies demonstrated a priming potential of 
the phorbol ester tumour promoter to the induction of skin 
catalase by oxygen. This dose-dependent induction is also seen 
in untreated skin and may represent a possible compensatory 
response to oxygen toxicity. Such induction may confound the 
interpretation of other air-incubation studies in vitro.
The generation of hydrogen peroxide was stimulated as a 
consequence of abrasion, a known tumour promoting agent, and
this indicates that irritation, (and possibly the immune 
response) has a role in tumour promotion and in the variation 
in strain susceptibility to tumour promoters.
Current techniques for the assay of enzymic activities 
specific for cytochrome P-450 and cytochrome P-448 failed to 
detect these in mouse skin. The presence of these activities 
in mouse hepatic tissue was demonstrated.
Preliminary data is presented for a novel skin 
irritation screening test based on phorbol ester-stimulated 
oxygen consumption by inflammatory cells responding to the 
applied test material. The technique may offer a more precise 
and convenient measure of irritancy than that provided by the 
currently used Draize test.
To the memory Of my father 
Basil Martin Bird, OBE
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CHAPTER 1
INTRODUCTION
INTRODUCTION
Although the mouse skin as a model for tumour 
initiation-promotion in humans was originally described over 
forty years ago (Berenblum 1941) many details of the specific 
cellular and biochemical events necessary for the formation 
and progression of tumours remain to be elucidated. The role 
of oxygen derived radicals and peroxides in radiation 
toxicity has also been long recognized but it is only 
recently that these oxygen species have also been seen as 
important mediators in the multistage carcinogenesis process 
(Totter 1980) including tumour promotion (Goldstein et al. 
1979)* In fact, many reactive intermediates of toxic 
chemicals are electrophiles, free radicals or free radical 
generators, which may potentiate the toxicity of tissue 
oxygen, depleting intracellular glutathione and biological 
antioxidants, resulting in membrane damage, impairment of the 
calcium pump, cell death, and damage to DNA (Parke 1982).
Normal alkanes are prominent components in many 
petroleum and petrochemical products. This thesis examines 
the possible involvement of reactive oxygen products in the 
known tumour promoting activity of certain normal alkanes in 
the mouse skin since this activity, where present (e.g. 
phorbol esters), has been found to be associated with the 
ability to generate reactive oxygen species.
The initial studies seemed to validate findings of 
hydrogen peroxide formation in the mouse skin (Goldstein et 
al 1984) using an assay based on the hydrogen peroxide (H2O 2 ) 
dependent inhibition of catalase by 3»4-aminotriazole (ATZ). 
Of the various known assay systems for reactive oxygen 
products/H202» this ATZ-catalase inhibition method, although
indirect, was selected for its specificity. The method was 
validated here by demonstration of H2O2 formation from
dose-dependent topical application of the known tumour
promoter phorbol 12,13-myristate acetate (PMA), as described 
in Chapter 2.
Since it had been found that maximal H2O2 gene ration 
is achieved by topical application of active phorbol esters
to irritated skin, a two treatment regimen was adopted. The
first treatment produced an inflammatory response in the 
mouse skin, as seen from histological sections, during the 
twenty-four hours prior to a second stimulatory treatment 
which elicited H 2O 2 formation detected by the 
aminotriazole-catalase inhibition. This is consistent with 
the hypothesis that PMA-stimulated generation of free 
radicals and/or active states of oxygen _in vivo in the mouse 
skin is mediated in part by infiltrating phagocytic cells 
responding to the inflammatory state.
In Chapter 3» the effect of abrasion on H 2O2 formation 
in mouse skin in vivo is examined since repeated abrasion is 
a known tumour promoting agent. The two treatment regimen 
was also used to investigate the effects of the alkane series 
on pre-irritated skin and whether those alkanes, lacking 
irritancy or with high volatility, were able to generate H 2O2 
in the presence of inflammatory cells.
Organ culture offers a controlled environment, and in 
Chapter 4 , three comparative and parallel studies are 
described: iji viv o , in vi tro, and the intermediary stage of 
in vivo dosing and subsequent ill vitro culture of whole skin. 
The different responses obtained led to subsequent 
experiments which showed that non-physiological oxygen
tensions may cause an increase in catalase activity 
compensatory to the increased tissue oxygen.
It is known that reactive oxygen can be generated by 
the mixed function oxidase system. Since the forementioned 
studies indicated (by H 2O2 formation) that reactive oxygen 
was generated from treatments with PMA or alkanes, the 
determination of any inducing effect of these treatments on 
the mixed function oxidase system was attempted.
Specifically, Chapter 5 contains studies to determine 
benzpheta.mine demethylase and ethoxyresorufin deethylase, 
specific activities of cytochrome P-450 and cytochrome P-448 
respectively.
PMA-stimulated phagocytic cells generate H2O2 and show 
a rapid increase in oxygen consumption. A practical 
application is the use described in Chapter 6, of 
PMA-stimulated oxygen consumption as a quantitative measure 
of skin irritation. This might be utilized as an alternate 
test system to determine skin irritancy of a compound of 
unknown irritant potential and, to exclude irritant members 
of a product development series, thus minimizing i_n vivo 
experimentation.
The three elements, the mouse skin, petro-chemical/ 
alkanes, free radicals/disease states are now described.
STRUCTURE OF MOUSE SKIN 
The Epidermis
Normal mouse epidermis, as seen in conventional 
paraffin sections (Plate 1), appears as a stratifed 
epithelium; a schematic representation is shown in Figure 1. 
The cell layer resting on the underlying connective tissue or
dermis, is the basal cell layer and above this lies the 
suprabasal layer of keratinocytes (spinous cell layer) and 
the keratinized stratum corneum. The cells of the stratum 
corneum are present in an orderly stacked columnar 
arrangement (called squames) particularly in body areas where 
the skin has a low rate of new cell production. The squame 
columns, arranged in roughly a hexagonal outline with 
associated 10-11 basal cells can be regarded as an epidermal 
proliferative unit. This structure becomes disorganized if 
the mitotic rate of the basal layer rises above one cell per 
day per squame as occurs with certain hyperplastic or 
wound-healing states (Allen and Potten 1974). Christophers 
et al. (1974) reported a 20-24 day transit time in the mouse 
ear for a cell to pass from the basal cell to the cornified 
layers with the squame structure present; in disorganized 
states the passage time was 6-7 days. Rapid keratinocyte 
proliferation usually fails to maintain a normal epidermal 
barrier and in consequence provides rapid transepidermal 
absorption; this is important in considering the effects of 
petrochemical and other materials discussed elsewhere.
Mouse dorsal interfollicular epidermis has a vertical 
organization of approximately 1400 Epidermal Proliferative 
Units/mm^. At the centre of each epidermal proliferative 
unit (EPU) a single dendritic Langerhans cell devoid of 
desmosomes, but held in position by the surrounding 
keratinocytes. The dendrites of the Langerhans cell radiate 
outward between the keratinocytes to the periphery of the 
EPU. A schematic diagram of the epidermal layers and EPU is 
shown in Figure 2. The normal cell attachments - desmosomes 
which maintain structural integrity, are replaced by a
modified cell-to-cell attachment or squamosome, at and 
between squame columns. Therefore, individual cells within 
squame columns and the columns themselves are interconnected 
forming a multi-layered and compartmentalized sheet of 
keratinized cells; this provides high resistance to 
mechanical damage and to permeability.
Dark basal keratinocytes have been described from 
electron microscopy studies as extremely electron dense.
These are considered less differentiated than normal basal 
keratinocytes; dark keratinocytes are present in foetal 
epidermis prior to the onset of differentiation but decrease 
with the production of orthokeratinized squamous epithelium. 
Their increased numbers following dermal application of 
tumour promoters has led to their suggested involvement in 
the first step of the 2-stage tumour promotion process 
(Klien-Szanto and Slaga 1981).
In any discussion of epidermal structure and 
biochemical response, the heterogeneity of the structure must 
be considered. The non-keratinocytes of the basal layer 
include Merkel cells, Langerhans cells, melanocytes and Type 
3 or indeterminate cells. Each cell type is now described 
briefly.
Merkel Cells
Merkel cells are characterized by an irregular nuclear 
profile and dense-cored cytoplasmic granules 80-100 nm in 
diameter. They are believed to be derived from nerve cells 
and to function as sensory receptors, (Winkleman & Breathnach 
1973)* Their frequency in mouse dorsal epidermis is low.
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Schematic Representation of the Epidermal Proliferative Unit (EPU)
[Note: Central langerhans cell (LC) between adjacent keratinocytes (K)
and a migrating keratinocyte (MK). Desmosomal attachments are 
indicated around each cell membrane except the cornified layer 
where they do not occur]
Langerhans Cells
Langerhans cells are in greater evidence than* Merkel 
cells and key to the epidermal proliferative unit 
organization. These cells are clear, dendritic with a 
characteristic Langerhans cell granule and radiating 
centriole. A phagocytic function has been suggested but 
studies with peroxidase and ferritin show no phagocytic 
activity (Wolff and Schreiner 1970). They are now known to 
be immunocompetent cells playing a crucial role in 
cell-mediated hypersensitivity reactions and in the 
pathogenesis of skin disease.
Melanocytes
Melanocytes are multidentritic cells occurring in the 
basal cell layer. A known function of melanocytes is the 
synthesis of pigment granules (melanosomes) containing 
melanin, but the mouse dorsal interfollicular epidermis 
contains only non-melanogenic melanocytes or melanoblasts 
(Allen and Patten 1974; Quevedo and Smith 1968). However, 
irradiation with X-rays or ultraviolet light causes an 
increase in epidermal pigmentation which is attributed to the 
activation of melanogenesis in these cells (Quevedo and Grahn 
1 958).
Indeterminate Cells
These cells are usually classified by their lack of 
other characteristics such as Langerhans granules or 
melanosomes. Suggested roles are as a premelanocyte, or 
precursor to Langerhans cells (Wolff 1972).
The Dermis
The dermis consists of a relatively dense fibroelastic 
connective tissue composed of collagen fibres, elastic fibres
and an interfibrillar gel of glycosaminoglycans, salts and 
water. Distributed in the dermis are fibroblasts, 
perivascular mast cells and tissue macrophages which as seen 
later, have an important role in inflammation and disease.
In addition to this cell population, the dense connective 
stroma of the dermis encloses a rich blood supply from an 
extensive plexus of the vasculature. This serves the hair 
follicle bulbs and capillary loops running between the 
core-like rete ridges of papillae which project into the 
epidermis. The plexus is under interrelated neural and 
humoral control influences.
It is unclear whether the skin contains specialized 
dermal macrophagesi Monocytes/macrophages (of average human 
tissue lifespan 20-60 days) are associated with acute 
inflammatory responses and granulomas, and are readily 
available from within and around the dermal plexus. In 
addition, the Langerhans cells of the epidermis have many of 
the antigen presenting and surface characteristics of 
macrophages.
The Skin Appendages
The skin appendages (hair follicles, sebaceous, 
apocrine and eccrine glands) can be an important absorption 
pathway during the first few minutes of dermal contact with a 
material, though, for other than large and lipid soluble 
molecules, transepidermal absorption soon becomes more 
prominent.
Hair Follicles
Of principal relevance to this thesis is the pillary 
apparatus containing the compact keratinized hair in its 
follicle. This is generated in cycles; the hair is grown
during the anagen phase, and retained as a dead club hair 
during the subsequent resting or telogen phase.
In the mouse, waves of hair growth sweep posteriorly 
and dorsally every 17-19 days, and it is frequently possible 
to find regions more anteriorly and ventrally which are again 
in the resting phase (Winkelman 1980). This is of importance 
since it has been shown that the activity of enzyme systems 
involved in carcinogen activation, such as that of 3-methyl 
cholanthrene by aryl hydrocarbon hydroxylase, changes during 
the various phases of the hair growth cycle (Manil et al., 
1981). Standardisation of the timing of dosing to coincide 
with telogen phase in all experiments, and the use of young 
mice where the hair cycle is better synchronized than with 
older animals, has been of prime consideration in the studies 
described throughout this thesis.
Follicle activity may be stimulated by plucking, or 
possibly by shaving, the area to be treated. Anagen phase is 
accompanied by an increased mitotic rate, metabo lism and 
vascularity; these are discussed in Chapter 5»
Sebaceous Glands
Usually found in association with the hair follicle, 
the gland has several lobules of aggregates of acini which 
lead into a common excretory duct, the pillary canal, 
composed of stratified squamous epithelium. The acini 
synthesize and accumulate lipid droplets, which together with 
autolysed cells make up the sebum.
Apocrine Glands
These are scent glands, tubular in structure, which 
usually lead to the pilosebaceous follicle. Apocrine 
secretion contains proteins, lipoproteins, reducing sugars
and lipids. Metabolism of the secretion by surface bacteria 
is in part responsible for the scent odour.
Epocrine Glands
These glands are not present in rodent skin. In human 
skin, these glands possess a basal coil from which a duct 
leads through the dermis directly into the epidermis.
Eccrine sweat is a dilute saline solution which also contains 
lactate ion, urea and ammonia; evaporation of water from its 
secretion gives rise to its cooling function.
PHYSIOLOGICAL RESPONSE TO INSULT 
Inflammation
Winkelman (1971) has classified inflammation by host 
condition (eg., genetic-angiodema), by stimulus of direct 
injury (physical, chemical, immunological) or of indirect 
injury (mediator release), and by response (immediate or 
chronic such as persistant activity and healing). The 
stimulus by direct injury is relevant to the irritant states 
produced in this thesis study, however, such inflammatory 
responses have also been ascribed to the release of 
pharmocological mediators which cause a further tissue 
response. Such mediators e.g., histamine, prostaglandins, 
and serotonin are released by enzyme systems such as those 
of kinin, complement, lysosomes, plasmin and coagulation. 
Protein inflammatory mediators such as proteases and 
permeability factors produce vascular permeability, or 
leukocytic migration or both. Ultraviolet light, cold, heat, 
X-irradiation and crush injury of the skin result in early 
Stage I inflammation (histamine, venular, leukocyte 
reactivity) and a later phase II inflammation (delayed kinin,
arteriolar and mononuclear cell type). With reduced stimulus 
only Stage II inflammatory response may occur, Stage I 
requiring greater intensity; this separation has been 
elegantly demonstrated in rodent studies of thermal response 
(Rocha 1960).
H y p er pl asia/in fl ammatio n- Rela tionshi p
For the mouse at least, many kinds of mechanical-, 
chemical-, thermal-, and radiation-induced damage may invoke 
immediate hyperplastic transformation due to a disturbance of 
mechanisms which control tissue homeostasis. This can be 
seen by an increase in mitotic figures of the cells of the 
epidermal basal layer. These cells show greatly enlarged 
nuclei and cytoplasm; in this state the adult skin resembles 
neonatal epidermis. This hyperplastic state can persist for 
a few days during which the stratum corneum can become 
thickened and hyperkeratotic. Accompanying this response are 
inflammatory reactions overtly seen as oedema and/or erythema 
but actually include infiltration of the skin by white blood 
cell types. A more subtle response of epidermal 
hyperproliferation is produced from non-damaging, 
non-irritant external stimuli or internal influences such as 
hormones which do not induce inflammatory reactions (Bertsch 
et al. 1 9 7 6 ;  Furstenberger 1 9 8 2 ) .  This response does not 
show the biochemical changes which accompany hyperplastic 
transformation; namely, induction of epidermal ornithine 
decarboxylase activity from stimulations of polyamino 
synthesis (Boutwell et al. 1979)» and a refractoriness of the 
epidermis to hormones such as prostaglandin E2 (Marks et al. 
1 9 8 1 )  and epidermal G-j chalone (Marks 1 9 7 8 ) .
The Role of Prostaglandin in Hyperplasia
Chemical stimulation such as the topical application 
of the phorbol-ester tumour-promoter phorbol myristate 
acetate, discussed later, causes an increase wi thin minutes 
of prostaglandin E 2 in the epidermis (Marks et al. 1981) and 
increased phospholipase A2 resulting in the liberation of 
arachidonic acid from cellular phospholipids. This in turn 
has been shown to be dependent on the presence of Ca^+ ions 
in the extracellular fluid. While it is known that PMA can 
alter the cellular retention of Ca^+ (Schimmel 1980), efflux 
of this Ca2+ into the cytoplasm upon stimulation, has not yet 
been observed (Marks et al. 1983); rather, a local 
rearrangement of Ca^+ within the plasma seems to occur.
The inhibition of this initial prostaglandin E2 
increase achieved by cyclo-oxygenase inhibitors, inhibits 
epidermal hyperplasia. Thus, hyperplastic responses are 
differentiated from inflammatory reactions which do not 
respond to these inhibitors and, therefore, are not mediated 
through prostaglandin E2 • However, a common mediator of both 
responses may be arachidonic acid. Marks et al. (1981) have 
shown that both hyperplastic growth and inflammation are 
inhibited by 5,8,11,14-eicosatetraynoic acid (ETYA) which 
blocks both the cyclo-oxygenase and the lipoxygenase pathways 
of arachidonic acid metabolism.
The Role of Cell Types in Inflammation
During the development of local acute non-specific 
inflammatory reactions, the function of various cell types 
such as macrophages and lymphocytes, which may be distant 
from the inflammatory foci, are affected by the rapid 
liberation of low molecular weight phlogokins which are
distinct from lymphokines, monokines and other mediators of 
inflammation (Giroud et al. 1983)* The resultant macrophage 
response includes increased phagocytic activity and 
inhibition of tumour cell proliferation. Both aspects 
involve an increase in superoxide which may also cause the 
premature death of the macrophages. Death of the macrophages 
and concomitant or subsequent release of hydrolytic enzymes 
and chemotactic factors play major roles in the perpetuation 
of the inflammatory response (Slaga et al. 1975)* The 
protective function of catalase and superoxide dismutase, and 
their use in the measurement of superoxide and other oxygen 
degradation products, are discussed in Chapter 2.
PETROCHEMICAL AND PETROLEUM DERIVED MATERIALS 
Material Description
Individual hydrocarbons are used in industry and 
commerce, but the petroleum-derived hydrocarbons encountered 
in petroleum refinery operations and products are complex 
mixtures which may contain hundreds of hydrocarbons in 
concentrations which vary on a daily basis depending on 
refinery treatment and crude source. These hydrocarbons 
belong to three main classes, aliphatic, alicyclic and 
aromatic, various ratios of which are to be found in the 
range of refined petroleum products which includes gasoline, 
kerosine, jet fuels, petroleum ether, white spirits, 
home-heating oil, diesel oil etc. (Figure 3). The lighter 
boiling aliphatic hydrocarbons to be considered here, are the 
predominent components of gasolines and low aromatic 
hydrocarbon solvents (Table 1).
TABLE 1
COMPOSITION (%) OP TYPICAL SOLVENTS
"HEXANE" WHITE SPIRIT
(63/70 °C) (130/200°C)
n-PARAFFINIC HYDROCARBONS 50 20
ISOPARAFFINIC HYDROCARBONS 35 32
NAPHTHENIC HYDROCARBONS 12 32
AROMATIC HYDROCARBONS 3 16
Crude
Oil
Fuel
Gas
C 3 /C4
Gasoline
Naphtha
Stabilizer
Powerformer
Aromatics
>  Copper 
Sweetener
Jet Fuel
Edeleanu
Process Kerosine
White
SpiritHydrofiner
^ Hydrofiner Diesel
Sulphur 
.Plant__
Sulphur
Heavy Gas Oil
Alkene Feedstocks
- — Cat •
- 1 Cracker
Lube Oil 
Complex
540°C+
> Fuel Oil
> Bitumen
Some Petroleum Processes and Refined Products
Alkane Toxicity
Certain alkanes have been associated with tumour 
promoting activity and involve skin contact in normal usage, 
the alkane series was therefore selected for investigation of 
early changes in the skin following topical application.
There is a limited amount of information available 
concerning the skin absorption of. n-alkanes. Skin irritation 
from prolonged and repeated contact, and the ability to 
remove the skin lipids are important factors in the 
absorption of these paraffinic hydrocarbons (Bird et a l . 
1984).
In such circumstances the percutaneous absorption can 
be rapid as shown by Kronevi et al. (1979) for n-hexane, 
where a number of the conditions for high skin absorption 
would be in effect i.e. lipid-and water-soluble properties 
about equivalent, skin irritation and/or barrier disruption, 
skin lipid removal, and occlusion (Bird 1981).
As is typical for most other hydrocarbons, the alkanes 
(Cg-C^g) produce local epidermal epiplasia and hyperkeratosis 
when applied repeatedly to the skin (Brooks and Baumann 
1956). These authors applied saturated hydrocarbons (Cg-C-jg) 
and the corresponding mono-unsaturated hydrocarbons on three 
occasions over a five day period. Virtually all members of 
the series produced hyperplasia and irritation with a maximum 
effect for carbon chain length of 14« Similar effects were 
seen by Scala and Burtis (1975) with an homologous series of 
branched chain alcohols (Cg-C-jg) where maximum irritation was 
shown to be at Cg (rat skin), and by Stillman (1975) with 
saturated Cg to fatty acids which produced a. peak
activity at C ^^  (human skin).
Brooks and Bauman (1956) also studied the dissolution 
of the skin sterol, A^-cholesterol from the sebaceous glands. 
These authors showed evidence that A^-cholesterol is normally 
concentrated in the sebaceous glands (and is not present in 
the skin of newborn rats and mice as these lack sebaceous 
glands). They then used the disappearance of A^-cholesterol 
from the epidermis as a marker for destructive effects of 
hydrocarbons on the glandular structures. The saturated 
alkanes and longer chain mono-unsaturated alkanes produced no 
loss of A^-cholesterol, leaving the follicular structures and 
dermis unchanged. The remaining smaller chain-length alkanes 
and certain alkylaromatics, applied in acetone, produced 
increases in epidermal and dermal weights, and sebaceous 
gland destruction. By comparison, the carcinogen 3-methyl- 
cholanthrene in mineral oil only affected the follicular 
structures, an effect which is likely to be caused by the 
mineral oil restricting penetration to the appendages.
Kirk and Hoekstra (1964) studied hexadecane applied to 
guinea pig skin, and found cellular hypertrophy, marked 
increases in epidermal mitotic activity, and marked 
hyperkeratinization of the stratum corneum. In a subsequent 
follow up study of the observed decrease in epidermal water 
content and water-binding potential, they found that the 
treated epidermis had decreased concentrations of 
non-essential amino acids, urea and ammonia. This possibly 
indicated an increased rate of metabolism in the 
hyperkerato tic epidermis and is considered further in the 
discussion of drug-metabolizing enzymes (Chapter 5).
I n a n o t h e r  study, Hoekstra & Phillips (1963) by 
repeated administration of a series of alkanes series on
alternate days to guinea pig skin showed that all paraffins 
from C-J2 ^18 produced marked skin damage, marked 
hyperplasia, hyperkeratosis and depilation. The shorter 
chain (Cy) hydrocarbon produced no such changes; this may be 
because of the high volatility, since a single, occluded 
application of n-hexane to guinea pig skin produced, within 
15 minutes, nuclear degeneration, junctional separation of 
basal cells from basement membranes, and inflammatory cell 
infiltration (Kronevi, et al. 1 9 7 9)-
Hoekstra & Phillips (1 9 6 5) also showed that 
intermediate size (C-jg) paraffins produced the maximal effect 
a n d , as boiling point and molecular weight increased, the 
potency was diminished rapidly at about n-eicosane (C2o)» a 
similar transition point also applies for the other usual 
solvent components for example, the isoparaffins. The 
limitation in response is likely to be due to the inability 
of the higher molecular weight hydrocarbons to penetrate the 
skin. Paraffins with an odd number of carbon atoms caused 
equivalent effects to those with an even number of carbon 
atoms. There was no difference in response found between a 
saturated structure and an unsaturated structure of the same 
carbon-chain length.
Tumour Promotion By Alkanes
Mottram (1944) and Berenblum and Shubik (1 9 4 7 , 1 9 4 9 ) 
proposed a two-stage mechanism for carcinogenesis. It is now 
generally accepted that "initiation" brings about some form 
of irreversible cellular change which at a subthreshold dose 
of a carcinogen remains latent until it is subsequently 
expressed by repeated exposure to a "promoting agent" (or a
complete carcinogen). By definition, a tumour promoter is 
not tumourigenic per s e .
SicA (1966) showed that repeated applications of 
n-dodecane promoted skin tumours in mice that had received an 
initiating dose of 7,1 2-dimethylbenz[a]anthracene; dodecane 
alone without preliminary initiating treatment is inactive 
(Horton et al. 1957). SicA also reported that tetradecane 
and decanol had similar promoting activity, and that weak 
activity was characteristic of decane, dodecanol and probably 
hexadecane* octadecane, eicosane, octanol, tetradecanol, and 
octadecanol. Hexanol, n-hexane and n-octane were without 
promoting activity. The promoting activity of dodecane has 
also been reported previously (Sic£, 1957; and Holsti, 1959)* 
The activity seen was considerably less than that of 
croton oil extracts (containing phorbol esters) tested 
previously under the same test method and protocol (Gilbert 
and Sic& 1960). The tumour-promoting activity of the alkanes 
does not appear to relate directly to the hyperplastic and 
cholesterol induced increases reported by Brooks and Baumann 
(1 966), activity being maximal with tetradecane (C-j^) and 
greatly diminished with eicosane (C2o)*
Although the potency of the n-alkanes and n-alkanols 
is considerably less than croton oil extracts (containing 
phorbol esters) tested under the same test method (Gilbert 
and SicA, 1960), their activity is of interest from the 
occupational viewpoint and also as they are normal components 
of certain mammalian tissue or secretions. They are 
constituents of human sebum (Hicolaides and Foster 1956), and 
the higher n-alkanes (C-i q- C ^ )  have been recovered from human
meninges, human urine, human and bovine heart, and mouse 
brain (Darriet et al. 1948).
The term tumour promoter is restricted to a substance 
which on subsequent application(s) causes the expression of 
more tumours and/or a shorter latency than occurs by prior 
application(s) of carcinogen or initiator alone. Tumour 
promoting activity is not expressed if the order of 
application is reversed, (Tahle 2).
Horton et a l . (1957) used the term "accelerant" to 
describe the activity of certain alkanes and alkyl benzenes, 
as their experiments showed that preconditioning of mouse 
skin with application(s) of, for example, dodecane, rendered 
it much more responsive to subsequent applications of a 
carcinogenic oil, particularly if the oil itself contained 
accelerating components. It should be noted that all the 
accelerants tested in this way were primary irritants. As 
will be seen in subsequent chapters the induced irritant 
state may be responsible for the preconditioning "accelerant" 
properties of materials such as dodecane; the tumour 
"promoting" activity only being experienced on combined 
application, such as in the above case.
Horton et al. (1957) also made the important 
observation that following application of a carcinogen, the 
average number of applications of the active alkane required 
before papillomas appeared was independent of the frequency 
of applications, but was dependent on the total dose applied. 
Finally, they stated that this activity is associated with 
solvent molecules of minimum carbon chain length 
corresponding to n-nonane; the activity rising sharply as the 
carbon chain length increased from C 3 to C^q* As will be
I
TABLE 2
SOME CHARACTERISTICS OF INITIATORS
1. carcinogenic by themselves
2 . single exposure is sufficient
3 . action is irreversible and additive
4 . must be given before the promoting agent
CANCER INDUCTION - A MULTISTEP PROCFSS 
Initiation + Promotion — » Cancer
1 ' v - ' ' '  I
Genetic Epigenetic
Effects Effects
(irreversible) (r ev er s ib l e)
SOME CHARACTERISTICS OF PROMOTERS
1 . not carcinogenic by themselves - -
2 . multiple prolonged exposures are required
3 . action is reversible at early stages and not 
during early stages
4 . must be given after the initiating agent
additive
seen later (Chapter 3), activity may in fact be associated 
with a carbon chain length of less than the stated (Cg) 
minimum.
Confusion of terms is prevalent in the literature and 
there are reports (Van Duuren and B. M. Goldschmidt, 1976) of 
the cocarcinogenic activity and tumour-promoting properties 
of certain alkanes, decane, undecane, and tetradecane. These 
authors define the term cocarcinogen as a material causing 
the enhanced tumourigenicity by the simultaneous and repeated 
application of the material together with low doses of a 
carcinogen. This is in contrast to the enhanced 
tumourigenicity only experienced when the material is applied 
subsequently to a carcinogen, which is characteristic of a 
tumour-promoter. By this definition, the alkanes, decane, 
undecane, and tetradecane which they tested, showed 
cocarcinogenic and tumour promoting properties.
FREE RADICAL MECHANISMS 
Auto-oxidation And Carcinogenesis
Many carcinogens including ionizing radiation, 
ultraviolet light, adriamycin, 3 ,4-benzpyrene, 7 ,12-dimethyl- 
benzanthracene, lipid peroxides, malondialdehyde, N-hydroxy- 
N-acetylaminofluorene, and the tumour-promoting phorbol 
esters, are either converted to free radicals .in v i v o , 
stimulate the production of free radicals, or are products of 
biological free radical reactions (Demopoulos et al. 1980). 
Antioxidants and free radical scavengers, such as BHT 
(butylated hydroxy-toluene) and ethoxyquin have been shown to 
inhibit the actions of many carcinogens (Wattenberg 1980). 
Trotter (1980) proposed that the mechanism of chemical
carcinogenesis may involve the generation of free radicals as 
well as the formation of DNA complexes. A property of 
several carcinogens is the facility with which they can 
develop free radical centres, for example, the polycyclic 
aromatic hydrocarbons, 3 »4-benzpyrene and benzanthracene, are 
metabolically activated to form epoxides and epoxide diols, 
which have stable radical structures. These intermediates 
are not only mutagenic and capable of alkylating DNA, but 
contain oxygen in a sterically hindered or bay region 
position . (Parke and Ioannides 1 982). These reactive 
intermediates appear to be formed only by cytochrome P448, 
and not cytochrome P450, as will be discussed subsequently in 
Chapter 5« Many carcinogens provide an in vivo redox cycle, 
shunting electrons from the electron transport chains of the 
endoplasmic reticulum and mitochondria to molecular oxygen. 
The resultant catalytic production of O2 and H2 0 2 » and thence 
lipid peroxidation, causes disturbance in membrane structure 
and function as seen by the destruction of glucose-6- 
phosphatase, cytochrome P-450, and the influence on cell 
division and dedifferentiation (Parke 1982).
The endogenous antioxidant system proximal to the 
endoplasmic reticulum controls many of the free radical 
mediated activations; such defence systems include the 
antioxidants and radical scavengers, ascorbic acid, 
superoxide dismutase, catalase, glutathione peroxidase, and 
retinoids. However, depletion of these defence reserves, 
such as occurs in chronic cellular toxicity, will allow free 
radical mediated damage, and associated disease, to occur.
The interaction of reactive oxygen species with the 
purine and pyrimidine bases and deoxyribose of DNA, causes
covalent bond breakage and strand scission (Schulte-Frohline, 
1983). Molecular oxygen can react with oxidant-damaged sites 
in DNA to form non-repairable peroxides. The clastogenic 
activity seen in Bloom syndrome fibroblast cultures and 
Fanconi anaemia cultured lymphocytes is believed to be due to 
a deficiency in the detoxication of active oxygen species 
(Emerit & Cerutti 1981; and Joenze et al. 1981).
OXYGEN REDUCTION PRODUCTS AND TUMOUR PROMOTION
There are three main lines of experimental evidence to 
support the concept that oxygen radicals are involved in 
tumour promotion.
1) A variety of chemicals, including known tumour
promoters, can cause a pro-oxidant state by either 
directly causing the production of oxy radicals, 
such as the interaction to be described between 
phorbol 12-myristate 13-acetate (Figure 4) and 
polymorphonuclear leukocytes (PMNs) or indirectly by 
disrupting the homeostasis that normally exists 
between the rate of cellular radical generation and 
the rate of radical dissipation. This imbalance, if 
it overwhelms defence and repair mechanisms, can 
lead to cellular injury and death (Kensler and Trush 
1984). Classes of tumour promoters that may act 
through an oxidant mechanism are listed in Table 3« 
It is the purpose of the studies covered by this 
thesis research to investigate whether the tumour 
promoting properties of n-alkanes and of 
irritation/abrasion also involve an oxidant 
mechanism.
PHORBOL MYRiSTATE ACETATE
' CH_OH
OH
CH.
OH
CHOCOCH.
OCO(CH_),_CH
Nomenclature
Two systems of nomenclature are in common usage in the scientific 
literature for the derivatives of phorbol of (by IVPAC rules) l,laet ,lb£* ,
4a,7a o < . ,8,9,9a-decahydro-4,7b«<. ,9aot -tetrahydroxy-3-(hydroxymethyl)- 
1,1,6,8 -tetramethyl-5H-cyclopropa[3,4]benz(1.2-c)azulen-5-one. Related
compounds are normally named as derivatives of phorbol. In the older, 
still widely used system (and as used here in this thesis) , the names and 
positions of the substituents together with the designation of the positions 
of the substituted hydroxyl groups follow phorbol, which thus gives phorbol 12- 
myristate 13-acetate (PMA), phorbol 12-didecanoate 13-acetate (PdA) etc. The 
alternative system eliminates trivial names for .the substituents and 
designates 12-0 ester group before phorbol, thus PMA would be called by its 
other common name 12-0-tetradecanoylphorbol-13-acetate (TPA). This becomes 
unnecessarily complicated when describing phorbol 12,13,20-triacetate (PTA) 
which would become 12-0-acetyphorbol-13,20-diacetate, and hence the former 
system of nomenclature has been adopted here.
TABLE 3
SOME TUMOUR PROMOTING AGENTS THAT MAY ACT THROUGH AN OXIDANT
MECHANISM
Reactive oxygen-generating agents: peroxidases, anthralin
Membrane active agents: phorbol esters, indole alkaloids
Peroxisome proliferators: hypolipidemic drugs 
Mixed function oxidase inducers: phenobarbital, DDT 
Hyperoxia 
UV radiation
Modified from Kensler and -Trush (X 984)
Most experimental observations linking oxygen 
free-radicals to tumour promotion are derived from 
studies of phorbol esters on the mouse skin. 
Structure-activity studies comparing the tumour 
promoting activity of phorbol ester analogues with 
their ability to stimulate active oxygen metabolism, 
and monitored by 0]> production and chemilumine- 
scence, show a strong correlation between radical 
production and tumour promotion; PMA is the most 
active, phorbol diacetate shows virtually no 
activity. (Goldstein et al., 1981; 1984; Kensler 
and Trush, 1981).
Active phorbol esters interact with membranes of 
inflammatory cells, such as leukocytes and 
macrophages, causing stimulation of oxygen 
metabolism. This is evidenced by increased oxygen 
consumption, increased glucose oxidation increased 
generation of O'? and H 2O 2 , chemiluminescence, and an 
enhanced capacity to reduce nitroblue tetrazolium 
dye (Goldstein et a l . 1975)* The superoxide anion, 
§2t can be generated enzymically; this is thought to 
be the case with phorbol ester, interaction 
occurring through activation of the NADP-dependent 
oxidase system (Briggs 1975) and is inhibited by 
compounds which have the ability to antagonise the 
effects of proteolytic enzymes (Goldstein et al.
1979)* Generation can also be photochemical or 
radiochemical in origin. The O'? can act as a 
precursor to more potent radicals such as the 
hydroxyl radical OH and singlet oxygen, and hydrogen
peroxide (H2O2 ) as shown in Table 4» These radicals 
have been shown to peroxidize lipids, depolymerize 
polysaccharides, alter enzyme activity and break DNA 
strands; the oxygen reduction products can deplete 
catalase and superoxide dismutase which are part of 
the cells' defence against free radical toxicity 
(Kono and Fridovich 1982; Solanki 1981) by the 
mechanisms indicated in Table 5.
Oxygen Reduction Products And Inflammation
Various studies have demonstrated that diffusable 
oxygen species act as mediators of inflammatory cell-induced 
genotoxicity. Goldstein et al. (1983) proposed that the 
reactive oxygen species and H 2O2 are formed _in vivo in mouse 
skin from PMA stimulation of infiltrating inflammatory cells. 
While inflammatory cells may provide a major contribution, 
the epidermal cells themselves can produce free radicals, as 
shown by the work of Fischer and Adams (1984) who 
demonstrated, by means of chemiluminescence, the generation 
of oxygen radicals from mouse epidermal cells to which PMA 
was added i_n vi tro, and is also indicated by the results of 
the ill vivo/in vitro explant studies to be described in 
Chapter 4«
Normally, free radicals are also formed within the 
cell, for example by NADPH-dependent lipid peroxidation; 
oxidants or metabolites which are oxidants, can accelerate 
this process. Some chemicals, for example carbon 
tetrachloride, form other reactive radicals during metabolism 
which initiate propagating chain reactions such as by their 
interaction with tissue oxygen. Again, the free radicals 
themselves may cause a mutagenic response (Weitzman and
TABLE 4
TOMOUR PROMOTION BY FREE RADICAL GENERATING COMPOUNDS
TUMOUR PROMOTORS
CHEMICAL
GENERATION
ACTIVATION OF 
CELLULAR SOURCES
REACTIVE OXYGEN SPECIES
O2 + e"
02t + 02t + 2H+ 
Fe5+ + 02t 
Fe2+ + H 202
° 2 ”
Hp O2 + O2 
02 + Fe2+
•OH + OH" + Fe3+
INTERACTIONS WITH BIOMOLECULESI I
LIPID PEROXIDATION
DNA ENZYME ACTIVATION
DAMAGE/REPAIR INACTIVATION
From Kensler & Trush (1984)
TABLE 5
MECHANISMS OF ENZYMIC SCAVENGING OF REACTIVE OXYGEN
INTERMEDIATES
SOD
O2 + O2 ) H 2 O2  + O2
Catalases
H 2 O 2  + H 2 O 2  -   "• •') 2 H 2 O  + O 2
Peroxidases
H202 + RH2  > 2H20 + R
Stossel 1981; Weitberg 1983), and also toxicity (Parke 1981). 
The latter is mediated through disturbance of lipid 
peroxidation which can lead to disruption of cellular 
membranes and cell death.
Phagocytic cells are capable of chemotaxis and 
congregate at the site of injury or infection. The Oj 
produced by the activated phagocytes to which would 
facilitate killing of engulfed bacteria, can exacerbrate the 
inflammatory process. It has been shown that O'? can convert 
a normal plasma component, arachidonate, into a neutrophil 
chemotactin (Petrone 1980) attracting more neutrophils into 
the area to counter the original cause of O'? stimulated 
release; these polymorphonuclear neutrophils may in turn 
become activated generating further reactive oxygen species. 
Macrophage Deficiencies/Animal Models
Several diseases of mononuclear phagocytes have been 
characterised. These include microbiocidal defects 
associated with increased susceptibility to infection (as in 
chronic granulomatous disease occuring primarily in children 
with an X-linked trait), enzyme defects leading to storage 
diseases such as Gaucher's (deficiency of the enzyme 
glucocerebrosidase), and neoplastic diseases.
Neutrophils from patients with chronic granulomatous 
disease are deficient in the primary oxidative and secondary 
peroxidative responses to phagocytosis, and consequently have 
an impaired ability to generate superoxide ions and hydrogen 
peroxide; this causes these patients to have a marked 
infectious diathesis (Schlegel 1975)* In myeloperoxidase 
deficient neutrophils there is a normal oxidative ability but 
an impaired peroxidative ability. In another state,
Chediak-Higashi Syndrome, there is impaired bactericidal and 
fungicidal activity. This is due to faulty degranulation 
(resulting in lack of discharge of lysomal contents onto the 
surface of the microbe) and migratory defect of the 
polymorphonuclear leukocytes. Although polymorphonuclear 
leukocytes from different animal species show remarkable 
variations in composition and function so that caution is 
needed in evaluating an effect modeled in another species, 
there does exist another species with the congenital 
Chediak-Higashi syndrome (Oliver et al. 1978); this is the 
beige mouse, a derivative of the C57 Black.
Unfortunately, no such animal model exists for chronic 
granulomatous disease which would otherwise have provided a 
research tool to examine the exact role of phagocytic 
generation of 0£ in tumour promotion. The impaired ability 
of the polymorphonuclear leukocytes to generate superoxide 
and hydrogen peroxide would allow the contribution to be 
assessed of other cell types to the generation of reactive 
oxygen and hydrogen peroxide in this animal model when 
compared to a normal strain or species.
FREE RADICALS IN DISEASE STATES 
Malignancy
A number of studies have implicated polymorphonuclear 
leukocytes in the destruction of tumour cells. Macrophages 
can be activated to selectively and efficiently kill 
neoplastic cells. Activated murine macrophages selectively 
bind to tumour cells and secrete multiple lytic effector 
substances including cytolytic factor. One of the same 
antimicrobial systems - myeloperoxidase is involved in the
cytotoxicity of normal and tumourigenic cells. These 
cytotoxic effects are mediated by the extracellular secretion 
of myeloperoxidase and hydrogen peroxide. This occurs when 
the polymorphonuclear leukocytes are activated, as previously 
mentioned, by phorbol esters,but also by exposure to 
phagocytic particles, immune reactant-coated surfaces, or 
soluble agents such complement fragments and lectins.
The cytotoxicity of myeloperoxidase and hydrogen 
peroxide requires the participation of an oxidisable 
cofactor,, most often a halide, to generate reactive oxidants 
that damage the target cells (Clark and Szot 1981). There 
are doubtless other mechanisms, since antibody-dependent 
cellular cytotoxicity by polymorphonuclear neutrophils has 
been shown to be dependent on oxygen radicals under some 
conditions but apparently not dependent on myeloperoxidase 
(Clark and Klebanoff 1979)• Others (Nathan, et al. 1979)» 
have shown that PMA-activated mouse peritoneal granulocytes 
killed tumour target cells by secretion of hydrogen peroxide 
which acted independently of a peroxidase.
If hydrogen peroxide and oxygen species are involved 
in the above process, it has been hypothesized that the 
tumour target cell may use protective biochemical mechanisms; 
the oxidation-reduction cycle of glutathione is one such 
protective pathway against oxidative injury. The anticancer 
activity of 1 ,3-bis-(2-chloroethyl)-1-nitrosourea may be due 
to its removal of this protective ability, by its inhibition 
of glutathione reductase (Nathan et al. 1982).
Degenerative Joint Diseases
The release of ()£ from polymorphonuclear neutrophils 
(PMNs) has also been implicated in degenerative joint
disease. It is presumed that polyarthritis, osteoarthritis 
and hypoxia initiate inflammation in the joints. The fall in 
oxygen tension in rheumatoid arthritic joints leads to the 
release of lysosomal enzymes from the accummulated PMNs. The 
resultant cell debris causes further infiltration of PMNs 
which by their phagocytic action release (}£ and other oxygen 
derived radicals. These will cause the death of some PMNs, 
reinforcing the release of further lysosomal enzymes which 
can destroy bone and cartilage (Lund-Olesen 1982). In 
addition,, it has been shown that enzymically-generated O2 can 
depolymerize hyaluronate, a substance that provides viscosity 
and lubricating properties to the synovial fluid (McCord 
1974).
Psoriasis
Psoriasis is characterised by a hyperproliferative 
epidermis, elongated dermal papillae and an accumulation of 
PMNs in the parakeratotic stratum corneum. Wahba et al. 
(1978) have reported increased chemotaxis and phagocytosis by 
PMNs from patients with psoriasis. Sedgwick et al. (1982) 
describe significant alterations in the appearance of 
peripheral blood PMNs from psoriasis patients when compared 
with PMNs from normal control subjects. Other evidence which 
points to the participation of granulocytes and monocytes in 
the pathogenesis of the disease is the finding that monocytes 
and PMNs in psoriatic patients had a higher "respiratory 
burst activity" (as seen by chemiluminiscence) than normal 
subjects (Schopf et al. 1982). The term "respiratory burst" 
is used to describe increased oxygen uptake, production of 
oxygen reactive products and hydrogen peroxide and an 
activation of the hexose monophosphate shunt.
Increased hexose monophophate shunt activity (Holzmann 
and Morshes 1970), decreased cyclic nucleotide c-AMP 
(Geerdink et al. 1980), and elevated protease levels 
correlate well with the above psooriatic enhanced state. 
Geerdink et al. (1984) rule out the concept of an intrinsic 
abnormality of the psoriatic phagocyte; instead, proteases 
have been shown to activate PMNs resulting in the increased 
respiratory burst. Protease inhibitors have been reported to 
antagonize activation of PMNs (Goldstein et al. 1979). 
Finally, chemotactic factors have been isolated from 
psoriatic scales (Lindroos and Nelson 1978); these factors 
may act not only locally, but may also diffuse from the 
cutaneous lesion to produce a more generalized effect on the 
function of PMNs.
Central Nervous System Ischemia And Trauma
Ischemic or traumatic injuries to the brain or spinal 
cord often result in greater tissue damage than the 
equivalent insult to other organs and this is thought to be 
the result of proliferating free radical reactions initiated 
by oxygen species (Demopoulos et al. 1982). The brain and 
spinal cord contain cells rich with extensive membranes - the 
lipids of which can be readily attacked by free radicals 
unless protective enzymes are present. Because of the 
demands for ATP, neuronal cells are replete with components 
of electron transport and oxidative phosphorylation such as 
the ubiquinones (coenzyme Q). Ubisemiquinones readily 
autoxidise, generating reactive oxygen products.
As a defence, brain tissue contains high 
concentrations (10-fold higher than plasma levels) of the 
antioxidant ascorbic acid. However, in the presence of
copper or iron released by extravasation of blood in ischemia 
or trauma, ascorbic acid produces large quantities of 0£ and 
H2O2 . Superoxide and other radicals have the potential to 
initiate membrane free radical pathology, to inhibit both 
prostacyclin formation and adenylate cyclase activity which, 
as a result of inhibition of the latter, can lead to blood 
coagulation by platelet aggregation and muscle spasm 
respectively (Demopoulos et al. 1980).
SECONDARY PATHOLOGY AND FREE RADICALS 
Chronic Inflammation - A Precursor
Cancer or other diseases often develop at sites of 
ongoing inflammation or even chronic ulceration as has been 
described in the preceding section. In the instances cited, 
chronic inflammation is a requisite step in the development 
of the disease condition at a particular site. Chronic free 
radical pathology can cause depletion of protective 
antioxidants and such depletion has been associated with the 
heightened cancer risks seen with ulcerative colitis and 
fibrocystic disease of the breast.
Certain agents may only cause a carcinogenic response 
after first causing extensive ulceration or cellular 
inflammation. Formaldehyde.causes squamous cell carcinomas 
in nasal cavity of rodents but only at doses that result in 
extensive mucosal ulceration and acute rhinitis (Svenberg 
1980). Studies show no evidence of nasal cancer in humans 
from occupational use of formaldehyde where repeated severe 
irritation would not be tolerated. The fact that a 
carcinogenic or toxic response is consequent to "secondary 
pathology" or "metabolic overload" should be considered in
the estimation of the potential hazard to man of such 
chemicals.
HYPOTHESES TESTED IN THIS THESIS
The following hypotheses have been examined in 
subsequent chapters:
1) the extent to which the mouse skin tumour promoter, 
phorbol 12-myristate 13-acetate, produces free 
radicals and/or active oxygen jln vivo in the mouse 
skin, is determined by the presence of inflammatory 
cells.
2 ) abrasion, which is known to be tumour promoting, 
causes free radical and/or active oxygen generation 
in the mouse skin _in v i v o , as determined by H2 O2 
formation.
3 ) n-alkane tumour promoters stimulate production of 
reactive oxygen products, and therefore may be 
grouped with those agents with tumour-promoting 
activity mediated through reactive oxygen (Table 3)*
4 ) n-alkanes currently not considered to be tumour 
promoters cause free radical and/or active oxygen 
generation in the presence of inflammatory cells.
5 ) the increased catalase activity seen with skin 
treated in. vivo with PMA and subsequently cultured, 
is due to the non-physiological concentration of 
oxygen used during incubation.
6 ) reactive oxygen generated by stimulation of 
phagocytes may increase mixed function oxidase 
activity.
In this thesis, data are presented to indicate that 
the skin tumour-promoting properties of certain alkanes are 
latent unless an inflammatory response is present, either 
from the irritant properties of the alkane itself or from 
some other irritant treatment. As with abrasion, this 
irritation causes migration of polymorphonuclear leukocytes 
into the area which, in combination with the alkane or an 
alkane metabolite, results in stimulated free radical 
generation. It is further suggested that decane, dodecane, 
and abrasion all produce stimulation of 0£ production (mostly 
from polymorphonuclear leukocytes (PMNs) and other 
inflammatory cells) but lack some other property of the Type 
1 promoters, such as phorbol myristate acetate, to show 
complete tumour promotion.
Hyperplastic transformation alone (as seen by single 
application of alkanes) is insufficient to cause inflammation 
with infiltration. Substances that only produce hyperplasia 
e.g. ethylphenyl propionate, do not have tumour-promoting 
properties nor cause free radical generation in the mouse 
skin. Repeated application of the irritating alkanes 
studied, or abrasion, all cause the infiltration of 
inflammatory cells and increased H 2O2 (and free radical) 
formation in the mouse skin.
As the increased hydrogen peroxide and free radical 
formation of phorbol myristate acetate-stimulated PMNs in in 
vitro suspension results in increased oxygen consumption, and 
as PMNs have been associated with a similar stimulatory 
response in the intact skin, a model system has been 
developed which utilized oxygen consumption as a measure of 
inflammatory cell infiltration (Chapter 6 ).
CHAPTER 2
MEASUREMENT OF REACTIVE OXYGEN SPECIES
INTRODUCTION
In the preceding chapter it was indicated that O2 and 
H2O2 are either secreted by phagocytic cells or escape from 
them, causing injury. Further, singlet oxygen and *0H can be 
generated from O2” by dismutation of superoxide such as:
2H+ + 202” — > 102 ’ + H202
O2" + *0H *— > H0“ + ^02 (Koppenol and Butler 1979)
and by the Haber - Weiss reaction, particularly if catalysed 
by metal ions:
02“ + H2O2 — > #0H + 0H“ + O2 (Fridovich 1 975)
Singh (1978) lists a further 50 different interconversions of 
oxygen species and their generation.
These interconyersions, the short half lives of the 
oxygen species in aqueous solutions (Nilsson and Kearns 
1973)» and the presence of interfering substances in the 
biological milieu, makes quantitative measurement of these 
species difficult. The methodologies often currently used to 
measure superoxide generation in biological systems involve 
the oxidation, reduction or binding of superoxide with an 
indicator to form a stable product. Some of the methods for 
quantitating superoxide are listed in Table 6 . As can be 
seen from the rate constants listed, there is marked 
difference between the various methods. Some of this can be 
accounted for by interference. For instance, the cytochrome 
C reduction method is inhibited by ascorbate and thiols, and 
by cytochrome oxidase. For the epinephrine method involving 
the reduction of the quinone by superoxide to the 
semiquinone, endogenous NADPH - cytochrome C reductase causes
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this same reduction step, thus resulting in an over estima­
tion of the amount of superoxide generated (Aust et al., 
1972).
Another method, the Hitroblue Tetrazolium (NBT) 
reduction to formazan is not only caused by NADPH - cyto­
chrome c reductase, but the free radical intermediate, in the 
presence of oxygen, generates superoxide which also reduces 
NBT (Auclair et al., 1978). The OXANOH method 
(2-ethyl-1-hydroxy-2 , 5 , 5 trimethyl-3-oxazolidine) is not 
inhibited by thiols or NADPH-cytochrome P450 reductase nor 
subject to turbidity, a problem occurring with methods using 
electron paramagnetic resonance; however, it suffers from 
perturbation by metal ions (overcome to some extent by the 
use of chelators) and from the effects of pH gradients. The 
cytochrome c reduction method is the most efficient of those 
covered above in detecting superoxide (Rosen et al., 1982), 
and, by use of acetylated ferricytochrome c, avoids the 
complicating presence of cytochrome c reductases or oxidases 
(Azzi et a l . 1 975)•
There are indirect methods which have been used 
successfully such as the use of fluorescence to detect 
aminoiminopropene derivatives of malonaldehyde as an index of 
free radical enhanced lipid peroxidation (Goldstein et al.,
1980). Other methods used here, utilize the interaction of 
endogenous catalase with hydrogen peroxide; the hydrogen 
peroxide dependent inhibition of catalase by 3-amino-1 , 2 , 
4-triazole (ATZ) is described in the next section.
THE PEROXIDE/CATALASE/AMINOTRIAZOLE MODEL
Aminotriazole has been used specifically to measure 
H 2O2 in studies carried out both ill vivo and i_n vi t ro. Cohen 
and Hochstein (1965) demonstrated H2O2 formation with this 
method in erythrocytes iii vivo after treatment with 
haemolytic drugs, and H 2O2 secretion iii vitro by Mycoplasma 
pneumoniae (Cohen and Somerson 1969)* The reaction sequence 
is shown in equations [1] and [2 ]:
[1] Catalase + H2O2 -- * [catalase - H2O2 ] compound I
[2 ] Compound I (in excess) + aminotriazole -— >
irreversibly inhibited catalase complex 2 + excess Compound I
Procedure For Determination Of Tissue Hydrogen Peroxide
The main sequence of reactions occurring in the assay 
procedure used to determine hydrogen peroxide formed in the 
skin is illustrated below, where C0 is the initial 
concentration of catalase in the skin:
catalase (C0)
1
PMA t0 s  ^H2C>2 (°x) + catalase (Cx )
ATZ to skin ^TZ + H2O2 (Cx ) + catalase (Cx ) > Complex 2
T
Added H2O2 to homogenate H2O2 + catalase (C0 - Cx )
 ^ ---
H20 + V 2O2
Amount of HpOp produced in skin (C-,r)o< — L------- ■ ..
residual catalase (Cc - Cx )
Amount of HpOp produced in skin (Cx )o^________ , ^--------------;—
rate (extent) of decomposi­
tion of added H9 O?
In the case of the above irreversibly inhibited 
catalase complex 2, the aminotriazole has reacted with the 
[catalase-H202] Compound I and all the aminotriazole is 
firmly affixed to the enzyme protein (Cohen and Hochstein 
1964)* The residual catalase activity reacts with added 
hydrogen peroxide
The rate or extent of the decomposition of the added 
H2O 2 is proportional to the residual catalase (C0 - Cx ) which 
is inversely related to the amount of H 2O 2 produced in the 
skin. Thus, measurement of residual catalase activity in 
this assay inversely determines the amount of H 2O2 produced 
in the skin.
The aminotriazole is not present in excess since, as 
described later (Materials and Dose Selection), further 
increments of aminotriazole caused reductions in catalase 
activity. Since aminotriazole is only present as a terniary 
and irreversible complex, free aminotriazole would not be 
contained in the skin homogenate preparation and would not 
therefore be available to cause any further complexation with 
the residual catalase and. that hydrogen peroxide added during 
the assay. Other relevant reactions of compound I are:
[3 ] Catalytic activity
Compound I + H2O2 — catalase + 02 + 2H2O
[4 ] Peroxidative activity
Compound I + ethanol— > catalase + acetaldehyde + 2H2O.
The mechanism of formation of Compound I, the 
inhibition of catalase and the role of ethanol af£ discussed 
in the next section.
Mechanism Of Complex Formation
Chance (1967) using a rapid spectrophotometric 
technique recorded the spectrum of the primary hydrogen 
peroxide-catalase complex (compound I) from the iii vitro 
reaction of catalase and hydrogen peroxide (Equation 1).
When Chance saturated the catalase by continuously generating 
hydrogen peroxide from an oxidizing system, he found that 
this primary catalase-hydrogen peroxide complex (Compound I) 
was converted into a new secondary complex with a different 
and persistent absorption spectrum; this complex (compound
II) is catalytically inactive.
Chance (1953) showed that addition of an alcohol 
caused a decrease in the steady state concentration of 
compound I with the oxidation of the alcohol to aldehyde 
(Equation 4)* The catalase - hydrogen peroxide complex 
(compound I) also participates in the decomposition of 
hydrogen peroxide into water and oxygen (Equation 3)» but 
Equation 4 takes precedence with ethanol present. In the
.j
assay/residual catalase activity (Cohen et a l ., 1970) to be
described here, addition of ethanol was used to reverse the 
formation of compound^ which would otherwise have formed 
spontaneously in the homogenate prior to measurement.
The Role Of Aminotriazole (ATZ)
Heim et al. (1956)) showed that when ATZ was injected 
intraperitoneally into rats, it produced a 90$ inhibition of 
liver catalase activity within 3 hours; this is thought to
reflect the high steady static level of hepatic H 2O2 
production. Margoliash et a l ., (i960) went further however, 
and using labelled ATZ, showed that the isotope becomes
irreversibly bound to the H 202-catalase molecule with 
resulting enzymatic inactivation of Compound I (Equation 1 
and 2). They also showed that the binding of the ATZ is to 
the protein moiety of the catalase since on denaturization of 
the enzyme, removal of the haematin prosthetic group, left 
the inhibitor attached to the protein.
When ethanol was injected prior to ATZ injection, 
hepatic catalase activity was not affected (Nelson, 1958). 
Chance (1951) had proposed that ethanol and other alcohols 
which were known to react with the peroxidate system 
(Equation 4 ), compete with ATZ for the hydrogen peroxide - 
catalase complex (compound I) as shown in Equations 5 and 6 :
(5) Catalase-H2 0 2  ^ + alcohol — > Catalase-H202-alcohol (5)
(6 ) Catalase-H202-alcohol — > Catalase + aldehyde + 2H 2O (6 )
Margoliash et al. (i960) and Tephley et al. (1961) 
using various alcohols showed that alcohols which have equal 
affinity for compound I, equally antagonize the ATZ 
inhibition of hepatic catalase activity both in vivo and in 
vitro, and so confirm Chance's hypothesis.
That H2O2 is necessary for the catalase - ATZ 
inhibition is shown by the lack of ATZ inhibition of catalase 
activity in intact erythrocytes; inhibition, using the 
reaction with aminotriazole, was only observed after adding a
suitable concentration of hydrogen peroxide (Margoliash and 
Novogrodsky 1958) or after the addition of haemolytic agents 
which generate H 2O2 via autooxidation or coupled oxidation 
with oxyhaemoglobin (Cohen and Hochstein 1964). This failure 
of ATZ to inhibit erythrocyte catalase under normal 
conditions has been shown to be due to insufficient hydrogen 
peroxide generation by these cells. Inhibition of liver 
catalase occurred under the same conditions due to greater 
generation of H 2O2 in that tissue.
Thus, the inhibition of catalase by ATZ (Equation 2) 
only occurs in combination with H 2O2 as compound I. Since 
the rate of Compound I formation is dependent upon the rate 
of H 2O2 generation or addition (Cohen 1966), the inhibition 
of compound I by ATZ can be used as a specific measure of the 
H2O2 present (Cohen and Somerson 1969; Sinet et al., 1980; 
Goldstein, 1973)*
Reversible Inhibition Of Catalase By ATZ
Relatively high concentration of ATZ jLn vitro causes a 
reversible inhibition of catalytic activity of either free 
catalase (in the absence of H2O2 ) or catalase-H202 (compound 
I); this reversal occurs on dilution. Margoliash et a l . 
(1960) determined the reaction constant (first order) for the 
decomposition of H 2O 2 in the presence of varying 
concentrations of ATZ. The equilibrium constants (at 22°C) 
for the reversible reactions of ATZ with free catalase (K =
40 mM) and of ATZ with catalase-H202 (K2 = 20 nM) were 
calculated according to equation developed by Beers (1955) 
from the first order reaction constant determined above for
H2O2 decomposition both with and without ATZ. These findings 
have been confirmed by direct spectroscopy (Nicholls 1962). 
Irreversible Inhibition Of HpOp - Catalase II By ATZ
Margoliash and Novogrodsky (1958) showed that a 
relatively low and constant concentration of H 2O2 is required 
to cause the irreversible inhibition of catalase by ATZ. 
Margoliash et al. (i960) determined the reaction kinetics by 
dialysing hydrogen peroxide into catalase solutions and 
determining the catalytic activity according to Feinstein et 
al. (1949).
They considered the two options for the hydrogen 
peroxide requirement for the irreversible inhibition 
reaction;
(A) a catalase - hydrogen peroxide complex was the reactive 
species.
(B) the hydrogen peroxide reacted with a catalase-inhibitor 
complex.
Applying kinetic equations derived from assumption (A) 
to the kinetic data obtained from the initial rates of the 
irreversible inhibition reaction and the reversible 
inhibition, they determined that the ATZ reaction with 
compound I was second order with a reaction constant k =
0.025 sec “1 at 22°C. In addition, the equations fitted
the experimental data which supports the concept that the 
inhibition of catalase by ATZ occurs through a reaction with 
the catalase-hydrogen peroxide compound I.
Reaction Of Compound II With ATZ
In vitro addition of ATZ to catalase - H2O2 compound 
II causes the rapid disappearance of the compound II spectrum 
to he replaced by a spectrum similar to that of free 
catalase; here ATZ acts as an endogenous hydrogen donor to 
cause compound II reduction. The kinetics of this reaction 
was found by Margoliash et al. (i960) to be second order with 
a reaction constant (at 37°C) of k = 0.26 M “  ^ sec”^ ; a very 
much slower reaction than that occurring between ATZ and 
complex I.
Unlike other ionic ligands (e.g. azide, nitrite), ATZ 
does not accelerate the reduction of compound I to compound 
II and thus the level of compound II remains low in the 
presence of ATZ and continuous low-level H 2O2 generation.
Addition of ethanol in various excesses to compound II 
did not cause the rate of disappearance of compound II to 
vary with the ethanol added and, in fact, was slower than the 
reaction of compound II with ATZ. Hence, the disappearance 
in catalase-H202 II with ATZ was determined not to be due to 
a shift in the equilibrium between compound II and compound I. 
Structural Requirements For Inhibition Of C a t a l a s e / H p O ? ^ )
The minimum structure required for inhibitory activity 
was determined by Margoliash et al (i960) to be isometric 
structures where the primary amino group attached to the C 
atom had to be unsubstituted, and R was S, 0 or NH.
>N.NH.C(NH2 ) :R 
(1 )
>N.N;C(NH2 ).R.H 
(2)
The ring structure of 3-amino-1,2,4-triazole as such 
was not required. The inhibitory activity of ATZ was 
surpassed by S-methyliso - thiosemicarbazide which would tend 
to indicate structures such as that of (2 ) would be the 
active species of inhibitory compounds.
Active Site Of Catalase-HpO? (Compound I)
The spectrum of the irreversibly inhibited catalase is 
similar to those of other catalase preparations in which the 
protein moiety has been modified (Nicholls 1962). Margoliash 
(1960) reported that while the catalase incorporated 1 mole 
of ATZ for each mole of catalase haematin, on liberation of 
the haematin by acid-acetone, the incorporated ATZ remained 
attached to the protein. However, they also showed that the 
haem ferric ion was affected, since following ATZ 
incorporation, the haem Fe^+ could not bind cyanide. A 
change in structural configuration of the protein or steric 
hindrance from proximal attachment. of the ATZ near the haem 
Fe? + or both, could account for this.
So far, the active protein site in catalase has not 
been determined; in part this is due to the two different 
aspects affecting the reaction rate of the inhibitory 
reactions. These are (1) the equilibrium constant for the 
reaction of ATZ with compound I (Km of Fig. 5) and (2) the 
rate of monomolecular transition (K3 of Fig. 5)• Nicholls 
(1962) suggests that the irreversible inhibition may be due
to a particular intramolecular reaction involving an 
otherwise inactive but reversible compound I - ATZ complex.
FIGURE 5
SUMMARY OF REACTIONS BETWEEN CATALASE AND ATzO)
ATZ
k4
Catalase (Fe5+) —  ATZ Catalase <r
k 1
Kd
H202 ATZi-Catalase
A
ATZ
Compound I 
k2
—  Compound 1 - ATZ
Km
ATZ
Compound II —  Compound II - ATZ — — l
k5
Km
k1 =  6 X 106 M-1 sec“
k2 = 1 X 10-2 M-1 sec”
k3 = 4 X 10-5 M-1 sec-
k4 = 6 X 10-4 M-1 sec“
k5 = 4 X 10-2 M-1 sec“
Km = 0.16M 
Kd = 0.06M 
(estim.) temperature 20°C; pH = 5*4
ATZ^ catalase = irreversible inhibition
(1) modified from Nicholls (1962)
METHODS
Application Of Aminotriazole Assay For HpOp Measurement 
This technique (Cohen and Hochstein, 1964) uses 
3-amino-1 ,2 ,4-triazole (ATZ) to react with compound I and 
inhibit catalase activity (Equation 2). As has been 
discussed earlier in this chapter, the decline of catalase 
activity in the presence of ATZ is due to the formation of 
H 202 . This is used in this thesis, to provide confirmatory 
evidence that the decrease in catalase activity in mice 
treated i_n vivo with the tumour promoter phorbol ester P M A , 
is a index of the formation of H 202 in the skin when compared 
with ATZ-injected mice not treated with tumour promoters. 
Previous use of this method by Goldstein (1973) allowed the 
detection of hydrogen peroxide in the circulating red blood 
cells of rats and mice exposed to ozone. However attempts to 
use the technique to measure in. vivo hepatic H2 02 have not 
been successful since injection of.ATZ leads to an immediate 
decrease in hepatic catalase levels to near zero; it is 
presumed that this is a reflection of the high hepatic 
generation of H 202 (Goldstein B.D. unpublished).
The selection of the phorbol esters as the tumour 
promoters to be used is supported by the following;
(1) The stimulation of human polymorphonuclear
leukocytes (PMN) to produce superoxide anion in 
vitro by phorbol esters correlates with the skin 
tumour promoting activity of these phorbol esters 
as opposed to their inflammatory potency. Of the 
two other non-phorbol ester tumour promotors 
examined, these also stimulated 02T production 
(Goldstein, et al. 1981).
(2) Protease inhibitors (and retinoids) which inhibit 
tumour promotion by phorbol esters also inhibit the 
stimulation by phorbol esters of phagocytic cell 
production of 02T and H202 in vitro (Witz, et al.
1 981 ) .
(3) Anti-inflammatory agents, such as steroid hormones, 
have been shown to inhibit the promotion phase of 
2-stage carcinogenesis in mouse skin by PMA (Beeman 
& Troll, 1972); PMA causes both influx of 
inflammatory cells into the treatment area and 
superoxide anion production.
Since part of the foregoing hypothesis depends on the 
chemotactic properties of the skin tumour promoter (or other 
agent with this property applied concurrently), and 
subsequent applications cause free radical production from 
the PMNs then present, a two dosage regimen was adopted 
(Goldstein et al. 1984)* The first, application of the tumour 
promoter PMA would act primarily as a chemotactic agent, only 
subsequent applications of PMA to the skin, where now 
phagocytic cells are present, would result in free radical 
generation. The generation of free radicals and H 20 2 is 
known to be an immediate sequalae occurring maximally during 
30 minutes following a second application; hence the method 
described below measures catalase activity at this time. 
Experimental Procedure
CD1 female mice were purchased at 6 weeks of age and 
acclimatized to laboratory conditions for one week prior to 
treatment. This particular strain and sex of mice was chosen 
because published data ware available for this strain and sex
of the tumour promoting activity as well as the inflammatory 
activity of the phorbol esters of interest. Mice were housed 
in stainless steel suspended cages with mesh flooring, and 
fed Purina laboratory chow and water jui libitum. The backs 
of mice were shaved free of hair 10 days prior to treatment 
using an Oster electric shaver with a No. 40 blade. 
Immediately prior to treatment the mice were inspected and 
those showing rapid hair growth during the 10-day period 
subsequent to shaving of the dorsal area, or those with any 
abrasion of the shaved area, were not used in the study.
The test compound (described below) was applied in 0.1 
ml solvent with an automatic pipetter to the shaven dorsal 
area of each mouse. There were 4 mice per treatment group. 
This procedure was carried out between 9*00 and 11.00 a.m. to 
minimize diurnal variation (O'Brien et al. 1975)* A second 
dose of the test compound was applied 24 hours later followed 
15 minutes later by intraperitoneal injection of 0.2 ml of
0.1M ATZ in phosphate buffered saline pH 7*4 (56 mg/kg). 
Appropriate untreated or solvent treated control groups were 
also maintained. The mice were sacrificed by cervical 
dislocation 15 minutes after ATZ injection.
After sacrifice the dorsal skin was immediately 
excised and placed inverted on the bottom of a beaker nestled 
in ice. The subcutaneous fat and blood vessels were scraped 
off with a scalpel and the skin diced into small pieces 
directly into a weighing vessel on a top-loading Sartorius 
balance. The skin samples (0.265g) were suspended in 5 ml 
cold phosphate buffered saline containing 1$ Triton X-100 and 
1$ ethanol to restore enzyme activity, as suggested by Cohen
et al. (1970). Both reagents cause an increase in observable 
catalase activity. Ethanol reverses the formation of 
compound I which will otherwise form spontaneously in 
homogenate preparations prior to measurement. Triton X-100 
solubilises particle bound catalase and thereby reduces 
variation caused by differences in homogenization of tissue.
After homogenization (10 x 3 second runs, in ice) in a 
Brinkman polytron, the homogenates were centrifuged at 4°C 
for 30 minutes at 20,000 x G in a Beckman J2-21 refrigerated 
centrifuge. The lipid layer was aspirated from the surface 
and the supernatant was filtered through Whatman No. 1 paper. 
At this stage, the supernatants could be stored overnight at 
4°C and assayed for catalase activity the following day; 
previous studies utilizing aminotriazole had shown that the 
catalase activity was stable to allow assay of activity 
during the 24-hour period subsequent to filtration if 
maintained at 4°C.
The catalase activity of the mouse skin homogenates 
was determined essentially as described by Cohen et al. 
(1970). The supernatant (0.1 ml) was mixed with 1.0 ml of 
cold 6 M H 202 (0.06 ml 30$)by vortexing at time zero (tso) . 
The samples were kept in an ice bucket and at t=3 min., the 
reaction was quenched by addition of 0.2ml of 2N H 2S04 . The 
samples were removed from the ice bucket, 1.4 ml of 0.1 N 
KMn04 was added and the optical density at 480 nm was 
measured against H202 in the reference cuvette one minute 
after addition of KMn04 . Sample blanks and sample standards 
were prepared and measured at 480 nm as described by Cohen et 
al. (1970) The sample blank was prepared by reversing the
addition of sample and acid; the sample standard was prepared 
by adding 100 ul sample and 200 ul acid to 1.0 ml of the 
phosphate buffer. The blank and standard were incubated for 
approximately 3 minutes as above and subsequently treated as 
for the other samples. Catalase activity was equated to the 
first order reaction rate constant (K) of the decomposition 
of H 20 2 as shown below where So is the H 202 concentration at 
t=0 (O.D. of standard - O.D. of blank) and S3 is the H202 
concentration at t=3 min (O.D. of standard - O.D. of test 
sample). K values were computed for 200 ug protein. Protein 
was determined by the Lowry method (Lowry 1951)* Under the 
conditions of this assay, K, the first order reaction rate 
constant, is directly proportional to the catalase activity 
of the sample.
K = 2.3 log So 
t S3
While catalase activity in subsequent studies have 
been expressed in International Units from a prepared 
standard curve, the expression of activity as K/200 ug 
protein has been retained here to facilitate comparision with 
data from other investigators such as Goldstein et al. 
Materials And Dose Selection
Phorbol-12-myristate-1 3-acetate (PMA) and phorbol-12, 
13-diacetate were purchased form P. Borchert (Eden Prairie, 
MN).
PMA (2.5 ug/0.1 ml acetone) had been shown not to 
alter the catalase activity of CD1 mouse (male) skin despite
a further application 24 hours subsequently (Goldstein et al. 
1983)* Yet, this dose is known to be irritant to CD-1 mice 
and was used here and also by Goldstein et al. (1983) as the 
initial chemotactic dose. The second dose, 24 hours later, 
employed a dose range from 0.1 - 10.0 ug PMA in 0.1 ml 
acetone or 10 ug PdA in 0.1 ml acetone. Phorbol diacetate 
which is inactive with regards to tumour promotion and does 
not elicit an inflammatory response in Charles River CD-1 
mice (Slaga et al. 1976) served as a control in addition to 
mice treated with acetone only.
The effect of ATZ on mouse skin catalase, a 
dose-dependent decrease, had been determined previously by 
injecting the mice with 0.2 ml of 0.1 - 1.0 M ATZ (56-560 
mg/kg) as shown in Figure 6 . Treatment with 0.2 ml of 0.5 M 
ATZ (280 mg/kg) 15 minutes prior to sacrifice, reduced mouse 
skin catalase to 55 6$ of control while treatment with 0.2
ml of 1.0 M ATZ (560 mg/kg) reduced, the activity to 34 5%
of control. Injection of 0.2 ml of 0.1 M ATZ (56 mg/kg) was 
found to cause minimal inhibition of mouse skin catalase 
activity and hence was used here in the present studies.
Two different types of inhibition of catalase by 
aminotriazole have been distinguished (Mangoliash and 
Novogrodsky 1958); the above is illustrative of the first, a 
simple reversible inhibition in which the enzymic activity 
can be recovered by dilution. The second, occurs in the 
formation of catalase-H202 Compound I which serves as a 
detection system for hydrogen peroxide since the 
aminotriazole can no longer be dissociated by dilution.
CATALASE ACTIVITY  
(% OF CONTROL)
ro -p» <j> cd o ro
o o o o o oo
»
l
m
ro
' Si o
»
I
I
;’ o o
I
i
1 CD 
Oo
>
M
PJ —O to O o(D • • •r+ ui/-s to toU3 £ 3 3CD iQ H* H'"X >o• O O
Ul Ul3M 3 3
EFFECT 
OF 
3-AMINO 
1
,
2
,
4
-TRIAZOLE 
ON 
MOUSE 
SKIN 
C
A
T
A
L
A
S
E
A similar dose response study was also carried out 
without the use of a first treatment of 2.5 mg PMA nor the 
use of ATZ treatment prior to sacrifice. Hence, total 
catalase was measured in that study for purpose of 
comparison, a decrease in this case may be due to 
inactivation of the catalase by free radicals, a possibility 
which is supported by the literature (Firazzi-Agro, et. al.,
1 978).
Inflammatory Response
Samples from the excised skin of PMA treated and 
untreated skin were fixed in 10% formalin in saline and 
subsequently processed and stained with haematoxylin and 
eosin. Histological examination of mounted 4 u sections 
allowed the inflammatory response from treatment to be scored 
using the method of Van Duuren (1973)• On this scale, grade 
0 corresponds to no inflammation, grade 1 to mild 
inflammation as seen by phagocytic infiltration increasing 
with grades 2 and 3 , and sloughing of the epidermis and 
dermal inflammatory cell invasion characterising grade 4 «
RESULTS
Using the second application dose range (0.1 - 10.0 ug
PMA in 0.1 ml acetone), a dose dependent decrease in catalase 
occurred (compared to the ATZ injected acetone mice),
reaching statistical significance (p 0 .0 5 ) with the 10.0 ug
PMA treatment.
As can be seen from Table 7 and Figure 7, the catalase 
activity of the acetone treated group appeared to be elevated
compared with the untreated controls. Although this
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elevation has no statistical significance it has occurred in 
repeat dose response studies and in every subsequent study 
involving acetone as a vehicle control. The essentially 
inactive phorbol diacetate, in.acetone produced an equivalent 
response to the vehicle control. Plate I shows evidence of 
increasing inflammatory cell infiltration from application of 
2.5 ug PMA/5»0 ug PMA in acetone; Plate 2 shows no such 
infiltration from acetone treatments per s e .
The measurements of total catalase (that is without 
the use of ATZ) showed some reduction in catalase relative to 
the increasing dose of PMA (Table 8, Fig. 8).
Direct addition of 5*0 ug PMA in 0.1 ml acetone to an 
homogenate of untreated skin was without effect on catalase 
activity when compared to the activity from assay of the 
untreated skin homogenate per se. However, 0.1 ml acetone 
alone added to the homogenate, did cause some increase in 
activity as seen under _in vivo conditions.. These results are 
summarized in Table 9*
DISCUSSION
The dose dependent decrease of catalase activity in 
mouse skin iii vivo with PMA confirms the findings of 
Goldstein et a l . (1983)* The statistically significant 
decrease in catalase activity in the presence of PMA with ATZ 
compared with ATZ alone is consistent with the formation of 
H 2O2 in the mouse skin induced by the PMA treatment.
Hydrogen peroxide is just one of the products of oxygen 
reduction produced by the dismutation of the superoxide anion 
radicalj other radicals, including superoxide, would also be 
present. These may be the cause of the observed catalase
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TABLE 9
The effect of PMA/acetone on the Catalase assay^
Treatment (K/200 ug protein)
no treatment 3-93
5.0 ug PMA/0.1 ml acetone (2) 3.04
5.0 ug PMA/0.1 ml acetone (1) 1 .99
acetone (0.1 ml) (2) 5.93
Amount of PMA indicated applied in 0.1 ml acetone 
directly to dorsal skin of shaved CD1 female mice 6 
weeks old (3 mice per group).
Direct addition to skin homogenate.
Results are means of duplicate determinations on each of 
the three animals per group.
inactivation without the presence of ATZ, since Finazzi-Agro 
et al. (1978) suggest the likelihood that catalase is 
deactivated by free radicals. A similar decrease has been 
observed by Solanki et a l . (1981) in PMA-treated Senear mice
also without the use of ATS.
The apparent enhancement of catalase activity by 
acetone is discussed more fully in Chapter 7, however, it is 
suggested here that acetone provides an alternate substrate 
for free radical attack and therefore, protects endogenous 
catalase.. The existence (suspected) of free radical activity 
in normal skin would result in somewhat lower catalase 
activity in this skin compared to acetone treated skin. The 
protective effect of acetone as an alternate substrate would 
also be applicable to the skin homogenate stage and is in 
fact observed.
Another solvent, dimethylsulphoxide (DMSO), is an 
excellent free radical scavenger. When PMA is applied in 
DMSO to mouse skin rn vivo less tumour promotion is obtained 
than when PMA is applied in acetone (Lowengart et al. 1977). 
It is possible in this case that the DMSO captures free 
radicals generated by PMA interactions thus preventing their 
participation in the tumour promotion process.
Alternatively, DMSO may cause the rapid transport of PMA 
through the skin so that effects due to cutaneous retention 
are not able to occur.
The ATZ assay results demonstrate specifically the 
formation of H 2O 2 in mouse skin from the in vivo treatment 
with an active tumour promoter. Neither iii vitro 
(homogenate) PMA addition nor iii vivo application of
essentially inactive phorbol diacetate cause the formation of 
hydrogen peroxide under the same conditions. It has been 
found that this H 2O 2 formation can be enhanced by PMA 
pretreatment which, as demonstrated by histology carried out 
here, resulted in some influx of inflammatory cells over the 
24-hour period between treatments. This enhanced response is 
therefore supportive of the hypothesis that the reactive 
oxygen species is primarily generated from interaction of PMA 
with infiltrating phagocytic cells. The generation of free 
radicals . from PMA interaction with polymorphonuclear 
leukocytes ill vitro has been demonstrated indirectly by 
Goldstein (1978) using cytochrome C reduction measurements 
(Fig. 9)« Subsequent studies to be described in the present 
thesis suggest that other cells may also generate hydrogen 
peroxide, albeit to a lesser extent, on contact with PMA; 
these support the findings of Fischer and Adams (1980) who 
show that epidermal cells themselves can produce free 
radicals to some extent.
The above suggests that the ATZ assay is a valid model 
for the detection of hydrogen peroxide iii vivo and also that 
the H2O2 generation may be associated with tumour promotion. 
The two stage dosage regimen employed offers a more sensitive 
system, as is used in the study series to be next described, 
in which it is examined whether alkanes can cause H2O2 
formation and whether a chemotactic stimulus is first needed 
for this potential activity to be expressed.
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CHAPTER 3
ATZ - CATALASE MODEL APPLIED 
TO PROMOTION/INFLAMMATION STUDIES
INTRODUCTION
Inflammation has long been suggested to play an 
important role in tumour promotion since many tumour 
promoters are themselves potent inflammatory agents.
Repeated epidermal regeneration per s e , produced by abrasion 
of the skin of CD1 female mice, already initiated with 200 nM 
of dimethyl-benzanthracene, resulted in the appearance of 
carcinomas and papillomas; this suggested that repeated 
epidermal regeneration is a sufficient stimulus for the 
promotion of benign and malignant neoplasms in mouse skin 
(Argyris et al. 1981)
In this chapter, the association of the inflammatory 
response with PMA induction of H 2O 2 will be examined and 
compared with the effect of epidermal regeneration per se on 
H 2O2 formation. The comparison is particularly pertinent 
since in vivo data exist (Argyris 1980) for the CD1 mouse for 
tumour incidences from abrasion treatment and from combined 
abrasion/PMA treatments.
As noted earlier (in Chapter 1), certain alkanes are 
tumour promoters and have irritant properties seen 
particularly on repeated cutaneous application. In studies 
to be described here, members of the alkane series (Cg - ^ 14) 
when applied per se to the skin and also when applied 
subsequent to an irritant non-stimulatory dose of PMA, were 
studied for their effect on H 2O2 formation and the possible 
association of this with any known tumour promoting activity. 
Both of these study series build on the hypothesis of 
Goldstein et al. (1982) that promotion by phorbol esters is 
mediated at least in part by reactive oxygen species derived
from phagocytic cells. These cells invade the treatment area 
as a chemotactic inflammatory response. The likely response 
pathway (Figure 10) is indicated below together with the 
impact of tumour promoter inhibitors such as the 
anti-inflammatory agent, dexamethasome. A further hypothesis 
tested here was that alkanes normally devoid of tumour 
promoting activity would initiate H2O2 formation if contact 
with inflammatory cells could be engineered by a preceding 
irritant treatment (2.5 ug PMA), and then subsequent alkane 
application.
FIGURE 10
INFLAMMATORY AGENTS
DEXAMETHASONE
VI/
INFLUX OF PHAGOCYTIC CELLS
ANTI-PROT]
RETINOIDS
INFLAMMATION
REACTIVE OXYGEN SPECIES 
AND PRODUCTS
TUMOUR PROMOTION
(GOLDSTEIN AND WITZ 1982)
METHODS
Effect Of Phorbol Esters And Abrasion On H?0? Production In 
Mouse Skin In Vivo
The procedure used was essentially that previously
described and validated in Chapter 2 - the ATZ/catalase
method for the detection of H2O2 formation:
PROCEDURE
Shave dorsal skin of mice (CD1 ^ 5 - 7  weeks).
Reject mice in hair growth phase.
Random allocation of remaining mice into treatment 
groups (4 mice/group).
Apply first topical treatment of PMA (2.5 ug/0.1 ml 
acetone) or mechanically abrade skin (Norelco SC 
77 87:0.1 m m ).
Apply second topical treatment at T=0 min. of PMA or 
phorbol 12,13 acetate (5*0 ug/0.1 ml acetone).
I.P. injection of 200 ul 0.1 m ATZ (56 mg/kg) at T=15 
min.
Sacrifice by cervical dislocation T=30 min.
Prepare homogenate of the excised skin.
Centrifuge at 0-5°C: 12.000 X g for 30 min.
Aspirate lipid layer and filter.
Measure catalase activity of filtrate by procedure 
modified from Cohen, G., et al. (1-970).
The two day treatment regimen was used as described in 
Chapter % (Methods Section). The PMA, phorbol diacetate and 
abrasion treatments are tabulated for clarity (see Table 10). 
Abrasion
The abrasion was achieved using a Norelco dermatome 
set at a cutting depth of 0.1mm; this effectively removed the 
stratum corneum as seen in comparing the histological section 
(Plate 1 and Plate 5) • No discomfort was experienced when
DAY
1
10
10
1 1
1 1
1 1 
1 1 
1 1 
1 1 
1 2
this treatment was applied to human skin nor was any evident 
when performed on mice. An area of 2 sq. cm was abraded in 
each case, equivalent to the phorbol ester treatment area.
In the occasional instance where frank bleeding occurred the 
mouse was not used.
Haemoglobin Assay
Since the formation of superoxide radical O2 , its 
dismutation to hydrogen peroxide and oxygen, and the 
formation of hydroxyl radical are affected by the presence of 
iron, the haemoglobin contents of untreated skin and abraded 
skin/PMA treatment were measured using the method described 
by Markland (19T 9)•
The method is based on the specific binding of 
haemoglobin by haptoglobin. The peroxidase activity of 
haemoglobin only is protected by serum haptoglobin which 
stabilizes this activity of haemoglobin. The homogenate 
containing any haemoglobin is incubated under denaturing 
conditions in the presence of serum haptoglobin or a protein 
solution with egg white haptoglobin. The difference in 
peroxidase activity between samples incubated with serum and 
those incubated with egg white is proportional to the amount 
of haemoglobin. Skin homogenate (10 ml) was added to 10$ 
human serum (100 ml) in 0.15 M NaCl. This was mixed and 
incubated for 10 minutes at room temperature. Then, at 3 
minute intervals 3 ml of 1.5 2,2 azino-di-(3-ethyl
benzthiazoline sulphonic acid) were added and mixed at 25°C 
for 24 minutes. At this time, the solution was placed in a 
cuvette and at 25 minutes precisely, 25 ml of 30$ H2O2 were 
added. The change in optical density at 418 nm was recorded
for 1 minute against a water blank. The assay was repeated 
substituting 5$ egg white for the 10$ serum. The specific 
AOD min. was determined as the difference between AOD serum 
and AOD egg white and plotted versus concentration. The 
unknown sample haemoglobin concentrations were read directly 
from this standard curve.
Histological Examination
Skin samples excised from each of the treatment sites 
of the mid-dorsal region were fixed in 10$ buffered formalin 
for subsequent histological preparation. The samples were 
dehydrated in a Histokinette (British American Optical Co., 
Ltd.) using increasing concentrations of ethanol (70$ - 
100$), washed in toluene and immersed in a wax bath.
Sections (10 nM) were cut such that the orientation permitted 
longitudinal section of the hair follicles. The sections 
were transferred to microscope slides, dewaxed, and 
rehydrated using diminishing concentrations of ethanol.
These were then stained in haematoxylin and then eosin and 
mounted in paraffin wax ("Paraplast"). On microscopic 
examination inflammatory reactions, where observed, were 
graded according to the scheme defined by Van Duuren et al. 
(1973).
Effect Of Alkanes On HpOp Production In Mouse Skin In Vivo
The same two day treatment regimen as outlined in the 
Methods Section (3:1 ) were used except the second treatment 
with PMA was replaced by application of 25 mg of the 
appropriate n-alkane in 0.1 ml acetone (a dose consistent 
with in vivo tumour promotion studies of these compounds).
Day 1 treatment used an inflammatory, but not H202»
O2V, etc. stimulatory, dose of PMA (2.5 mg/0.1 ml acetone). 
This dose caused an influx of macrophages into the treatment 
area in the 24 hour period prior to the application of the 
n-alkanes. The alkanes were applied by automatic pipette.
In the case of the known tumour promoter and irritant, 
tetradecane, an additional comparative test group was also 
used where day 1 PMA irritation treatment was replaced by 
treatment with acetone (0.1 ml).
Catalase activity was measured by the modified pro­
cedure of Cohen et al. (1970) and the results expressed in 
terms of K/200 ug protein for comparison with the results 
presented here and in the literature.
A subsequent in. vivo study was also carried out using
only single treatments of (0.1 ml) n-hexane, isooctane,
n-decane, n-dodecane, and PMA (10 ug/0.1 ml acetone); total
catalase activity was measured 24 hours later with no i.p.
injection of ATZ given prior to sacrifice; otherwise, the
subsequent homogenization and assay procedures were as
reported previously. Since hydrogen peroxide generation from
PMA action had already been demonstrated using the specific
aminotriazole assay method, the assay procedure was now
simplified by omission of the ATZ with the assumption that a
decrease in total catalase measured would be the result of
H2O2 formation and free radical action on the catalase.
Effects Of Initiation/Promotion Treatments On H?0? Production 
In Mouse Skin In Vivo
Either primary treatment of the complete carcinogen
3,4-benzpyrene (0.15 ug/0.1 ml acetone) or acetone were 
applied to the shaved dorsal skin of mice (day 1). On day
1). On day 2, acetone (0.1 ml), or tetradecane (0.1 ml) or 
PMA (0.25 ug in 0.1 ml acetone) was applied and the ip. ATZ 
injection given to all groups 15 minutes prior to sacrifice 
as described in the Methods Section. The treatment regimen 
is shown in T a ble'1.5*
Materials
n-Hexane was obtained from Fischer Scientific Co. 
(Fairlawn NJ). n-Decane, n-dodecane, n-tetradecane were 
supplied by Eastman Kodak Co. (Rochester NY) and isooctane 
from Burdick & Jackson Laboratories (Muskegon, Ml). Triton)^
(octylphenoxy-polyethoxyethanol) and 3-amino-l,2,4-triazole 
were supplied by Sigma Chemicals (St. Louis, MO) and P. T. 
Baker Co., Phillipsburg, NJ, respectively.
Statistical Treatment
For all the above studies, arithmetic means and 
standard deviations were calculated as indicated. The 
significance of a difference between two means was evaluated 
using the Wilcoxon test for independent series; significance 
at p <_ 0.05 or p <_ 0.01 is noted where applicable.
RESULTS
Effect Of Phorbol Esters And Abrasion On HpOp Production In 
Mouse Skin In Vivo
Hydrogen peroxide formation, as indicated by the level 
of residual catalase activity, is summarized in Table 11 (and 
Figure 11) for the PMA, phorbol diacetate and abrasion 
treatment groups. The activity (expressed as the first order 
reaction constant K/200 mg protein, as per Cohen et a l . 1970)
decreased significantly in the mouse skin treated with PMA 
(2.5 ug/0.1 ml acetone) followed 24 hours later by treatment
with PMA (5 ug/0.1 ml acetone). No such decrease occurred 
with similar treatments of phorbol diacetate despite the 
presence of inflammatory cells (Plate 4) from the preceding 
abrasion treatment.
Abrasion treatment removed the stratum corneum and 
caused severe inflammatory response as seen from extensive 
infiltration of leucocytes into the paniculum (Table 11; 
Plates 5-1)• This treatment (followed on day 2 with acetone) 
gave a significant decrease in catalase activity as did 
abrasion/PMA (5*0 ug/0.1 ml acetone) treatment. Finally, 
abrasion/PMA (5»0 ug/0.1 ml acetone) treatment is as 
effective as PMA (2.5 ug/0.1 ml acetone)/PMA (5*0 mg/0.1 ml 
acetone.) treatment in causing a decrease in catalse 
activity/stimulation of H2O2 production. No significant 
difference in the haemoglobin content was found between the 
abraded skin or the abraded/PMA treated skin and the 
untreated control.
Effect Of Alkanes On HpOp Production In Mouse Skin In Vivo
The results shown in Table 12 indicate that alkanes in 
combination with irritant-, but sub-stimulatory-, doses of 
PMA (> 2.5 ug PMA/0.1 ml acetone) cause formation of H2O2 as 
evidenced by a decrease in catalase in the ATZ model assay. 
n-Tetradecane, a known tumour promoter and irritant, also 
caused a stimulation of hydrogen peroxide production. While 
application of these alkanes without prior irritation was not 
tested in the ATZ model, single application caused no 
statistically significant decrease in total catalase activity 
(i.e. assay conducted without ATZ). In both cases the 
positive control PMA, produced significant decreases in
catalase (both in the ATZ model and for total catalase) as
would be expected; total catalase activities were higher than
the residual catalase activity in the ATZ model.
Effects Of Initiation/Promotion Treatments On H?0? Production 
In Mouse Skin In Vivo
Table 14 shows that both 3 > 4-benz.pyrene per se and 
when followed 24 hours later by a single application of a 
normally non-stimulatory dose of PMA, resulted in a 
substantial (though not statistically significant decrease) 
in catalase activity, thus indicating H2O2 and free radical 
formation. n-Tetradecane was without effect on the H2O2 
formation induced by prior 3»4-benzpyrene treatment.
DISCUSSION
Consistent with the hypothesis that promotion in mouse 
skin by phorbol esters is mediated by reactive oxygen 
species, the above data confirm that PMA stimulates 
production of H2O 2 ia CD1 mouse skin; no such stimulation 
occurred with the inactive PMA analogue, phorbol 
12,13-diacetate. That this stimulatory activity lacks 
dependence on inflammatory potency is demonstrated by the 
failure of phorbol diacetate to stimulate H 2O2 production 
even when in the presence of inflammatory cells attracted 
into the skin by the epidermal abrasion. In fact, in this 
case the abrasion-induced H202-generation is minimized due to 
the suggested protective effect of the phorbol diacetate 
vehicle (acetone). Segal et al. (1978) have also shown that 
phorbolol myristate acetate has the same inflammatory 
response as its parent compound PMA, yet has only one fifth
TABLE 10
EFFECT OF PHORBOL ESTERS AND ABRASION ON H202 PRODUCTION IN MOUSE SKIN
TREATMENT REGIMEN
GROUP #  DAY_1________________________   DAY 2__
SOLVENT ABRASION COMPOUND SOLVENT COMPOUND ATZ/PBS
1 - - - - +
2 +  -  -  +  -  +
3 + 2.5 (PMA) + 5.0 (PMA) +
4 + - 2.5 (PdA) + 5.0 (PdA) +
5 - + - + - +
6 - + - + 5.0 (PMA) +
7 - + + 5 * 0  (PdA) +
Dose of PMA or PdA indicated in ug in 100 ul acetone
Intraperitoneal injection (200 ul) of 0.1 M ATZ in phosphate buffered saline (PBS), 15 
minutes following second treatment (first treatment + 24 hours); sacrifice followed 15 
minutes after ATZ injection.
PdA = phorbol 12,13-diacetate
TABLE 11
EFFECT OF PHORBOL ESTERS AND ABRASION ON H202 PRODUCTION IN
MOUSE SKIN
RESULTS
CATALASE ACTIVITY INFLAMMATION 
GROUP # TREATMENTS (K/200 UG PROTEIN) GRADE
1 None 1 .09 +' 0.20 0
2 Acetone/Acetone 1.78 + 0.53 0
3 2.5/5-0 ug PMA in 
acetone
0.57 + 0.1 2 2
4 2.5/5*0 ug PdA in 
acetone
1 .17 + 0.1 8 0
5 Abrasion/Acetone 0. 89* + 0.23 4
6 Abrasion/5.0 ug PMA 
in acetone
**
0.73 + 0.04 4
7 Abrasion/5.0 ug PdA 
in acetone
1 .22 + 0.1 9 4
Amount of phorbol ester indicated was applied in 0.1 ml 
acetone, directly to the shaved dorsal skin of CD-1 female
mice, 6 weeks old (4 per group). Second treatment applied 24
hours later followed at 15 minutes by i.p. injection of 200 
ul, 0.1 M ATZ and sacrifice 15 minutes subsequently.
Results are means _+ SE of duplicate determinations on each of 
4 animals per group.
Inflammatory response graded according to Van Duuren, et al. 
(1983).
PdA = phorbol 12,13-diacetate.
p < 0.05 from Group 2 vehicle control
p < 0.01 from Group 2 vehicle control
hfiWwW*
U \NSO 3 0 0.ttOI-UlHZ
TABLE 12
EFFECT OF ALKANES ON H202 PRODUCTION IN MOUSE SKIN IN VIVO 
WHEN PRECEDED BY IRRITANT PMA TREATMENT
CATALASE ACTIVITY 
GROUP # TREATMENT (K/200 UG)
(PROTEIN)
1 Acetone (0.1 m l )-vehicle 4»46 1.71
control/acetone (0.1 ml)
2 PMA (2.5 u g )/PMA (5.0 ug) 2.70 _+ 0.59
in 0.1 ml ace tone
3 PMA (2.5 u g )/n-Hexane (25 mg) 2.23 ± 0.29
in 0.1 ml acetone
4 PMA (2.5 ug)/n-Decane (25 mg) 1.45 ± 0.16
in 0.1 ml acetone
5 PMA (2.5 ug)/n-Tetradecane 3*12 +_ 0.48
(25 mg) in 0.1 ml acetone
6 Acetone (0.1 m l )/n-Tetradecane 2.54 0.19
(25 mg) in 0.1 ml acetone
Amount of PMA indicated was applied in 0.1 ml acetone, 
directly to the shaved dorsal skin of CD-1 female mice, 6 
weeks old, (4 in group). Second treatment applied 24 hours 
later followed at 15 minutes by i.p. injection of 200 ul, 0.1 
M ATZ and sacrifice 15 minutes subsequently.
Results are the means _+ SE of duplicate determinations on 
each of 4 animals per group.
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TABLE 13
EFFECT OF ALKANES ON H202 PRODUCTION IN MOUSE SKIN IN VIVO
TREATMENT TOTAL CATALASE
ACTIVITY
GROUP # (Single Application) (K/200 UG PROTEIN)
1 Acetone (0.1 ml) 7.12 + 0.74
2 PMA (10 ug in 0.1 ml acetone) 3.67** + 0.49
3 n-Hexane 5.16 + 1 .30
4 iso-Octane 3-94* + 0.10
5 n-De'cane 2.71 * + 0.44
6 n-Dodecane 4.95 + 0. 81
7 Untreated skin 6.14 + 0.78
Amount of PMA in 0.1 ml acetone or 0.1 ml of alkane indicated
was applied directly to dorsal skin of shaved CD-1 female
mice 6 weeks old (4 in group). Animals sacrificed 24 hours 
later without prior ATZ injection.
Results are the means _+ SE of duplicate determinations on 
each of 4 animals per group.
p < 0.05 from Group 1 vehicle control
p < 0.01 from Group 1 vehicle control
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TABLE 14
TOTAL CATALASE ACTIVITY 
GROUP # TREATMENT (K/200 UG PROTEIN)
1 BaP (0.15ug) in 0.1 ml acetone/
acetone
2 BaP (0.15ug)/PMA (0.25 ug) in
0.1 ml acetone
3 acetone/PMA (0.25 ug) in 0.1 ml 
acetone
4 BaP (0.15 ug in 0.1 ml acetone)/
n-Tetradecane
5 acetone/n-Tetradecane
6 acetone/acetone
3,4-benzpyrene (BaP) or acetone as indicated applied to shaved 
dorsal backs of CD1 female mice, 6 weeks old (4 in group) and 
second treatment shown applied 24 hours later, with subsequent 
injection of 200 ul, 0.1 M ATZ and sacrifice 15 minutes later.
Results are the means SE of duplicate determinations on each of 
4 animals per group.
2.08 _+ 0.03
1 . 88* +_ 0.07
2.05 +, 0.05
2.46 +_ 0.28 
2.20 _+ 0.31 
2.70 + 0.24
* p < 0.05
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of the tumour-promoting activity and is a much less potent 
stimulatory of C>2“ production.
The inflammatory response - the presence of responding 
phagocytic cells - does however appear to contribute 
significantly to the PMA stimulated production of H2O2 in 
mouse skin. In the present studies the severe inflammatory 
response and macrophage infiltration caused by abrasion 
treatment gave rise to a greater generation of H2O2 by PMA 
(5*0 ug in acetone) than when this PMA dose was preceded by 
the mildly irritant treatment of PMA (2.5 ug in 0.1 ml 
acetone). It is known that anti-inflammatory agents (e.g. 
dexamethasone) decrease the number of infiltrating 
inflammatory cells and act as inhibitors of PMA-tumour 
promotion in the mouse skin.
The question of whether an inflammatory response and 
epidermal hyperplasia are necessary prerequisites for PMA 
tumour promotion has been argued. Raick et a l . (1972) 
concluded that cell proliferation and hyperplasia are not 
sufficient to explain the action of PMA (and other compounds) 
as promoting agents. Nebert et al. (1972) using the 
offspring of crosses of inbred mice with widely different 
inflammatory responses to PMA, showed that there was no 
correlation between inflammation and tumour response from 
DMBA/PMA treatments of these mouse strains. Van Duuren et 
al. (1973), showed that inflammation and epidermal 
hyperplasia occur concomitantly with tumour promotion of PMA 
but, at low doses of PMA (< 0.1 ug/ml) an inflammatory 
response was observed on repeated topical application,
without subsequent tumour induction, even after treatment for 
one year at this dose.
A more specific explanation would be the influx/ 
presence of phagocytic cells which in contact with PMA are 
stimulated to provide the major source of free radicals which 
are associated with the subsequently observed tumour 
promotion. This is compatible with the report that the known 
non-tumour promoting but hyperplastic agent, ethyl phenyl 
propionate, is not a tumour promotor, nor does it induce free 
radical formation in the mouse skin. Further, Goldstein et 
al. (1981) report that neither phorbol 12,13-diacetate , nor 
4-0-methylphorbol myristate acetate stimulate superoxide 
anion production by human polymorphonuclear leukocytes and 
both lack tumour promoting activity iii vitro; PMA and phorbol 
dibutyrate do have this stimulatory activity and have tumour 
promoting action.
Polymorphonuclear leukocytes when in contact with 
active phorbol esters or other stimuli e.g., zymogen 
granules, etc. show marked perturbation of oxidative 
metabolism including the generation of H2O2 and free 
radicals. These responses are believed to be initiated by 
activation of a pyridine nucleotide - dependent oxidase 
system localized in the plasma membrane.
Van Duuren (1969) suggested that the effects of PMA on 
cells are mediated via membrane perturbation. Goldstein 
(1978) noted that only those phorbol esters with lipophilic 
side chains and capable of interacting with membranes are 
active as tumour promoting agents. These same properties 
seem to be necessary for the stimulation by the phorbol
esters of oxidative metabolism and generation of free 
radicals by polymorphonuclear leukocytes (Goldstein, et al. 
1981). Schmidt et al. (1983) note a correlation between 
complete or second stage tumour promoters, and specific 
binding to mouse skin (or epidermal fractions).
Membrane interaction has also been studied by Horton 
et al. (1981) who compared the promoting activity of pristane 
(2,6,10,14-tetramethylpentadecane) and n-alkanes in skin 
carcinogenesis with their physical effects on micellar models 
of biological membranes. For the n-alkanes examined 
(n-CQHiQ» n”^18^38 an<* n"^24^5o) they found a correlation 
between their tumour-promoting properties and their effects 
on the rate of transfer of an anionic organic probe across 
lipid/water interfaces. They suggest that the primary effect 
of such alkanes in the epidermis is to alter critical phase 
relationships at water/cell membrane interfaces; hence the 
cellular membrane may play an important role in hydrocarbon 
promotion.
The results of the alkane studies reported here show 
that n-hexane, n-decane and n-tetradecane caused stimulation 
of H2O2 generation in pre-irritated skin. Whether this 
action is mediated through membrane receptor site interaction 
that is believed to occur .for PMA stimulation of H2O2 
production, is not known, but the correlation of n-alkane 
promoting activity with membrane interaction reported by 
Horton et al. (1981) supports this possibility.
Horton et al. (1981 ) also report _in vivo data for the 
tumour promoting activity of n-octane. While no such in vivo 
study is known to have been conducted for n-hexane it would
not be surprising if similar activity were to be seen with 
the more volatile n-hexane if evaporation from the skin could 
be prevented and if repeated application was to induce 
irritation and macrophage infiltration. However, the lower 
alkanes, Cy and below, are not irritant unless repeatedly 
applied to the skin and this suggests that any tumour 
promoting potential may remain latent unless exposure is in 
combination with a source of irritation. n-Decane, and to a
greater extent, dodecane and tetradecane, are irritant
per s e . Their tumour-promoting activities in the skin 
in vivo are known, but also readily detectable using current 
tumour promotion test methods.
An alternative explanation for the n-alkane-stimulated 
production of H 2O 2 is that these alkanes undergo 
hydroxylation in the skin by cytochrome P450-dependent
processes which are known to generate (in other tissues) free
radicals and H2O2 ; this process is discussed in Chapter 5«
Hydroxylation of 3>4-benzpyrene (BaP) in the skin by 
cytochrome P450 is known to occur. Again, the 3»4-benzo- 
pyrene-stimulated generation of H2O2 reported in Section 3:2 
may be mediated by H202/free radicals generated from 
increased activities of cytochrome P450 rather than by 
H 202/free radical release from macrophages as occurs with 
PMA. The former explanation is supported by the lack of 
irritation and observed reduction in total catalase: (2.08 +_
0.03) compared with the vehicle control (2.70 _+ 0.24), in the 
mouse skin from the single application of 3,4-benzpyrene 
(Table 14). A decrease in catalase activity over a similar 
time frame, 30 and 60 minutes, has been seen in the present
studies with PMA treatment, but in these instances obvious 
oedema occurs with presumed inflammatory cell infiltration. 
The suggested free radical formation produced by
3,4-benzpyrene is in line with its known properties as a 
complete carcinogen (i.e. it possesses both initiation and 
promotion activities); the stimulation of free radical 
formation would thus reflect this compound's tumour promoting 
activity.
Finally, the effects of abrasion on hydrogen peroxide 
formation suggest that the known tumour promotion in mouse 
skin arising from repeated abrasion, may be mediated by 
H202/free radicals.
If the irritative state has such a role per se in 
tumour promotion, this may offer a partial explanation for 
the different sensitivities to tumour formation shown by 
various mouse strains. For example, SENCAR mice are 
extremely sensitive to two-stage carcinogenesis protocols 
using PMA as the promoting agent. Reiner et al. (1984) 
suggest that these and strain-dependent differences in mice 
may not be due to major differences in the metabolism of 
initiating hydrocarbons, but are partially due to other 
effects (e.g. irritancy) produced by tumour promoting agents.
It seems more likely, however, that the different 
strains respond in different degrees to the same imposed 
irritant treatment. It could be predicted that the SENCAR 
mouse would show a greater inflammatory response than C57BL/6 
mice since the latter are relatively refractory to PMA tumour 
promoting activity.
However, while it is tempting to extrapolate the 
possible free radical-mediated tumour promoting properties of 
abrasion to other degrees of irritancy, it has to be noted 
that abrasion triggers significant structural and biochemical 
reparative processes, and these in fact may be instrumental 
in the expression of the tumour promotion activity observed.
CHAPTER 4
ORGAN CULTURE STUDIES USING THE CATALASE MODEL
INTRODUCTION
The preceding studies confirm the ability of phorbol 
12-myristate 13-acetate (PMA) and certain alkanes to produce 
hydrogen peroxide in mouse skin jln vivo as measured by a 
reduction in skin catalase activity. The use, to be 
described here, of an iii vitro system of metabolically viable 
and structurally intact mouse skin explants, provides the 
defined conditions needed to pursue this association more 
fully.
V e n a  and Boutwell (1 930) established the skin explant 
system using skin from adult CD-1 mice to study the effects 
of PMA on viable explants over a 48 hour period. The 
incorporation of ^H-thymidine into DNA and the induction of 
epidermal ornithine decarboxylase occur to a similar extent 
and have a similar time course as those seen in the intact 
mouse receiving topical application of PMA. Verma and 
Boutwell .(1 980) also noted a l a r g e .increase in epidermal 
ornithine decarboxylase activity activity in incubated skin 
pieces without the addition of PMA.
Kao et al. (1983) used a similar system (C3Hf/HeBd 
mouse) to examine the morphological and biochemical changes 
induced by a toxicant as early quantitative indicators of 
cutaneous toxicity. In particular their use of measurement 
of intracellular enzyme activities in the culture medium as 
an index of cellular injury has been adopted here as a check 
that the effects reported are due to factors other than 
toxicity. The 48-hour period, established by these 
investigators and in the present studies, as a period over 
which the explants remain viable and metabolically competent,
allows the iii vitro effects to be reported corresponding to 
those that have been determined to occur i_n vivo over this 
period.
Although explant systems have been used to study the 
in vitro biochemical changes in skin following iii vivo 
exposure to irritant chemicals (Middleton 1981), this is the 
first use of an explant system to study the.effect of PMA on 
irritated skin maintained in culture over 24 hours. The 
combination of cutaneous treatment _in vivo and subsequent in 
vitro explant culture allows the study of a particular 
captive population of cells free from the effects of 
infiltrating inflammatory cells etc. which occurs _in v i v o . 
Thus the objectives of the research described below were:
1 ) to adapt and further develop an in. vitro mouse 
skin system for studying the effects of tumour 
promoters such as PMA and n-dodecane on 
antioxidant enzymes, specifically catalase;
2) to differentiate the contribution of resident
hyperplastic cells from infiltrating inflammatory 
cells, with respect to the production of hydrogen 
peroxide mouse skin.
As will be seen from the results described later in 
this Chapter, PMA treatment in the in vivo/in vitro explant 
model produced an unpredicted dose-dependent elevation in 
catalase compared with the untreated skin, and even the 
catalase activity of this control was higher under the 
conditions of this model than untreated skin _in viv o . This 
elevation in the catalase activity of control tissue led to 
the hypothesis that the incubation conditions (e.g. 
circulating atmosphere of 95$ air; 5% CO2 ) may be implicated 
in this effect. In Part II studies are reported which have 
been carried out to examine the effect of incubation.
atmosphere on cutaneous catalase activity, and demonstrate 
that hyperoxic conditions may have a significant effect on 
basal catalase activity.
PART I - EFFECTS OP TUMOUR PROMOTERS ON MOUSE SKIN CATALASE 
METHODS
(Mouse Skin Explant System)
As previously described in Chapter 3, the dorsal skin 
of CD-1 female mice was shaved 10 days prior to the 
experiment. At day 10, those mice were rejected which showed 
significant hair growth or minor abrasions, and the remaining 
mice were randomly allocated into treatment groups, 4 mice 
per group.
Probe Study: Effect Of PMA On Mouse Skin Explants
Ethanol-swabbed skin was excised in a sterile hood 
from the shaved backs of female CD-1 mice, aged 6 weeks, 
which had been killed by cervical dislocature.
The application of the ethanol {10%) served to 
sterilize the skin surface and minimized the possible 
introduction to the culture system of contaminating 
micro-organisms. Halprin, et al. 1979, showed that topical 
application of 70$ alcohol for up to 5 minutes prior to 
excission had no noticeable effect on the subsequent rate of 
epidermis outgrowth of the excised mouse skin placed in 
culture.
The subcutaneous fat and muscle were scraped off with 
a sterile scalpel blade under aseptic conditions. Skin 
explants (approximately 2 x 2 cm and 2 per animal) were 
transferred to sterile tissue culture plates containing
Dulbecco's MEM medium and 10$ foetal bovine serum and 
gentamycin (0.1 mg/ml). Each explant was placed within a 10 
ml well and laid upon a mesh supporting platform, such that 
the medium subsequently added totally surrounded the tissue.
PMA in acetone was added to the culture medium at 
final concentrations of 0.9 ug/ml or 0.1 ug/ml; for the 
vehicle control, acetone alone was added at a 1% final 
concentration. The explants were incubated at 37°C for 24 
hours and in one case 120 hours, without light and with a 
circulating atmosphere of 95$ air, 5$ carbon dioxide and 100$ 
humidity; this method is essentially that of Verma and 
Boutwell (1980).
The above procedure was carried out within the Genetic 
Toxicology Unit of Exxon's Environmental Health Sciences 
Laboratories. At 24 hours the explants were transferred in 
ice to CMDNJ-Rutgers Medical School for determination of 
total catalase activity on each skin flap (0.265g) by the 
procedure modified from Cohen et al. (1 970).
In all i_n vivo and _in vitro studies reported in this 
and previous chapters, tissue was trimmed to an initial 
tissue weight to avoid possible different degrees of tissue 
homogenization between tissue samples of dissimilar weights.
A tissue weight of 0.265g was found to be a convenient sample 
size for complete homogenization.
These determinations were carried out without the use 
of aminotriazole since previous studies (Chapter 2) had shown 
a PMA-dose dependent decrease in catalase activity in the 
absence of ATZ, but of a somewhat greater magnitude than when 
the treatment regimen included ATZ. This difference may be
accounted for by a free radical-mediated inactivation of 
catalase (Finazzi-Agrd et al. 1978) as well as that decrease 
caused by the inactivation of catalase through complex 
formation with hydrogen peroxide and ATZ.
The following viability tests were also carried out on 
retained tissue or culture medium:
• Examination of morphological appearance under phase 
contrast microscopy.
• Ability of explant cells to exclude Trypan Blue.
• Ability of explant cells to reduce tetrazolium chloride 
to formazan.
• Retention of the intracellular enzymes - lactate 
dehydrogenase, aspartate aminotransferase and alanine 
aminotransferase, otherwise appearing in the culture 
medium (method of Kao et al. 1983)*
Validation - Comparative In Vivo/In Vitro Studies Of Catalase 
With PMA
The purpose of this study was to compare the effect of 
a range of doses of PMA on mouse skin iii vivo to:
(1) that of the same dose range of PMA applied to the 
mouse skin iji vivo but subsequently maintained in 
vitro;
(2) that of the same dose range of PMA applied 
directly to the medium containing mouse skin 
explants in culture.
Procedure
48 Charles River CD-1 female mice (aged 6 weeks) were 
ear tagged and shaved to remove hair from the dorsal area. 
Seven days subsequently, 36 of these mice showing minimal 
hair growth were assigned at random to 18 suspended wire 
cages (2 per cage).
(1 ) I_n vitro
Mice from the first six cages were sacrificed by 
cervical dislocation and explants (2 per animal) prepared as
described in Chapter 3» A series of doses of PMA in acetone 
(0.1 - 10 ug final concentration), or acetone (1 % final 
concentration), or phorbol 12,13 diacetate in acetone (10 ug 
final concentration) was added directly to the medium and the 
explants then incubated for 24 hours under the conditions 
described in Chapter 3« At 24 hours, sections of explant 
tissue were examined for structural integrity, and for the 
ability to exclude Trypan Blue (0.2$ in phosphate buffered 
saline) and to reduce tetrazolium chloride to formazan 
(iversen 1960).
Total catalase activity of the explant tissue was 
determined in replicate by the modified method of Cohen et 
al. (1970) and expressed as the first order reaction constant 
both as K/200 ug protein and as K/mg protein to allow 
comparison with results of other investigators Goldstein et 
al. and Slaga et a l ., respectively. The protein content of 
each explant was determined by the method of Lowry (1954)
(2) In vivo treatment/in vitro incubation
Each pair of mice in the second set of 6 cages 
received topically to the dorsal shaved skin, either PMA 
treatment (0.1 - 10 ug/0.1 ml acetone) or acetone alone (0.1
ml), or phorbol 12,13-diacetate (10 ug/0.1 ml acetone).
After 1 hour, these animals were sacrificed by cervical 
dislocation and skin explants removed and cultured as 
described in #1 above, but without the additions to the 
incubation medium. Catalase activity of the explants was 
measured 24 hours later by the method referenced above.
(3) .In vivo
Each pair of mice in the remaining set of 6 cages 
received topically to the dorsal shaved skin, PMA treatment 
(0.1 - 10-ug/0.1 ml acetone). After 24 hours, these animals 
were transported to CMDNJ - Rutgers Medical School and 
sacrificed by cervical dislocation. The catalase activity 
was determined on an excised skin flap (0.265 g) from each 
mouse by the method referenced above.
COMPARATIVE STUDY OF n-DODECANE IN VIVO AND IN VITRO
The objective of this study was to compare the effects 
of dodecane on total catalase under ijn vivo or _in vitro 
conditions with those induced by PMA treatment under the same 
conditions.
(1 ) Ln vivo
Either n-dodecane (0.1 ml) or PMA (10 ug/0.1 ml 
acetone) was applied to the dorsal,shaved backs of 4 CD1 
female mice (6 weeks old). After 24 hours, the mice were 
killed by cervical dislocature and total catalase determined. 
(2) Ln vivo application/in vitro incubation
n-Dodecane (0.1 ml) or PMA (10 ug/0.1 ml acetone) or 
acetone (0.1 ml) was applied to the shaved dorsal skin of 4 
CD1 female mice per group. One hour later the mice were 
sacrificed and the explants of the treatment area were 
incubated for 23 hours as described in Chapter 3. For one 
PMA and vehicle control group, total catalase activity was 
determined at time of cervical dislocation (i.e. one hour 
post treatment); for the remainder, total catalase activity 
was determined following the 23 hour incubation.
TABLE 15
COMPARISON OF ENZYME LEAKAGE FROM SKIN EXPLANTS CULTURED IN THE PRESENCE AND 
ABSENCE OF PHORBOL-12-MYRISTATE-13-ACETATE (PMA)
TREATMENT
LACTATE
DEHYDROGENASE
( i . u . )
ASPARTATE
AMINOTRANSFERASE
( i . u . )
ALANINE
AMINOTRANSFERASE
( i . u . )
No Treatment 129 71 11
Acetone, 1 % 115 76 9
0.1 ug PMA/ml; 
1$ Acetone 128 70 13
0 .9  ug PMA/ml; 
1$ Acetone 110 77 11
No Treatment @ 
120 hr. 778 36 N.D.
Medium Alone @ 
120 hr. “ N.D. 24 5
The shaven dorsal skins of CD-1 female mice (2 per treatment group) 6 weeks old 
were excised aseptically and incubated for 24 hours at 27°C in Dulbecco's MEM 
with 10$ foetal bovine serum and 0.1 mg/ml gentamycin. Enzymes were assayed from 
aliquots of medium frozen at 24 hours. The data shown are the average of 
duplicate determinations from two experiments.
PMA and acetone were added, at the final concentrations indicated, to medium 
containing explants which were then incubated for 24 hours unless otherwise 
stated.
ND = Not detectable.
Enzyme activities were determined in the incubation medium and expressed in 
international units (l.U.); this is the amount of enzyme that catalyzes the 
conversion of 1 micromole (micro equivalent) of substrate per minute under the 
defined conditions of the test, the results are the average of 2 determinations.
TABLE 16
CATALASE ACTIVITY IN MOUSE SKIN TREATED WITH PHORBOL-12-MYRISTATE-13-ACETATE 
(PMA) AND PHORBOL-12,13-DIACETATE (PdA) COMPARED WITH THAT OF 24 HOUR SKIN 
EXPLANTS FROM MICE SIMILARLY TREATED OR WITH THAT OF EXPLANTS TREATED IN VITRO
TREATMENT IN
CATALASE ACTIVITY 
(K/mg Protein)
VIVO IN VIVO/IN VITRO IN VITRO
No Treatment 11.45 + 0.15 18.43 +_ 4.28 11.90 + 1.35
Acetone 12.93 + 0.93 19.83 2.28 14-50 + 0.95
0.5 ug PMA 12.48 + 2.83 11.48 + 3-93 16.15 + 2.10
1.0 ug PMA 12.43 + 1.28 17.95 _+ 1.35** 18.75 + 2.80
5.0 ug PMA 8.53 + 0.98** 19.15 _+ 3.05** 17-00 + 2.50
10.0 ug PMA 8.10 .+ 0.90* 26.10 _+ 2.90** 16.30 + 4.40
10.0 ug PdA 15.88 + 1.38 11.15 1  0.50** 14.25 + 1.35**
Amount of PMA indicated was applied, in 0.1 ml acetone, directly to the dorsal 
skin of shaved CD-1 female mice 6 weeks old (4 per group) or present, at the 
amount indicated as the final concentration per ml, in the explant system.
Animals were sacrificed by cervical dislocation 24 hours after treatment followed 
by determination of catalase activity of excised skin flaps.
Animals were sacrificed by cervical dislocation 1 hour after treatment. 
Aseptically excised skin flaps were incubated at 37° in Dulbecco's MEM with 10$ 
fetal bovine serum and 0.1 mg/ml gentamycin. Skin explants were cultured for 23 
hours followed by catalase determination.
Catalase activity of explants incubated with the phorbol ester in the medium was 
determined after 24 hours in duplicate on each of the 4 explants per group as is 
shown here as the mean + SE.
**
p <_ 0.05 from solvent control.
p <_ 0.05 between equivalent treatments from different groups,
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TABLE 17
CATALASE ACTIVITY IN MOUSE SKIN TREATED WITH DODECANE IN VIVO VERSUS
IN VIVO/IN VITRO COMPARISON
TREATMENT
CATALASE ACTIVITY 
(K/mg Protein)
IN VIVO IN VIVO/IN VITRO
No treatment 6.14 ± 0.78 4.17 ± 0.48
Acetone 7-12 _+ 0.74 12.30 +. 1.44
10 ug PMA (1 hr.) 3.67 ± 0.49 n.d.
10 ug PMA (24 hr.) n.d. 12.79 +. 5*21
n-Dodecane (24 hr.) 4.95 + 0.81 3.46 + 0.27
Amount of PMA indicated in 0.1 ml acetone, or 0.1 ml acetone per se, or 0.1 ml 
n-dodecane, applied to dorsal skin of shaved CD-1 female mice.
In vivo: animals were sacrificed by cervical dislocation 24 hours (except as
indicated) after treatment followed by determination of catalase activity of each 
excised skin flaps (2 per animal, 2 per group) shown here as the mean +_ SE.
In vivo/in vitro: animals were sacrificed by cervical dislocation 1 hour after
treatment. Aseptically excised skin flaps were incubated at 37°C in Dulbecco's 
MEM with 10$ foetal bovine serum and 0.1 mg/ml gentamycin. Skin explants were 
cultured for 23 hours followed by catalase determination.
n.d. = Not determined.
RESULTS
Probe Study: Effect of PMA on Mouse Skin Explants
At 24 and 48 hours all treated and control explants 
showed structural integrity under phase contrast microscopy. 
Representative slices removed from the explants at this time 
showed no uptake of Trypan Blue apart from the cut edges of 
the skin flap which were readily stained. . Other slices which 
were incubated for 30 minutes in an aqueous solution of 
tetrazolium chloride showed the ability to reduce this to 
formazan which could be seen as fine red granules within the 
explant tissue.
PMA was not toxic as seen by the lack of increase of 
lactic dehydrogenase, aspartate aminotransferase and alanine 
aminotransferase in the culture medium; Table 15* The enzyme 
values obtained are in good agreement with those reported by 
Kao et al. (1983) with a similar and untreated jLn vitro 
system. These investigators clearly demonstrated the 
sensitivity of these enzyme parameters to toxic insult from, 
for example, tributyl chloride.
At 120 hours in the present study, there is indication 
of leakage of lactate dehydrogenase into the medium. While 
no obvious morphological changes were seen then, it is 
concluded that the explant was beginning to deteriorate at 
this time.
For the PMA treatments of 0.1 ug/ml and 0.9 ug/ml 
final concentrations, the total catalase levels of the tissue 
increased over those of control (acetone treatment) by 
approximately 200$ and 90$ respectively. No increase in 
catalase was detected in the culture medium containing these
explants. It was therefore evident that the concentrations 
of PMA selected were without apparent toxicity to the skin 
explant but were capable of causing changes in total 
catalase.
Validation - Comparative In Vivo/In Vitro Studies Of Catalase 
With PMA
In vivo
As reported previously, PMA-treatment of mouse skin in 
vivo produced a dose-dependent decrease in tissue catalase 
compared with the untreated control and the acetone (vehicle) 
control. Enhancement of tissue catalase was again noted for 
the acetone control and for the phorbol 12,13-diacetate (10 
ug in acetone) when compared with that of the untreated 
control (Table 16; Figure 14).
In vivo treatment/in vitro incubation
Catalase activity of mouse skin treated i_n vivo with 
the dose range of PMA jLn vivo for 1 hour, and subsequently 
cultured i^n vitro for 23 hours, was significantly higher than 
that in the dorsal skin of mice 24 hours after treatment.
This increase was dose-dependent (Table 16; Figure 14).
Again, enhancement was found of the tissue catalase 
for the acetone and for the phorbol 12,13-diacetate (10 ug in 
0.1 ml acetone) with values similar to those obtained i_n vivo 
above.
In vitro
As seen earlier in this chapter, a slight increase in 
catalase with dose was observed initially (28$) at 0.1 ug 
PMA/ml final concentration then decreasing (10$) at 0.1 ug 
PMA/ml final concentration (Table 16; Figure 14). These 
changes did not have statistical significance.
Tissue samples removed from the explants (2) and (3) 
above at 24 hours showed structural integrity, and cell 
viability by Trypan Blue exclusion. No evidence of bacterial 
or fungal contamination of the cultures was seen in any of 
the explant studies report here.
Comparative Study Of n-Dodecane In Vivo And In Vitro 
(1 ) Iii vivo
Topical treatment with 0.1 ml dodecane caused a 
reduction in catalase in vivo although this was without 
statistical significance (Table 17). This decrease was of 
the same order as reported for the other alkanes (Chapter 3)* 
PMA (10 ug in 0.1 ml acetone), applied as a positive control, 
produced a significant decrease in catalase only 1 hour after 
topical application in vivo. At the time of the postmortem 
it was noted that the treatment area appeared hyperplastic 
and oedematous.
(2) _In vivo treatment (1 hr)/iii vitro explant (23 hr)
Skin treated with n-dodecane (1 hr) and subsequently 
incubated as explants in culture (23 h r ) , produced the same 
decrease in catalase as seen iji vivo after 24 hours (Table 
17)» This response is therefore in marked contrast with the 
observed responses to PMA under the same treatment regimen, 
where a marked catalase elevation was found (Table 16).
DISCUSSION
With little modification, the methods of Verma and 
Boutwell (1980) and Kao et al. (1983) allow skin explants to 
be incubated for 48 hours as reported here, with maintenance 
of morphology and viability. The tetrazolium chloride
reduction test (iversen 1960) applied here to the explant 
system demonstrated active metabolic reduction; heat-treated 
(dead) skin did not effect reduction of tetrazolium chloride 
to formazan. Of the cellular enzymes used as indicators of 
cell integrity, lactate dehydrogenase proved to be the most 
valuable; this is in line with experience with kidney culture 
studies (Parke 1984).
Halprin et al. (1979) reported the effects on explant 
integrity of various incubation conditions; the conditions 
used here adopt those found to be optimal, specifically 37°C, 
100$ humidity, and incorporation of foetal calf serum. While 
maintenance Of an uncontaminated culture for 24 hours was 
initially believed to be a problem due to the anticipated 
contamination from outer surface of the mouse skin, use of 
ethanol spray, aseptic conditions, and gentamycin in the 
medium, proved very effective procedures in producing sterile 
culture conditions.
Under purely in vitro condtions, PMA (added directly 
to the medium) produced negligible to slight elevation of 
mouse skin catalase. This lack of effect, in contrast to the 
marked elevation with the in vivo/in vitro system described, 
may be due to the known rapid absorption of PMA onto plastic 
surfaces such as the incubation plate itself, or to the 
possible instability of PMA in the culture medium. The 
likelihood of these possibilities occurring could be 
minimized by direct prior application of the PMA to the 
explant placed on filter paper dampened with saline, and then 
subsequent transfer of the explant to the incubation medium. 
It is also possible, under the in vitro conditions and a
captive cell population, that interaction of PMA with 
otherwise infiltrating phagocytic cells cannot occur. Such 
slight elevation that is observed may be due to the slight 
interaction of PMA with endogenous phagocytes and epithelial 
cells.
The decreased catalase activity seen iii vivo from PMA 
application is in good agreement with that reported in 
Chapter 3* It is also in agreement with the findings of 
Solanki et al. (19S1) of decreased catalase and superoxide 
dismutase in mouse epidermis observed within 3 hours, and 
maximally at 16 - 17 hours, with topical application of 1 ug 
PMA/0.1 ml acetone.
As reported here in Chapter 4, PMA has an effect on 
skin catalase within 1 hour from one topical application of 
this phorbol ester. This observation and the occurrence of 
oedema and hyperplasia at 1 hour sacrifice, is of consequence 
to discussion of the ill vivo treatment/jLn vitro explant 
finding. Here, the dose-dependent enhancement of skin 
catalase is in contrast to the decrease seen under totally in 
vivo conditions or the neglible changes seen with ill vitro 
conditions (Figure 14). A possible explanation is that the 
one hour time lapse between PMA treatment and explant 
excission is sufficient infiltration of phagocytes. Under in 
vivo conditions, the applied PMA would stimulate these 
phagocytes to produce Op and HpOp with consequent reduction 
in total catalase from the free radical interaction. Under 
in vitro conditions, the skin explants are exposed to higher 
concentrations of oxygen (i.e. approximately 20$, in 95$ 
air:5$ COp circulating incubation atmosphere) than would be
the case under iii vivo condtions (2-3$ oxygen in arterial 
blood). Hyperoxic exposure of rat pulmonary macrophages is 
known to be associated with 3-fold increases in catalase and 
SOD, within 24 hours (Stevens and Autor 1977). These 
investigators also showed that no such changes were seen 
following hyperoxic exposure to lung tissue devoid of 
pulmonary macrophages.
The elevation of catalase observed in the present in 
vivo/in vitro model could be partially due to the PMA 
chemotactically attracting macrophages in the skin which on 
subsequent hyperoxic exposure (as an explant) produce a 
hyperoxic-induced increase in catalase activity. This 
increase may occur to such an extent that any radical 
destruction of catalase activity is masked.
It might also be the case that the smaller initial 
enhancement of catalase in the in. vitro situation may be due 
to the effect of hyperoxia on the few endogenous phagocytes. 
In the isolated iii vitro system, this initial smaller 
catalase increase may not be sustained since the increasing 
PMA dose may cause the stimulated generation of free radicals 
and H 2O 2 resulting in the destruction of the catalase.
An objection to the above hypothesis is that the one 
hour time period between dosing with PMA and excission of the 
skin explant may be too short to permit significant 
infiltration of polymorphonuclear leukocytes. However, Van 
Duuren (1969) found that inflammatory changes were present at 
the first observation time interval he studied of 4 hours 
after PMA cutaneous application. These reached a peak in 
severity at 24 hours, and generally subsided by about 72
hours after application; diffuse epidermal hyperplasia was 
not observed until 24 hours after application. In the 
present studies, extensive oedema of the treated skin was 
found to be present by one hour post PMA treatment.
Similarly, a free radical generating system was reported to 
give rise to a protein-rich oedema in the lung over the same 
short time period (Tate et al. 1982) and the associated 
increase in alveolar-capillary membrane permeability was 
attributed to the oxygen radicals formed.
The hyperoxic associated increase in catalase provides 
an explanation for the overall elevation of catalase found in 
untreated tissue under _in vitro conditions. Again, however, 
the short time frame may limit the degree of phagocytic 
mobility and is it certainly insufficient for the catalase 
elevation to be the result of protein synthesis. It is 
speculated here that the apparent elevation may be the result 
of structural conformational changes providing an enhanced 
activity of the catalase present; guanylate cyclase, a 
prominent enzyme involved in regulating cell growth and 
transformation, is known to be activated in the presence of 
an oxidant-generating system. The possible effects of carbon 
dioxide and of oxygen on cutaneous catalase are studied and 
discussed more fully in Part II of this chapter.
The effects of the tumour promoter, n-dodecane, were 
the same (i.e. a reduction in catalase activity) regardless 
of whether studied totally i_n vivo or in the iri vivo/in vitro 
model. Dodecane, although irritant to the skin, does not on 
single topical application induce the pronounced inflammatory 
response seen with PMA. However, a single topical
application was able to cause a reduction in catalase 
activity, over 24 hr, possibly caused by free radicals 
generated either from phagocytes or from induction of the 
cytochrome P450 monooxygenase system.
n-Dodecane, a weak irritant in comparison to PMA, 
would not be anticipated to cause the chemotaxis of 
polymorphonuclear leukocytes into the skin during the 1 hour 
treatment prior to explant excission. Hence, few phagocytic 
cells would be subjected to the hyperoxic exposure and little 
catalase elevation would occur.
The lack of effect of PMA on catalase activity of skin 
cells treated In vitro supports the hypothesis that 
inflammatory cells play an important role in free radical 
generation. But, this is only indirect evidence and there is 
the possibility that the PMA becomes bound to plastic 
material or breakdowns in the medium. The findings from the 
intermediary _in vivo/ in vitro model, coupled with a possible 
hyperoxic effect, provides further indirect evidence of the 
participation of inflammatory cells in PMA stimulated free 
radical generation although other mechanisms and cell types 
may be involved in the period immediately following exposure.
PART 2 - EFFECTS OF THE INCUBATION ATMOSPHERE ON MOUSE SKIN 
CATALASE
METHODS
The studies to be reported here were initiated to 
clarify the findings of Part I, namely that mouse skin 
catalase activity appears to be elevated under the conditions 
of incubation. Of these conditions, study of the incubation 
atmosphere seemed to be most pertinent since Przygoda et al.
(1985) were in the process of reporting increased growth
rate, saturation density and greater transformation
susceptibility and frequency in Syrian hamster embryo cells
incubated with 20$ CO2 (80$ air). As such effects may be the
result of the altered CO2 content, or consequent change in
other incubation air components such as oxygen, the effects
on mouse skin catalase of varying carbon dioxide and oxygen
concentration in the incubation atmosphere was investigated.
Effect Of 20$ Carbon Dioxide On Catalase In Mouse Skin 
Explants
PMA (10 ug/0.1 ml acetone) or abrasion treatments were 
each applied to the shaved dorsal skins of two groups of 4 
CD1 mice (female, 6 weeks old). After one hour the mice were 
killed and explants from the treatment areas were placed in 
culture under aseptic conditions as described previously.
One group from each treatment was incubated under 
conditions of high carbon dioxide i.e. an 80:20 air/C02 
mixture, the other groups were incubated normally i.e. 
air/C02 (95 s 5)• Total catalase activity of these explants 
was determined as described earlier in this chapter and 
expressed as K/mg protein.
Effect Of 50$ Op Concentrations On Catalase In Mouse Skin In 
Vivo And In Vitro
Acetone (0.1 ml) was applied to shaved dorsal skin of 
3 groups of 3 CD1 female mice (6 weeks old) per group; a 
similar set of 3 groups remained untreated. After 30 
minutes, one set of groups representing the treatments were 
sacrificed by cervical dislocation and skin explants from 
the treatment areas incubated for 30 minutes in a 1 cubic 
metre chamber with an atmosphere containing approximately 60$
oxygen (air/oxygen 50:50 mixture) and a flow rate of 2 
litres/minute. The other set of groups was at this time 
placed in a chamber receiving this same incubation 
atmosphere. At the end of the 30 minute exposure of the live 
animals and explants, the animals were sacrificed by cervical 
dislocature.
The final groups of animals exposed during this period 
to air (100$) were also sacrificed at this time and 
equivalent skin flaps excised. Total catalase was determined 
for each explant and skin flap as described previously in 
this chapter. Tissue samples from each group were retained 
in 10$ buffered formalin for subsequent histological 
preparation, staining with haemotoxylin and eosin, and 
examination for structural integrity and possible 
hyperplasia. Other samples were immersed in Trypan Blue 
(0.2$ in phosphate buffered saline) to assess dye 
exclusion/viability.
Effect Of Hyperoxia And Hypoxia Exposure On Catalase In Mouse 
Skin Explants
Dorsal skin explants from shaved CD1 female mice (6 
weeks old) were placed in Dulbecco's MEM and foetal bovine 
serum as described previously, however, the lid of the 
incubation tray was deliberately omitted and the plate was 
placed on the perforated floor of a 1 cubic litre dessicator. 
Sets of 4 explants were exposed for 30 minutes to 
oxygen/nitrogen mixtures ($):5/95, 10/90, 21/79 (standard
air), 40/60, 60/40, 80/20. These atmospheres were obtained 
premixed and with certified analyses (MG Industries Ref. 
#15-14). However, an Oxygen Indicator (Model 0X-80 Gastech 
Inc. CA) was placed in the dessicator to verify the oxygen
content of the incubation atmosphere. An additional group of 
4 explants of abraded mouse skin was also exposed to the 80$ 
02^20$ N 2 atmosphere. Another group of 4 animals remained 
untreated and exposed _in vivo to laboratory air.
The pH of the medium post-exposure was measured, since 
earlier studies had indicated that a pH change might be 
occurring as seen by a slight colour change of the medium pH 
sensitive dye. Oxygen tension measurements of the medium 
during exposure were erratic (and discounted), because of the 
inability to ensure homogeneity of the medium with respect to 
oxygen tension in the absence of agitation of the medium. At 
the end of the incubation period total catalase was 
determined as described previously in this chapter.
RESULTS
Effect Of 20$ Carbon Dioxide On Catalase In Mouse Skin 
Explants
Incubation for 23 hr under a circulating atmosphere of
air/C02 (80:20), of mouse skin explants which had been
pretreated 'in. vivo for 1 hr with PMA (10 ug/0.1 ml acetone)
or abrasion, did not have any significant effect on catalase
activity (Table 18) when compared to activities of similarly
treated skin explants but which had been incubated under
air:C02 (95:5) for the same period of time (23 hr).
Effect Of 50$ Op Concentration On Catalase In Mouse Skin In 
Vivo And In Vitro
This i_n vivo/in vitro comparative exposure to 60$ air 
showed a marked elevation in catalase of untreated mouse skin 
both _in vitro and in viv o , compared with that from skin of 
mice exposed jLn vivo to air (Table 19); higher values were
TABLE 18
EFFECT OF 20% CARBON DIOXIDE ON CATALASE IN MOUSE SKIN EXPLANTS
TREATMENT
CATALASE ACTIVITY 
(K/mg Protein)
AIR (952):C02 (5%) AIR (80$):C02 (20%)
PMA (10 ug/0.1 ml 
acetone) 12.79 + 3-21 15.04 + 3-32
Abrasion 12.17 1  2.07 14.26 ^  3*79
Acetone (0.1 ml) 12.30 + 1.44 n.d.
n.d. = Not determined
Values given are means +_ SE of duplicate determinations of 4 mouse skin explants 
per group.
TABLE 19
EFFECT OF 60$ 02 CONCENTRATION ON CATALASE IN MOUSE SKIN IN VIVO AND IN VITRO
CATALASE ACTIVITY 
(K/mg Protein)
TREATMENT IN VIVO 
(Lab Air)
IN VIVO 
Air: 02 (50:50)
IN VITRO 
Air: 02 (50:50)
Acetone (0.1 ml) 11.87 14-57 17.40
Untreated skin 11.67 14.86 15.80
Values given are means of duplicate determinations on each of 3 mice per group 
(in vivo) or 3 mouse skin explants per group (in vitro).
EFFECT OF HYPEROXIA AND HYPOXIA
TABLE 20 •
EXPOSURE ON CATALASE IN MOUSE SKIN EXPLANT
SKIN TYPE NOMINAL
OXYGEN
EXPOSURES (%) 
NITROGEN
CATALASE ACTIVITY 
(K/mg Protein)
Explant 5.0 95.0 10.88 + 1.74
Explant 10.0 90.0 12.46 ± 2.26
Explant 21.0A 79.0 13-28 +_ 2.45
Explant 40.0 60.0 14*46 +_ 2.50
Explant 60.0 40.0 14.80 +_ 2.98
Explant 80.0 20.0 14-90 ± 2.75
Explant (abraded skin) 80.0 20.0 16.36 +_ 1.62
In vivo 20. 8b n.d. 8.14 i  1.62
A Standard air 
B Laboratory air 
n. d. = Not determined
Catalase activities are means +_ SE of duplicate determinations on 4 skin explants 
(or for the in vivo group, 4 mice).
TABLE 21
pH OF EXPLANT MEDIUM POST EXPOSURE
EXPOSURE GROUP (02£/N2$) pH OF MEDIUM
Medium per se 7»50
5/95 7.50
10/90 7.52
21/79 7.56
40/60 7.56
60/40 7.64
80/20 7.75
80/20 (abraded) 7.73
also obtained for acetone treated skin under the same 
hyperoxic exposure conditions.
Effect Of Hyperoxia And Hypoxia Exposure On Catalase In Mouse 
Skin Explants
Normal structural integrity and Trypan Blue exclusion 
were seen in sections from each group post exposure. There 
was evidence of a trend of catalase to increase with 
increasing oxygen concentration. The maximum in'vitro value 
(at 80$ oxygen) was 185$ that of mouse skin exposed in vivo 
to laboratory air (20.8$ oxygen). Explants from mouse skin 
abraded 24 hours prior to excision and exposure showed a 
200$, or two-fold, increase in catalase in the equivalent 
comparison. Actual oxygen concentrations were within +_ 2$ of 
nominal indicated (Table 20). The pH of the medium was found 
to increase slightly with increasing oxygen concentration as 
indicated in (Table 21)..
DISCUSSION
These findings of increased total catalase in skin, 
both in explants and iii vivo from exposure to increasing 
concentrations of oxygen is analogous to those reported by 
others for lung tissue. Stevens and Autor (1977) found a 
three-fold increase in catalase, and two-fold increase in 
mitochondrial superoxide dismutase of rat pulmonary 
macrophages following 24 hours of either in vivo or in_ vitro 
hyperoxic exposure. They noted that the superoxide dismutase 
and catalase responses were found to be age dependent in rat, 
the neonatal animal having more catalase than the adult; this 
correlated with the extraordinary resistance of this neonate 
to oxygen toxicity. They also reported, that the enzymes were
localized specifically in the pulmonary macrophages and the 
result of induced protein synthesis. For the latter however, 
the short observed response time (30 minutes) in the present 
studies seems too rapid for much protein synthesis to occur. 
This is supported by the similar values for catalase obtained 
whether expressed as protein weight or by weight of wet 
tissue.
Other changes have been associated with oxygen 
exposure. Lahr (1983) showed that normobaric oxygen (100$) 
exposure for 72 hours resulted an elevation of levels of 
exogenous serotonin in the lung by 183$ and 200$ at 0 hr. and 
24 hr. post exposure; the ability of lung tissue to hydrolyse 
angiotensinl via angiotensin converting enzyme, was also 
enhanced. Reaven and Cox (1968) report that 40$ oxygen 
dramatically increased the mitotic rate of human cells in 
culture. It is possible that the greater transformation 
susceptibility and frequency reported by Przygoda et al. 1985 
for Syrian hamster embryo cells incubated at 20$ C02/80$ air, 
may be due to the alteration in oxygen concentration rather 
than the concentration of carbon dioxide per s e .
In the present studies, there was a slight but not 
statistically significant increase in catalase when explants 
were incubated under 20$ C02 , however, a slight pH change 
towards alkalinity was observed. Margoliash et al. (i960) 
showed no effect of a pH change 5*5 to 9*0 for the inhibition 
of catalase by 3-amino 1 ,2 ,4-1riazole in the presence of 
hydrogen peroxide. Reaven and Cox (1968) noted that a change 
in the pH of the growth medium from pH 7.1 to pH 7.5 induced
the continual production of keratohyalin granules but was 
without increase in mitotic rate in the human skin explant.
In their study of the reparative changes following 
oxygen-induced lung injury, Lahr et al. (1983) reported that 
one form of lung monoamine oxidase was increased throughout 
the reparative phase, being significantly elevated 128$ at 72 
hours and 139$ at 168 hours. This finding and the results 
here of elevated catalase associated with hyperoxia may be an 
alternative explanation of the findings by Verma and Boutwell 
(1980) of a dramatic 20 fold increase in ornithine 
decarboxylase of PMA treated mouse skin in vitro, since they 
(Verma and Boutwell) used an incubation atmosphere of 95$ 
oxygen and 5$ C0 2 « While ornithine decarboxylase induction 
from PMA treatment has been reported in vivo (O'Brien 1976), 
the dramatic increases reported by Verma and Boutwell may be 
due in part to the hyperoxic incubation conditions, or the 
combined effects of PMA and hyperoxia exposure. It would 
also suggest that such biochemical studies of explants in 
vitro should be carried out at two different incubation 
atmospheres to ensure differentiation of the effects 
observed. Better still, if viability can be maintained, the 
oxygen tension of the explant medium should better mimic that 
of body fluids i_n vivo (approximately 2-3$ oxygen).
Increased cell content of superoxide dismutase in 
response to increased oxygenation has been found in a wide 
range of microrganisms and in mammalian systems such as the 
mammalian endothelial cells described here. Where hyperoxic 
conditions are encountered in nature, superoxide dismutase 
elevations are also present. Examples of this include the
swim bladders of some fish which contain nearly 100$ oxygen; 
in these cases, the swim bladder epithelum has a much higher 
superoxide dismutase activity than other tissues (Morris and 
Albright 1981).
Unlike the internal organs of the mammalian body which 
are shielded against the toxicity of hyperoxia by the finite 
oxygen carrying capacity of haemoglobin, the lungs, skin and 
eyes are directly exposed. Retrolental fibroplasia, once a 
major cause of blindness in infants, is an expression of 
oxygen toxicity to the eyes and was incurred when premature 
infants were placed in oxygen-filled incubators. Since both 
skin and lung respond to hyperoxia by induction of catalase 
and superoxide dismutase, the-eye would also be suspected of 
possessing some similar protective mechanism.
The findings reported here of an apparent elevation in 
catalase in mouse skin exposed iji vivo to hyperoxic 
atmosphere are novel. Low pressure hyperbaric oxygen therapy 
is used clinically to facilitate wound healing such as in the 
treatment of leg ulcers; the oxygen has been shown to 
penetrate to the dermis and enhance collagen synthesis (Heng 
et al. 1984). Due to the thinness of the mouse epithelium it 
seems reasonable to suggest that the hyperoxic conditions 
used in the present studies increased the extracellular 
oxygen tension and allowed oxygen to be in direct contact 
with epidermal cells including endogenous macrophages; the 
result could be an elevation in catalase like that described 
for lung tissue under hyperoxic conditions.
Stevens and Autor (1977) showed that the increase of 
superoxide dismutase and catalase occurred from hyperoxic
exposure of pulmonary macrophages. These macrophages, while 
active in the phagocytosis of intra-alveolar debris resulting 
from oxygen toxicity, may contain under hyperoxic conditions 
an increased flux of reduced products of oxygen metabolism. 
The induction of catalase and superoxide dismutase may 
protect these cells from autoxidation by the high levels of 
reactive oxygen products generated.
Thus, these findings of catalase induction reported 
here for the skin both iri vivo and in vitro, and by others 
for the lung, indicate that the increase in catalase may be a 
compensatory response to counter oxygen toxicity; they also 
indicate the additional and significant role of inflammatory 
cells including macrophages in this respect.
CHAPTER 5
EFFECT OF FREE RADICAL GENERATION ON CYTOCHROME P450 
HYDROXYLATION REACTIONS IN MOUSE SKIN
INTRODUCTION
Since it has been confirmed.in the preceding chapters 
that hydrogen peroxide, and supposedly other oxygen reduction 
products such as superoxide anion and free radicals, are 
generated in mouse skin from treatment with PMA and with 
alkanes, a study of the influence of these treatments on 
cutaneous mixed function oxidase hydroxylation reactions was 
attempted. In addition, it was hoped to investigate whether 
induction of cutaneous mixed function oxidase hydroxylation 
activity was possible by application of alkanes to the skin, 
since induction of hepatic mixed function oxidase 
hydroxylation has been shown from Oral administration of 
n-alkanes (Rapovski et al. 1983).
Traditionally, the skin has been regarded as a passive 
structural barrier to the penetration of foreign compounds, 
but it is now known to possess enzymes capable of 
metabolizing a variety of xenobiotics. Few studies on 
xenobiotic metabolism in the skin have been reported because 
of the difficulty in isolating active enzyme preparations 
from the skin. Of these studies, most have examined the aryl 
hydrocarbon hydroxylase activity (AHH) in homogenates of skin 
from man, rat, and mouse; this activity appears to play a 
crucial role in the biotransformation of polycyclic aromatic 
hydrocarbons into reactive moieties including the ultimate 
carcinogens, such as the diolepoxides as shown in the study 
by Sims et al. 1974 of the metabolic activation of 
3 ,4-benzpyrene.
Extensive studies in strains of inbred mice have shown 
that any hydrocarbon hydroxylase activity and inducibility is
a dominant inherited trait. Those strains with inducible 
activity are more susceptible to induction of tumours by, for 
example, polycyclic aromatic hydrocarbons (Nebert et al.
1 972).
The Millers (1974) suggested that carcinogenic 
chemicals first undergo metabolic conversion to a proximate 
tumourigen by cytochrome P-450 dependent monooxygenases which 
are found on the cell membranes. Parke (1979) noted the 
broader role of mixed function oxidases in detoxification and 
activation and the conversion of cytochrome P-450 to 
cytochrome P-448. This is believed to be due to either 
damage to membranes, complex formation, or uncoupling of 
electron transport.
Virtually, all of the early studies of this mixed 
function oxidase system were conducted with the liver and 
while there is little doubt that hepatic tissue is a major 
site for drug metabolism in the body, recent studies show 
that active xenobiotic metabolism can occur in extrahepatic 
tissues such as the skin (Bickers et al. 1982).
All cytochromes are haemeproteins, and participate in 
electron transfer reactions by the iron atom of the haeme 
moiety undergoing a reversible oxidation - reduction. In 
determining the activities of these cytochromes, it is 
necessary to isolate and fractionate the endoplasmic 
reticulum, and to assay the microsomal fraction. The 
microsomal fraction is a heterogeneous mixture of vesicles 
and fragments operationally grouped as the slowest 
sedimenting particles of the subcellular homogenate.
Multiple forms (isoenzymes) of cytochrome P-450 are 
known to exist in the liver and other organs. These 
isoenzymes differ in their physicochemical properties, 
immunological characteristics, amino acid sequences, 
substrate specificity and enzyme kinetics (Lu and West 1980). 
They are all classified on the basis of distinctive 
spectrophotome trie characteristics and are segregated into 
groups designated by lower case letters (a, b, c, etc.). 
Cytochrome P450 is a cytochrome of the b type. This 
cytochrome was first identified, by Omura and Sato (1964), as 
a carbon monoxide binding pigment of microsomes; unlike other 
cytochromes which are named from the absorbence maximum of 
the reduced form in the visible spectrum, cytochrome P-450 is 
named for the unique absorption maximum of the carbon 
monoxide derivative of the reduced form at about 450 nm. It 
is also known to be the terminal oxidase in mixed function 
oxidase reactions.
Since microsomal preparations are particulate and 
therefore light scattering, difference spectroscopy is used 
to balance out light scattering and nonspecific absorption. 
For oxidized cytochrome P-450 the main difference binding 
spectra are Type I with an absorption maximum at 390-395 nm 
and a minimum at approximately 420 nm, and the Type II 
spectrum with maximum at 420-435 nm and minimum 390-410 nm. 
The most important difference spectra of reduced cytochrome 
P-450 are:
(1 ) the carbon monoxide spectrum with maximum absorbance at 
450 nm.
(2) type III spectrum (maxima at 430 and 455 nm) such as 
occurs with the potent MFO inhibitor SKF-525A.
The generally recognized mechanism for the cytochrome 
P-450 function is shown in Figure 15* The substrate is bound 
to the oxidized cytochrome followed by a one electron 
reduction of the cytochrome P-450 (Fe^+ )-substrate complex, 
via a reduced flavoprotein (NADPH)-cytochrome P-450 
reductase. By interaction with molecular oxygen, a ternary 
reduced cytochrome P-450 (Fe^+ )-substrate-oxygen complex is 
then produced. This, on accepting an electron from an 
unknown donor (suspected to be cytochrome btj), forms an 
active oxygen-cytochrome P-450 substrate complex. Internal 
rearrangement then results in one atom of molecular oxygen 
being lost as water, the other is incorporated to form the 
oxidized product which is released with generation of the 
resting ferric state of the enzyme.
As will be seen from Figure 15» the enzymically 
generated superoxide may serve as an activated form of oxygen 
in hydroxylation reactions. Externally generated superoxide 
anion (by means of xanthine and xanthine oxidase) has been 
shown to couple with cytochrome P-450 to support the 
hydroxylation of benzphetamine and ethylmorphine; further 
evidence for the involvment of this anion is that superoxide 
dismutase has been shown to inhibit benzphetamine 
hydroxylation in the rodent liver (Strobel and Coon 1971). A
number of investigators (Fridovich and Hanler 1958; Ballou et
al. 1969) have proposed that superoxide may play a role in 
reactions catalysed by mixed function oxidases.
Wickramsinghe and Vallee (1977) have extended this even 
further by suggesting that cytochrome P-450 has a role in the 
detoxification of tissue oxygen.
The potential of chemicals to promote carcinogenesis 
may depend on their ability to damage the endoplasmic 
reticulum and modify or inhibit cytochrome P-450 (Parke
1979); the tumour promotors of interest here, PMA and 
alkanes, have been reported earlier to interact with cell 
membranes. While previously it was thought that damage to 
the endoplasmic reticulum would lead to the conversion of 
cytochrome P-450 to cytochrome P-448 by a binding site 
blockage or conformational change, it is now known that 
cytochrome P-448 exists in its own right and can be induced 
by c[e novo synthesis (ioannides et al. 1984).
Cytochrome P-448 activity appears to be associated 
with malignancy, and in malignant tissue it has been shown to 
predominate over cytochrome P-450; its appearance, with 
simultaneous disappearance of cytochrome P-450, is one of the 
earlier events seen in malignant cell transformation (Parke
1980). It was for these reasons, and the fact that 
cytochrome P-448 activity is induced by many carcinogens, 
that it was included here in the present studies.
In the measurement of these cytochromes, the 
CO-binding spectra give only approximate estimates even for 
hepatic tissue. Moreover, they are difficult to obtain from 
the skin due to the low concentrations present and the even 
further destructive reduction of these concentrations during 
tissue homogenization. Measurement of aryl hydrocarbon 
hydroxylase as noted earlier, does not allow the distinction 
of the enzymatic activities of cytochrome P-450 and 
cytochrome P-448 due to the non-specificity of the substrate.
Aryl hydrocarbon hydroxylase activity determined 
fluorimetrically with 3»4-benzpyrene as substrate and 
3-hydroxybenzpyrene as standard measures primarily, those 
metabolites, 3- and 9-phenols with similar fluorescence to 
the 3-hydroxybenzpyrene. However, these phenols can occur 
from the activities of different isoenzymes of cytochrome 
P-450 and cytochrome P-448 and not specifically cytochrome 
P-448. Additional compounding factors are that 
3-hydroxybenzpyrene undergoes enzymic oxygenation with loss 
of fluorescence, and that 3 »4-benzopyrene is converted to a 
fluorescent product by artificial light. Because of the 
above, Phillipson et al. (1984) note that conclusions based 
•on data soley from the use of the aryl hydrocarbon 
hydroxylase assay, even if accompanied by inhibitor studies, 
must at best be regarded with scepticism.
In fact, Chapman et al. (1979 and 1980) reported a 
reduction in the activity of aryl hydrocarbon hydroxylase 
activity in epidermis from patients with psoriatic lesions 
compared to the skin of patients without this disease. 
However, members of this research team have subsequently 
recognized the limitation of the assay technique and have 
published a retraction of this data (Rawlins & Shuster 1982)
The 2-hydroxylation of biphenyl, although a specific 
assay for cytochrome-P448, lacks the necessary sensitivity 
particularly at the low concentrations encountered in 
extrahepatic tissues. Specific antisera do allow quantifica 
tion but there are associated problems of cross-reactivities
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The approach adopted here is the use of specific 
substrates that show high or absolute specificity towards 
only one form. Cytochrome P-450 may be specifically 
determined in solubilized hepatic tissue by N-demethylation 
of benzphetamine (ioannides 1983). Similarly, cytochrome 
P-448 can be exclusively determined by the deethylation of 
ethoxyresorufin to resorufin (Burke and Mayer 1975); this 
assay is as sensitive as the aryl hydrocarbon hydroxylase 
assay, much more specific, and more sensitive to induction of 
cytochrome P-448 activity (Phillipson et al. 1984)-
Other investigators (Bickers et al. 1984; Pohl et al. 
1976; Maloney, 1980) have had some success at determining 
less specific activities such as aryl hydrocarbon hydroxylase 
and 7-ethoxycoumarin O-deethylase in mouse and rat skin 
following induction. However, attempts to measure 
benzphetamine N-demethylation or ethoxyresorufin deethylation 
have not been reported previously using mouse skin.
A major problem in studying any such activities is the 
presence of structural proteins in the skin that are 
resistant to the conventional homogenizing techniques that 
have been shown to work so well for hepatic tissue. In 
consequence, the greater severity of the procedures that have 
to be used to obtain the subcellular fractions is liable to 
destroy the enzymes which in any event are present at much 
lower concentrations than occur in hepatic tissue.
The studies to be described were carried out in the 
Department of Biochemistry, Surrey University, Surrey, U.K., 
or in the School of Pharmacy, Rutgers University, NJ, U.S.A. 
In these studies, various procedures were utilized in an
attempt to minimize the denaturation and obtain the 
absorption spectrum of reduced cytochrome P-450 carbonyl 
complex. In addition, attempts were made to measure 
benzphetamine N-demethylation and ethoxyresorufin 
0-deethylation in microsomal preparations of whole mouse skin 
with and without pretreatment with PMA or n-dodecane.
MATERIALS AND METHODS 
Chemicals
Obtained from Sigma (Poole, Dorset, UK) were: NADPH,
tetrasodium salt type 1; NADP, sodium salt;glucose-6- 
phosphate, barium salt; glucose-6-phosphate dehydrogenase, 
type XII. Benzphetamine was obtained from Upjohn Co. 
(Kankehee, 111. USA). Resorufin and ethoxyresorufin were 
obtained from Pierce Chemicals (Rockford, 111. USA). All 
other chemicals were of laboratory grade or analytical grade 
where available.
Animals
CD-1 female mice of the same age (6 weeks) and source 
(Charles River) as those used in the studies reported in 
earlier chapters, were used here for biochemical 
determinations. As Manil et al. (1931) have reported that 
the induction of arylhydrocarbon hydroxylase activity by 
polycyclic hydrocarbons is only possible during anagen phase 
of the hair growth cycle attention was again paid to the use 
of test groups of mice in the same and known hair growth 
phase. This would minimize inter-animal responses and allow 
interstudy comparison of results obtained in each case.
NADH cytochrome c reductase and cytochrome oxidase 
(Carruthers et al. 1959)* and glucose-6-phosphate 
dehydrogenase (Crovato 1971) have also been reported to 
change during the hair cycle. With enzymatic and structural 
changes occurring it is important to use, as far as possible, 
animals in the same hair cycle phase when conducting 
biochemical investigations of the skin.
TREATMENT
To. the shaved dorsal region of each of 6 mice, 0.1 ml 
aliquots of either PMA (5 ug/0.1 ml acetone) or n-dodecane 
were applied by automatic pipette 24 hours prior to sacrifice 
and subsequent microsomal preparation. Groups of 6 shaved 
but untreated animals were also maintained as controls. This 
treatment regimen was selected based on the knowledge gained 
previously of the effects of this dose of PMA or n-dodecane 
on catalase activity. The induction of cytochrome P-450 
and/or cytochrome P-448 by this treatment was considered as a 
possible confounding factor; PMA has been shown to induce 
skin ornithine decarboxylase activity (involved in polyamine 
synthesis) 6 hours after dosing (Mufson et al. 1979)* however 
no information has been located as to the effects of PMA or 
n-dodecane on skin microsomal cytochrome P-450 activities.
PREPARATION OP TISSUE
Groups of four female CD-1 mice (6 weeks), either 
treated or control, were sacrificed by cervical dislocation 
and the treated area (2 sq. cm) of dorsal whole skin 
immediately excised; this and subsequent operations were
carried out in a cold room at 4°C. The underlying lipid and 
blood vessels were scraped from the skin while placed on an 
inverted beaker immersed in ice. The tissue was finely 
minced with scissors and 0.75 g of tissue was placed in a 
thick walled tube with 6.75 ml of ice-chilled 25mM 
hydroxyethylpiperazine-N-2-ethanesulphonic acid (HEPES) (pH 
7*6) containing 1.15% KC1.
Each tube was subjected to four separate bursts (#6 
setting) of a Polytron tissue homogeniser (Brinkmann 
Instruments, Westbury, NY) while ensuring a temperature of 
approximately 4°C using a surrounding ice-salt mixture. The 
homogenate was then placed in a ground glass Potter tissue 
homogenizer and homogenized by six passes of the teflon
pestle rotating at 400 r.p.m., again ensuring that the low
\
temperature condition was maintained. The homogenate was 
drawn through surgical gauze soaked in 0.15 M ice cold 
HEPES-KC1 using a Buchner flask and funnel.
The filtrate was centrifuged at 10,000 X g in a 
Beckman JS-21 centrifuge for 20 minutes to remove nuclei and 
mitochondria, and a sample of this resuspended pellet 
retained for spectral analysis (S9 fraction). The 
supernatant was spun at 105»000 g for 1 hour at 4°C in a 
Beckman L5-65 ultracentrifuge using a Ti-60 fixed angle 
rotor. The microsomal plug was washed by resuspending in 
ice-cold.HEPES-KC1 and recentrifuged for 1 hour. The 
microsomal pellet was stored overnight at -70°C by overlaying 
with a 0.1 M phosphate buffer (pH 7*4) containing 20$ 
glycerol (v/v), and 10 mM EDTA, and then frozen at -70°C.
The above procedure is essentially that of Pohl et al. 
(1976). These investigators, as well as determining 
arylhydrocarbon hydroxylase and 7-ethoxycoumarin deethylase 
activities, had also carried out characterization of the 
microsomal pellet by electron microscopy; the electron 
micrographs showed the presence of microsomal vesicles and 
some contaminating membrane fragments.
Liver S-9 and microsome fractions were also isolated 
from 33*3% (w/v) homogenates in KCl/HEPES by centrifugation 
as described for the skin. Washed microsomes (liver or skin) 
were resuspended in KC1-HEPES and the protein content 
determined by the method of Lowry et al. (1951)•
SPECTRAL ANALYSIS
The cytochrome P-450 difference spectra of the S-9 
fraction or of the microsomal preparations was attempted 
using an Hitachi 220 A scanning spectrophotometer. 
Modifications to the above microsomal preparative procedure 
were made to prevent denaturation of cytochrome P-450; these 
included use of deionized water and 0.1 mM EDTA, swinging 
bucket rather than fixed angle rotor, HEPES-KC1 containing 
20$ glycerol or sucrose. Use of HEPES-KC1 containing 20$ 
glycerol and 0.1 mM EDTA was subsequently adopted for the 
induction trial with PMA.
Microsomes were suspended (skin:0.5-1•5 mg of protein 
per ml in 0.1 M KC1-HEPES buffer pH 7*6; and liver:1.0 mg of 
protein per ml of buffer) and CO-and dithionite-treated minus 
dithionite-treated difference spectra were recorded according 
to the method of Omura and Sato (1964)*
ENZYME ASSAYS
Benzphetamine N-demethylation
Benzphetamine N-demethylation was determined by 
measuring the formaldehyde formation using the Nash reaction 
(Nash 1953; Werringloer 1978). The incubation mixture of 
total volume 2.55 ml, contained 0.06 M benzphetamine, 
approximately 3 mg microsomal protein, semicarbazide 
hydrochloride (2%) at pH 7*0, 0.1 M, MgCl2 , and 0.03 M 
glucose-6-phosphate . A 10 minute incubation was initiated by 
addition of 2.5 mM NADP+ and terminated by addition of 15$ 
ZnSO^. (1 ml) followed by a 2:1 mixture of Ba(0H )2 and Na2B^0y 
(1 ml). The protein was removed by centrifugation and 2 ml 
aliquots of the supernatant were added to 2.0 ml Nash reagent 
(4M-ammonium acetate containing 4 ml/litre of acetylacetone). 
The mixture was incubated for 40 minutes in a shaking bath at 
37°C. Appropriate blanks and standards were carried through 
the same procedure and a standard curve established. The 
absorption at 412 nm was measured using a Cecil CE292 digital 
ultraviolet spectrophotometer. The activity was expressed as 
n moles HCHO formed/g tissue/minute.
Ethoxyresorufin 0-deethylation
The 0-deethylation of ethoxyresorufin by microsomal 
suspensions derived from skin or liver was also carried out 
using a modification of the method of Burke and Mayer (1977). 
The reaction mixture containing 50 uM ethoxyresorufin (10 ul) 
and approximately 3 mg microsomal protein in a total volume 
of 2 ml of 0.1 M Tris-HCl buffer pH 7-8, was placed in a 
spectrofluorometrie cuvette thermostatically controlled at 
30°C.
After establishing a fluorimetric base line 
(excitation wave-length, 510 nm; emission wavelength of 586 
nm) on a Perkin Elmer MPF-3 fluorescence spectrophotometer, 
the reaction was initiated by the addition of 50 mM NADPH (10 
ul) and the increase in fluorescence was measured over a 5 
minute period. A standard curve was constructed using 10 ul 
aliquots of 0.01 mM resorufin in ethanol over the range 10 - 
50 ul. Based on the standard curve, the fluorescence 
intensity was proportional to the concentration of resorufin 
liberated in the range 0.5 - 400 nM. Ethoxyresorufin 
O-deethylase activity was expressed as n mol resorufin 
formed/g tissue/minute.
Glucose-6-phosphatase
The hydrolysis of glucose-6-phosphate was conducted 
using a modified method based on that of Zakin and Vessey 
(1973)- Hugan et al. (1971) included 1$ ethylene diamine 
tetraacetic acid in the incubation mixture as a zinc chelator 
to suppress alkaline phosphatase activity; this addition was 
incorporated in the assay used here.
The incubation medium of 1 ml total volume, contained 
0.4 M glucose-6-phosphate (sodium salt, 0.2 ml, in 1$ EDTA at 
pH 6.0), approximately 0.5 mg microsomal protein (skin) or 
0.1 mg protein (liver), and 1.0 M sodium acetate buffer (0.1 
ml) at pH 6.0. The reaction was started by the addition of 
glucose-6-phosphate and stopped after 15 minutes by the 
addition of 10$ (w/v) trichloroacetic acid (0.5 ml). The 
precipitated protein was removed by centrifugation. Ferrous 
sulphate solution (1.0 ml) was then added to 0.24 ml of 
supernatant in 5 ml ammonium molybdate solution (1 .6$ w/v in
0.5 M H 2SO4 ). A suitable standard (KH2PO4 (anhydrous 1 .36 1 
g/l) was treated similarly. After 15 minutes, absorbances of 
the test and standard mixtures were recorded at 660 nm using 
a Cecil 305 spectrophotometer. The colouration produced on 
addition of the ferrous sulphate solution was linear with 
inorganic phosphate concentrations up to an optical density 
of 1 .0 .
NADPH-cyt0chrome-c-reduc tase
The activity in skin and liver microsomal preparations 
was measured essentially by the method of Williams and Kaumin 
(1 962).
The following reagents were added to a sample and a 
reference cuvette: cytochrome c (0.1 mM, 1.0 ml), 0.2 ml
microsomal suspension (approximately 3 mg protein/ml) and 
potassium phosphate buffer (0.05 M, 1.7 or 1.8 ml at pH 1.6 
containing 10”3 m potassium cyanide). The total volume 
contained in each cuvette was 3*0 ml. After the 
establishment of a base line, the reaction was initiated by 
adding 0.1 ml of 0.03 M NADPH to the sample cuvette only and 
the reaction was immediately followed at 550 nm for 2 minutes 
using a Cecil 303 spectrophotometer.
RESULTS
Spectral Analysis
In agreement with Pohl et al. (1976) the microsomal 
protein yield from mouse skin preparations was 1 - 3 mg per
gram of tissue compared with 12 - 18 mg per g of liver from 
these animals. These authors showed that the preparative 
method used here produces microsomal vesicles albeit with
some contamination with membranous fragments. Further 
characterization of the microsomal fraction was not 
achievable using glucose-6-phosphatase, the usual liver 
microsomal marker, since this was not detectable in any 
fraction. This result confirms the same finding by Maloney 
(1 980) of apparent lack of glucose-6-phosphatase activity in 
skin microsome preparations. NADPH-cytochrome-c-reductase 
activity which is localized in the microsomes and believed to 
function as a component of mixed function oxidase was only 
present at 12$ of that found ■ here in the mouse liver; Pohl 
et al. (1976) report a similar percentage difference.
Identification of cytochrome P-450 from the difference 
spectra was made difficult by the low protein concentrations 
present, instability of the cytochrome, and the presence of 
contaminants thought to include mostly cytochrome oxidase and 
cytochrome P-420. The CO/dithionite-reduced minus 
dithionite-reduced spectra for PMA-treated and untreated 
mouse skin liver microsomes are shown in Fig. 16. Similar 
spectra were obtained with microsomal preparations of mice 
treated with n-dodecane. Cytochrome oxidase has an 
absorption minimum at 445 nm and maximum at 460 nm under the 
assay conditions used for cytochrome P-450 and has been 
reported by Pohl et al. (1976) to interfere with cytochrome 
P-450 measurements.
The spectral trace for mouse skin (Figure 16) shows a 
substantial absorbance peak at 420 nm which is probably due 
to (reduced) cytochrome P-420 present partly as a degradation 
product; indeed efforts to stabilize cytochrome P-450 by 
means of glycerol and EDTA resulted in a slight reduction of
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the absorbance maximum at 420 nm and a concommitant increase 
in the peak at 450 nm. It is suggested by Pohl et al. (1976) 
and Maloney (1980) that the variable absorbances obtained 
between 420 - 450 nm may be largely due to the degree of 
severity of preparative procedures effecting the presence of 
cytochrome P-420 and cytochrome oxidase. Haemoglobin, 
another possible contaminant, was not found to be present by 
Pohl et al. (1976), nor in the present study.
Despite a number of attempts, it was not possible to 
measure cytochrome P-450 spectrophotometrically in the skin 
microsomes from treated or control mice by this means in the 
present study. In fact, solubilizing and subsequent 
fractionation of skin microsomes to remove contaminating 
cytochrome oxidase and cytochrome P-420 as carried out by 
Pohl et al. (1976), appears to be the only way to obtain such 
quantification.
ENZYME ASSAYS
As an alternate to spectral measurement of cytochrome 
P-450, enzyme activity for a substrate (benzphetamine) was 
measured recognizing that it may not represent all the 
cytochrome P-450 types present. In this study, no 
benzphetamine demethylation activity was detected.
Similarly, for cytochrome P-448, no significant deethylation 
of ethoxyresorufin was detected in the skin preparation 
although the mouse liver preparation was found to have 
significant activity (0.135 n mols resorufin/g liver/minute). 
NADPH cytochrome c reductase activity was 2.3 u mols/g 
skin/minute in the mouse skin and 16.2 u mols/g liver/minute
TABLE 22
SUMMARY OF MIXED-FUNCTION OXIDASE ACTIVITY DETERMINATIONS
ENZYME ACTIVITY
MOUSE TISSUE 
(NO TREATMENT)
Skin Liver
Benzphetamine demethylase n mol HCHO/g tissue/min. n.d. --
Ethoxyresorufin deethylase n mol/g tissue/min. n.d. 0.13
Glucose-6-phosphatase u mol PO^/g tissue/hour n.d. 26.4
NADPH cytochrome-c-reductase u mol/g tissue/min. 2.3 16.2
n.d. = not deleted
  = not determined
Four CD1 £ mice per determination
for the mouse liver. These results are summarized in Table 
22. Treatment with PMA or n-dodecane had no effect on the 
above activities for liver or skin.
DISCUSSION
The ethoxyresorufin deethylase activity obtained above 
for the mouse liver is in the range of that obtained by Long 
et al. (1981) using non-induced mouse liver microsomes. Such 
agreement with the literature confirms that the assay was 
working appropriately for mouse liver tissue but it is 
realized that these same condiions may not have been suitable 
for the assay of these activities in mouse skin, nor 
sensitive enough to detect the low activities that might 
exist in skin. More likely, however, is the possibility that 
the homogenizing and preparative procedures caused a 
substantial degradation of both cytochrome P-450 and 
cytochrome P-448 in the skin, although the latter is 
relatively stable. The stability of these cytochromes in the 
liver under the same preparative conditions could be due to 
possible different types of these cytochromes being present, 
or to the presence of hepatic inhibitors of cytochrome P-450 
destructive factors or to the different tissue compositional 
matrix (lack of collagen) causing less disruption during 
homogenization.
Por benzphetamine N-demethylase activity in mouse 
liver, Levi and Hodgson (1983) reported an activity of 25 n 
mol product/n mol P-450 per 10 minutes, which is similar to 
the values obtained here for mouse liver.
The greater intrinsic activities present in hepatic 
tissues facilitates the distinction of the cytochrome from 
contaminants. In this respect, detection of the greater 
activities from induced skin might have been more'successful 
but this was outside the purpose of the study. Even with 
induced (and non-induced mouse skin) Maloney (1980) reported 
that substantial absorbance at 420 nm occurred in these 
microsomal preparations. In an attempt to protect cytochrome 
P-450 from degradation he added a variety of compounds, 
including benzphetamine to the medium; none decreased this 
absorption maximum at 420 nm. He commented that the 420 nm 
peak had not been proved definitely to be cytochrome P-420 
and even suggested that the 420 nm species might also be 
present iji vi vo. Pohl et al. (1976) show absorption at 420 
nm (and none at 450 nm) in the intact perfused mouse skin.
Bickers and Kappas (1980) state that, ”A major reason 
for the sparceness of information in the literature 
concerning drug metabolism in the skin is the extreme 
difficulty encountered in the preparation of cutaneous tissue 
for metabolic study.” The structure and composition make it 
very difficult to obtain sufficient cell disruption and 
fractionation. In addition, the relatively low enzyme levels 
in the skin frustrate the use of standard hepatic enzyme 
assays which for the most part lack the sufficient 
sensitivity for use in the skin.
It is a shared frustration that direct 
spectrophotometric measurement of cytochrome P-450 in 
untreated mouse skin has also defeated the majority of 
investigators. Pohl et al. (1976) overcame this to some
extent by separating the skin microsomal cytochromes from 
cytochrome oxidase by solubilisation with sodium cholate. 
Subsequent fractionation with ammonium sulphate allowed a 
cytochrome P-450 content in untreated skin to be computed as 
0.022 n mol/mg of protein and that for cytochrome P-420 of 
0.066 n mol/ml of protein.
Pohl and his co-authors further noted the distortion 
of the 450 nm band which they attributed to the presence of 
high concentrations of cytochrome oxidase released from 
disrupted mitochondria; the absorbance peak was displaced 
somewhat to a longer wavelength and appeared as a shoulder to 
the cytochrome P-420 absorbance peak.
Maloney (19SO) used succinic dehydrogenase as an 
indicator of mitochondrial disruption since its presence 
would also imply the contamination by cytochrome oxidase.
Some of the milder homogenization procedures (Potter/ 
Polytron) he adopted were attempted here, although the 
initial procedure of Pohl et al. (1976) was eventually 
selected to permit close comparison of the results this group 
had obtained.
Aniline hydroxylase was not chosen as a indicator of 
cytochrome P-450 activity although its activity in mouse skin 
microsomes has been reported by Pohl et al. (1976); it is not 
clear that aniline hydroxylase represents a cytochrome P-450 
dependent reaction since it has been shown that flavins and 
haemoproteins can also catalyze the reaction. Maloney (1980) 
in his thesis specifically advised against the choice of 
aniline hydroxylase for study of monooxygenase activity in a 
poorly-defined system such as skin.
Under the conditions of the assays used, no cytochrome 
P-450 activities were detected in microsomes from either 
untreated or PMA-treated or dodecane-treated skin. Hence, no 
assessment could be made of the possible contribution of 
treatment generated free radicals to the hydroxyiation 
reactions of cytochrome P-450 which had been proposed by 
Stobel and Coon (19T1) from their work on purified rabbit 
liver cytochrome P-450. No ethoxyresorufin deethylase 
activity was detected in the mouse skin indicating that no 
cytochrome P-448 activity was present. This is surprising 
since cytochrome P-448 is believed to activate carcinogens 
such as benzo(a )pyrene and the mouse skin is a sensitive 
mddel of the carcinogenic activity of this and other 
polycyclic hydrocarbons. The possible effect of free radical 
generation on cytochrome P-448 activity or integrity could 
not be further addressed here. This could prove to be the 
subject of worthwhile research once. techniques for the assay 
of these cytochromes in mouse skin are better established.
CHAPTER 6
STIMULATED OXYGEN CONSUMPTION 
SCREENING MODEL FOR INFLAMMATION POTENTIAL
INTRODUCTION
The increased respiratory hurst that accompanies 
superoxide and hydrogen peroxide production has been 
described as one of the effects of PMA stimulation of 
macrophages. The oxygen consumption associated with this 
respiratory burst is now described in more detail, together 
with experimentation, to support its use in a novel test 
system for assessing skin irritation potential.
OXYGEN CONSUMPTION
It has been noted in previous chapters that 
phagocytosis of bacteria by polymorphonuclear leukocytes and 
the action of other soluble and insoluble stimuli leads to 
the activation of a pyridine nucleotide oxidase. This is 
believed to be responsible for the resultant sharp increase 
in oxygen consumption which in the case of PMA, occurs 
approximately 40 seconds after addition of the phorbol ester 
to the PMA suspension. This phenomenon is the respiratory 
burst, measurement of which under these conditions reveals an 
oxygen consumption of 110 _+ 18 (mean _+ SD) nanomoles O2/5 X 
10^ cells/10 minutes. Markert et al. (1980) using opsonized 
zymosan particles demonstrated that the initial oxygen 
consumption could essentially be accounted for by measurement 
of the superoxide production, measured over the same time 
interval.
The pyridine nucleotide oxidase, believed to be 
dormant in resting cells, catalyzes the reduction of oxygen 
to 02~ (Babior 1982):
202 + NAD (P )H ----> 202~ + NAD (P)+ + H +
It is the action of this oxidase, located on the 
plasma membranes of neutrophils and macrophages, that 
accounts for the measured uptake of oxygen and for the 
liberation of O2" by activated cells.
Goldstein et a l . (1983) hypothesized that it is 
predominantly the infiltrating phagocytic cells which are 
involved in the superoxide/free radical generation in the 
skin following topical application of PMA and the other 
tumour promoters investigated. This is supported by the 
findings in this thesis that greater superoxide generation 
measured by hydrogen peroxide formation is achieved vivo 
by application of a standard dose of PMA to pre-irritated 
skin, than is achieved from application of the same dose of 
PMA to normal, unirritated skin. The work of Markert et al. 
(1980) suggests that oxygen consumption is proportional to 
the superoxide production.
A practical application of the above phenomenon is the 
novel technique now described for the quantification of skin 
irritancy. This is based on the premise that the oxygen 
consumption produced by a standard dose of PMA will reflect 
in part the number of inflammatory cells exposed. Hence, the 
irritative state (the extent of inflammatory cell presence) 
of the skin prior to application of the standard dose of PMA 
will be indicated by the increased oxygen consumption. As 
oxygen consumption with suitable calibration, can be 
expressed quantitatively in nanomol O2 min“ 1 , this test has 
the potential to provide a more precise and less subjective 
test of irritancy than is achieved by the currently practiced 
Draize score skin irritation assessments (Draize 1959).
METHOD
The animals and chemicals used were of the same 
origins and type as described in Chapters 3 and 4 . Oxygen 
consumption was determined by polarographic measurement using 
a Clark electrode. This electrode consisted of a platinum 
cathode, silver anode, and a saturated solution of potassium 
chloride held around the electrodes by a Teflon membrane.
The membrane interfaces with the liquid under study in the 
Gilson water-jacketed cell maintained at 37 0.2°C by a
thermostatic circulating water bath. The measurements were 
recorded using a Gilson Model 5/6H Oxygraph. The Clark 
electrode was supplied by Yellow Springs Instrument Co., 
Yellow Springs, Ohio and the Gilson cell was obtained from 
0X-15253> Gilson Medical Electronics, Wise. The apparatus is 
illustrated in Figure 17.
The principle of this polarographic system is that 
when a polarizing voltage is applied across the probe 
electrode, oxygen in the probe is reduced as the cathode 
current flows, in direct stoichometric relation to the rate 
of oxygen reduction i.e., consumption. As the oxygen 
pressure in the probe becomes zero, oxygen then diffuses from 
the test liquid through the membrane to the probe at a mass 
rate proportional to the oxygen pressure outside the probe. 
When a steady state is reached, in about 30 seconds, the 
current flowing through the probe will be at a rate 
proportional to the external oxygen pressure. A current- 
to-voltage converter is employed to convert the electrode 
current into a voltage which is then amplified and recorded 
by means of a heated stylus on heat sensitive chart paper.
Calibration is achieved by recording the known value 
of oxygen present in an oxygen-saturated solution maintained 
at 37°C; the oxygen content of this solution at different 
temperature is shown graphically in Figure 18. A zero value 
is then obtained on the recorder by the addition of sodium 
sulphite crystals to the cell contents; this causes a rapid 
depletion of oxygen in solution. A zero current switch, 
which interrupts electrode current, is used for the routine 
zero oxygen setting.
The interval between the initial (oxygen saturated 
solution) and the final value (zero point) is proportional to 
the oxygen concentration. The rate is calculated using the 
time scale trace which is recorded simultaneously; this rate 
is used as a calibration factor to express the rates obtained 
from the experimental series in terms of nanomoles 02/mg 
tissue/minute.
The measurements recorded in the studies described 
below, were obtained by using a constant polarizing voltage 
of 0.8 volts. However, the current/ oxygen pressure 
relationship is essentially independent of polarizing 
voltage, the output signal changing < 3% when the polarizing 
voltage is varied from -0.8 to -0.65 volts. Adequate 
stirring is essential to ensure an accurate output signal; 
this was achieved by using a small magnetic stirring bar, to 
which in some experiments a tissue holding device was mounted 
so that the skin flap was also rotated. Failure to ensure 
sufficient homogeneity of the cell liquid can result in 
localized oxygen depletion in the region of the electrode 
membrane.
FIGURE 17
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OXYGEN CONCENTRATION AT DIFFERENT TEMPERATURES
Probe Studies
Two CD1 female mice (6 weeks old) per group were used 
in a series of probe studies designed to determine the 
optimum conditions for measuring oxygen uptake of mouse skin 
tissue samples. Skin flaps (0.2 - 0.3 g) from the shaved 
dorsal region of these animals were either immersed directly 
into oxygen-saturated phosphate buffered saline (pH 7.4) at 
37°C in the Gilson cell or, as an homogenate contained in 2 
ml of oxygen-saturated phosphate buffered saline.
The reaction curve (i^ for 0£ versus time) was 
recorded for 3 minutes and the slope obtained compared with 
that obtained from a base line trace of oxygen-saturated 
phosphate buffered saline alone. PMA (0.1 mg/0.1 ml acetone) 
was added (0.1 ml) to the cell contents by means of a glass 
syringe introduced through the capillary bore stopper of the 
Gilson cell (Fig. 17). The final volume of the cell contents 
was such that liquid rose almost to the top of the capillary 
bore stopper (the capillary bore ensures negligible diffusion 
of atmospheric oxygen into the cell since the oxygen would 
have to pass through the narrow liquid column before reaching 
the cell). The reaction curve of skin flap or homogenate 
plus PMA (direct addition) was obtained over a further 3 
minute period.- The slopes of each curve were obtained and 
the oxygen consumption thereby expressed as nanomoles/02/mg 
tissue/minute using the appropriate calibration factor.
As an alternative to the direct addition of PMA to the 
cell contents, the skin flap, following oxygen consumption 
measurements in the absence of PMA stimulation, was placed on 
saline moistened filter paper and a dose of PMA (1 mg/0.1 ml
acetone or 10 ug/0.1 ml acetone) was applied (0.1 ml) by 
automatic pipette and allowed to evaporate for 3 minutes.
The skin flap was then placed in the Gilson cell containing 
oxygen-saturated phosphate buffered saline and the stimulated 
oxygen consumption recorded. As a check that this response 
was due to the living tissue and not due to the PMA per s e , 
the oxygen consumption of an untreated skin flap was 
determined (without PMA stimulation) and this skin flap was 
then placed in boiling water for three minutes. On removal 
and cooling, a stimulatory dose of 10 ug PMA/0.1 ml acetone 
was applied topically and the oxygen consumption measured as 
described above. This same dose of PMA added directly to the 
cell contents, but in the absence of skin tissue, did not 
affect the oxygen concentration of the phosphate buffered 
saline.
The ear of the mouse was also studied with regard to 
rate of oxygen consumption, both with and without application 
of a stimulatory dose of PMA (1 mg/0.1 ml acetone).
In these studies it was found that the traces recorded 
showed considerable signal interference. In the case of the 
homogenate samples, this was believed to be due to the 
suspended fragments disturbing the Teflon membrane. As lower 
magnetic stirrer speeds caused variation in the signal output 
due to localized oxygen depletion, use of the homogenate 
preparations for these measurements was discontinued. With 
the skin flaps it was noted that the tissue piece tended to 
float to the upper part of the Gilson cell and to be trapped 
there, occasionally becoming dislodged and hitting the probe. 
To prevent this, a tissue holder was constructed from
flexible plastic mounted directly onto the 1 cm magnetic 
stirrer (Figure 17)• The holder readily permitted gaseous 
diffusion into the tissue from the surrounding saline, yet 
ensured adequate agitation and homogeneity of the saline 
without disturbance of the probe. As a consequence, the 
signal interference was reduced, and a greatly improved 
reproducibility in the responses of equivalent tissue 
treatments was obtained. The tissue holder device was used 
for the studies to be reported here. Examples of the traces 
recorded using this system are shown in Figures 19 and 20.
Care was also taken to minimize suspended solids such 
as hair fragments by thorough cleansing of the Gilson cell 
between measurements, and saline rinsing of the skin flap 
prior to addition to the cell. The Clark electrode, by its 
construction, minimizes the signal disturbances caused by 
particle suspensions. Such disturbances significantly affect 
the alternative bare platinum electrode; however, the above 
procedure still improved the performance of the Clark 
electrode.
Comparison of Untreated Versus Abraded Skin
Abrasions to the shaved dosal backs of two CD1 female 
mice were produced using a Norelco dermatome set at a cutting 
depth of 0.1 mm; this is described in Chapter 3« Twenty four 
hours subsequent to this treatment, these animals were killed 
by cervical dislocation together with two untreated mice. 
Oxygen consumption measurements were made on each excised 
skin flap per se and on the same skin flap but subsequent to 
a stimulatory application of PMA (l0ug/0.1 ml acetone) 
applied to it 3 minutes prior to measurement.
Comparison of Irritant Treatments
Using two mice per group, 0.1 ml of either PMA (2.5 
ug/0.1 ml acetone), decane, dodecane, or tetradecane was 
applied to the dorsal shaved skin; two mice remained 
untreated and served as controls. Twenty four hours later, 
these mice were killed by cervical dislocation. Oxygen 
consumption measurements were made on each excised skin flap 
H I  se and on the skin flap subsequent to a stimulatory 
application of PMA (10 ug/0.1 ml acetone) applied 3 minutes 
prior to measurement.
In each of these studies, zero oxygen base line 
measurements (using sodium sulfite crystals), and spontaneous 
oxygen evolution from the oxygen-saturated phosphate buffered 
saline, were measured over a 3 minute time course 
periodically during the other determinations. A new teflon 
membrane was used at the start of each study. The polarizing 
voltage, sensitivity and zero adjustment controls were kept 
constant to allow ready interseries comparison of the 
results.
RESULTS
Probe-Method Development
As shown in Table 23» the higher PMA dosage of 1 
mg/0.1 ml acetone produces a greater stimulation in oxygen 
consumption than that produced by 10 ug PMA/0.1 ml acetone. 
However, the 10 ug PMA/0.1 ml acetone was selected for use in 
the main studies since the experience with this dosage for 
other parameters, both biochemical and histological, has been 
gained in studies reported in previous chapters. In 
addition, the increase in oxygen consumption produced by the
FIGURE 19
51 nmol 02
Untreated viable skin
Abraded skin
1 min. Abraded skin and PMA
Continuous assay for 0_ consumption-untreated versus abraded skin. 
Conditions as in Methods Section.
FIGURE 20 
---------- J_
51 nmol 0
PMA pretreated skin
1 min. PMA pretreated skin and PMA
Continuous assay for 0 consumption - PMA pretreated skin. 
Conditions as in Method Section.
higher dose was not deemed sufficient to justify its use in 
view of the increased potential hazard to laboratory 
personnel and the increase in cost which would be incurred.
The probe study in Table 23 clearly demonstrated that 
a topical application of PMA to the excised skin flap 
significantly stimulated oxygen consumption over that of the 
same untreated skin flap. That this consumption is due to 
the living tissue per se rather from some incidental effect 
produced by PMA itself was demonstrated by the negligible 
oxygen consumption seen with PMA stimulated skin which had 
been heat treated previously.
In the mouse ear comparison of untreated pinna versus 
the untreated pinna with PMA stimulation, an increase in 
oxygen consumption was also seen; this may be a system for 
future investigation since comparative work could easily be 
carried out using the right and left pinna. However, for the 
experimental series to be reported here, the dorsal skin was 
used to allow comparison with other parameters reported 
previously.
Untreated Versus Abrasion Comparison
The oxygen consumption of PMA-stimulated (10 ug/0.1 ml 
acetone) abraded dorsal skin was 4-5 fold greater than that 
of PMA stimulated intact skin (Table 24)» The histological 
appearance of the abraded skin was identical to that shown in 
Plate 5.
Comparison of Irritant Treatments
The dose of PMA (2.5 ug/0.1 ml acetone) applied is 
known to produce an inflammatory response in mouse skin at 24 
hours and has been used for this purpose in experiments
TABLE 23
METHOD DEVELOPMENT
j TREATMENT/TISSUE
OXYGEN 
CONSUMPTION 
(n mole 02/g 
tissue/minute)
i Untreated skin (no PMA stimulation) 244, 299
! Untreated skin (+ PMA 10 ug/0.1 ml acetone) 459, 443
j Untreated skin (+ PMA 1 mg/0.1 ml acetone) 554, 556
! Heat treated skin (+ PMA 1 mg/0.1 ml acetone) 0
j Right Pinna (no PMA stimulation) 153, 143
| Right Pinna (+ PMA 1 mg/0.1 ml acetone) 276, 265
Oxygen consumption values are the average of duplicate 
determinations on two CD1 $ mice, less the O2 dissociated from O2 
saturated buffer over the same period.
TABLE 24
COMPARISON OF IRRITANT TREATMENTS
TREATMENT/TISSUE
OXYGEN 
CONSUMPTION 
(n mole O2/S 
tissue/minute)
No treatment 474, 468
Abraded skin (No PMA stimulation) 587, 569
Abraded skin 1 850, 1 677
Decane . (1) 1199, (5 ) 574
Dodecane (2) 1384, (6) 948
Tetradecane (3) 1221, (7) 728 !
PMA (2.5 ug/0.1 ml acetone) (4) 1675, (8) 1105
Oxygen consumption values are the average of duplicate
determinations on two CD1 mice less the O2 dissociated from O2
saturated buffer over the same period. The treatments were made 
topically 24 hours prior to sacrifice and a stimulatory dose of 
PMA (10 ug/0.1 ml acetone) applied to the excised skin except in
the one treatment group noted above. The alkane and PMA
determinations were carried out sequentially, in the order noted, 
as a check that the observed ranking was not artefactual.
reported in previous chapters. Table 24 shows a dramatic 10 
fold increase in oxygen consumption in skin receiving this 
treatment and a subsequent PMA stimulatory dosing, compared 
with untreated PMA stimulated skin.
The alkane series shown produced responses of lesser 
magnitude, but these were still significantly higher than 
that of untreated PMA stimulated skin. Tetradecane produced 
an apparent greater increase in oxygen consumption than 
decane and dodecane at 24 hours after application to the 
dorsal skin.
DISCUSSION
These preliminary findings support the hypothesis that 
PMA application to mouse skin causes increased oxygen 
consumption in parallel to the stimulated production of free 
radicals. The inclusion of heat-treated PMA stimulated skin 
demonstrated that the oxygen consumption observed is not 
artefactual. It is also demonstrated (Table 23) that PMA 
stimulation of otherwise untreated skin causes an increase in 
the rate of oxygen consumption. That such an increase can be 
enhanced many fold by change to various known irritant 
states, is seen in the subsequent results with abraded skin 
and skin treated with alkanes and with PMA. As would be 
expected, the inflammatory response per se results in some 
enhanced oxygen consumption as seen by comparing the rates of 
oxygen consumption of abraded skin with and without PMA 
stimulatory treatment. The PMA stimulation greatly magnifies 
the response; this magnification is a desirable property of a 
predictive test where discrimination is a key factor.
With regards to the specificity of the model, the 
results reported for PMA treatment (2.5 ug PMA/0.1 ml 
acetone) and the alkane series are encouraging. The rate of 
oxygen consumption appears to reflect the histologically 
verified irritancy of the PMA treatment applied 24 hours 
prior to sacrifice. The known lesser irritancy of the 
alkanes results in enhanced oxygen consumption rates with the 
C-J2 chain length showing the greater response, but of an 
order of magnitude less than that produced by PMA (2.5 ug/0.1 
ml acetone). This finding is in agreement with the ranking 
of irritancy reported in the literature for this alkane 
series (Brook and Baumann 1955), albeit with repeated topical 
application.
That this increased rate of oxygen consumption is not 
reflective of the some incidental effect caused by the order 
in which the measurements were carried out was verified from 
the laboratory records. These showed that the measurement of 
oxygen consumption of the PMA treatment and that of the 
tetradecane treatment straddled the oxygen consumptions of 
the other determinations; in addition each group of animals 
was only sacrificed just prior to the actual oxygen 
consumption measurements.
The selection of a 5 minute dosing period was made 
with the knowledge that the respiratory burst and increased 
oxygen consumption occurs with a lag time of about 1 minute 
between stimulus (PMA addition to suspensions of neutrophils) 
and onset of the burst. Where such stimulation occurs 
Curnutte and Bobiar (1974) showed that the response only 
reaches a plateau after about 40 minutes. ■
While the application of PMA stimulated oxygen 
consumption as an index of the extent of inflammatory cell 
presence is novel, the interaction of PMA with 
polymorphonuclear leukocytes has long been used as a 
diagnostic tool to screen for the carrier state of chronic 
granulomatous disease since the cells in this disease state 
have a greatly reduced response to PMA stimulation of oxygen 
consumption. The concept of the test proposed here utilizes 
the reverse situation; the presence of inflammatory cells 
responding chemotactically to an irritant challenge are shown 
by the enhanced oxygen consumption on application of a PMA 
stimulatory dose.
In the development of the described irritative test 
for general use and acceptance, the potential health hazard 
from the use of a tumour promo ter as the standard stimulatory 
dose would pose a serious drawback. However, substitution of 
PMA by epinephrine, ascorbic acid or phenazine methosulphate 
may be possible since these all stimulate oxygen uptake of 
phagocytes _in vitro (Lehrer 1973)*
A major element of the proposed technique which 
requires further research is the relationship between the 
irritant stimulus and the chemotactic migration and 
accumulation of the macrophages at the inflammatory site. 
Several methods are available to measure the kinetics and 
magnitude of accumulation of macrophages at inflammatory 
sites ill vivo. Steele et al. (1 985) were able to detect and 
quantify macrophages using monoclonal antibodies which 
reacted to specific receptors and antigens expressed by 
macrophages. Wahba et al. (1984) utilized labelled
polymorphonuclear leukocytes to quantitate the iri vivo 
accumulation of these cells in the skin following application 
of chemotactic and inflammatory materials.
Another approach would be to adopt the method 
previously used by Dammaceo et al. (1979) for isolating 
phagocytic cells from human skin tumour slices. In this 
method, the excised skin is finely diced and digested with 
trypsin and collagenase followed by filtration through gauze, 
and collection of the cells from the supernatant by 
centrifugation. Resuspension of the subsequent pellet, 
incubation at 57°C with nitroblue tetrazolium, and 
counterstaining with Wright-Giemsa would confirm the presence 
of' stimulated phagocytic cells by the formation of dark blue 
diformazan. The PMA enhanced reduction of nitroblue 
tetrazolium by macrophages _in vitro has been reported by 
Ohkawa et al. (1984) and is in fact proposed by these authors 
as a test system for screening of PMA-type tumour promoters 
such as other phorbol esters and teleocidin.
The response to PMA of the mouse ear in terms of 
oxygen consumption supports the findings of Janoff et al. 
(1970) that PMA produces a severe local vasular reaction in 
the ear skin of CF1 and STS mice accompanied by, within 24 
hours, an intense leukocytic infiltration and increase in 
neutral protease. The source of the neutral protease was 
ascribed to the influx of hydrolase-rich phagocytic cells 
into the target tissue. Hence, measurement of oxygen 
consumption of stimulated ear skin may prove to be a 
worthwhile further development of the preceding findings.
Goldstein (1982) notes that the recruitment of 
phagocytic cells into an area, and the production of the 
burst of oxygen consumption, are distinctive processes, with 
very few agents capable of producing both effects. For those 
that can, there is variation in the degree of oxygen 
consumption produced. For instance, latex particles tend to 
cause minimal increases, zymosan particles are more 
effective, and PMA is among the most potent of the 
non-phagocytic stimuli with near maximal stimulation at 
levels as low as 10 ng/ml. In any event, any increased 
oxygen consumption caused by the applied test material would 
have reverted to near resting levels in the 24 hours prior to 
the stimulatory dose of PMA, based on the decline in 
respiratory burst activity with time reported by Curnutte et 
al. (1 979)• Hence, application of a test material with 
PMN-stimulatory properties should not effect the subsequent 
stimulated oxygen consumption measurements nor any estimate 
of skin irritancy based on these measurements.
Attention is being given worldwide to new methods in 
toxicology which eliminate or reduce the need for animal 
experimentation. One of the more promising skin irritation 
methods proposed is that based on measurement of the 
electrical resistance in skin as an indication of its 
breakdown in response to irritants and corrosive chemicals.
It is believed that the test method (stimulated oxygen 
consumption) outlined above may prove to be a more sensitive 
and direct measurement of skin irritancy, providing rapid 
screen information for utilization in subsequent 
toxicological studies. Examples of the latter are mouse skin
cancer bioassays and guinea pig sensitization studies where 
selection of a dose of low irritancy is important. The 
proposed method may also prove to offer benefits of 
precision, time and animal utilization over the currently 
used Draize Skin irritation test method (Draize, 1959): 
further research and validation are needed to develop this 
potential test method.
CHAPTER 7
FINAL DISCUSSION AND FUTURE RESEARCH DIRECTION
FINAL DISCUSSION
The thesis research described in previous chapters 
shows the successful adaptation of test methods for the 
measurement of hydrogen peroxide in the intact mouse skin, 
and the development of an explant system to study both 
hydrogen peroxide generation and oxygen consumption in an 
isolated iii vitro system.
The results obtained from these model systems are now
matched against the hypotheses proposed in Chapter 1.
Association Of Inflammatory Cells With H2O2 Stimulated 
Production
HYPOTHESIS:
1) the extent that the known mouse skin tumour 
promoter phorbol 12,13-myristate acetate produces 
free radicals and/or active oxygen In vivo in the 
mouse skin is determined by the presence of 
inflammatory cells.
2) abrasion, a known skin tumour promoting agent, 
causes free radical and/or active oxygen 
generation in the mouse skin iii vivo as determined 
by H 2O2 formation.
RESULTS:
t The tumour promoter phorbol 12, 13-myristate acetate
produced a dose dependent stimulation of hydrogen 
peroxide production in intact mouse skin; this was 
paralleled by an increased presence of inflammatory 
cells.
• Comparison of the effects found iri vivo and In vitro 
provide further evidence that the response observed may 
be due to an infiltrating cell population since a 
isolated endogenous skin preparation maintained dji vitro
had very different response from that of skin from an
in vivo trea tment/i_n vitro maintenance combination.
• Mechanically-induced irritation (abrasion) produced a 
stimulated generation of hydrogen peroxide in the mouse 
skin.
• Application of phorbol 12,13-myristate acetate (PMA) 
enhanced this stimulated generation, and did so to an
extent greater than that obtained from application of
PMA to normal skin.
The above is consistent with the i_n vivo finding of 
Argyris et al (1981) of skin tumour promotion produced by 
repeated abrasion. It is also consistent with the original 
hypothesis that the H 2O 2 is, in part, generated from the 
PMA-stimulation of inflammatory cells (Goldstein et al 1982).
The effects of abrasion and the suspected role of 
macrophages in PMA- and alkane-stimulated production of 
hydrogen peroxide in the mouse skin, indicates that the 
degree of response of the skin to an irritant stimulus may 
play a significant role in the expression of tumour promoting 
potential of an applied material. Furthermore, the different 
sensitivities of different murine strains to tumour promotors 
may be due to the degree of response to irritant stimuli.
This may, in turn, be dependent on the particular 
immunological status of the murine strain. Thus, the SENCAR 
mouse would be expected to be particularly sensitive to PMA
stimulated chemotaxis and possible hydrogen peroxide 
generation, since, as shown by Slaga et al. (1982), this 
strain is extremely sensitive in two-stage carcinogenesis 
protocols.
Slaga et al. ranked the response of CD1 mouse in such 
protocols below that of the SENCAR mouse. The reduction in 
catalase activities found with PMA treatment of the CD1 mouse 
reported in Chapter 3 is comparable to that reported by 
Solanki et al. (1 981 ) for the SENCAR strain, but this is 
based on acute exposure.
n-Alkane Stimulated Generation Of H?0? In Mouse Skin 
HYPOTHESIS:
3) Known n-alkane tumour promoters cause the 
stimulated production of reactive oxygen products 
and therefore should be grouped with those agents 
with tumour promoting activity mediated through 
reactive oxygen.
4) n-Alkanes currently not considered tumour 
promoters cause free radical and/or active oxygen 
generation in the presence of inflammatory cells.
RESULTS:
• Known skin tumour promoters, n-decane and n-dodecane
caused a stimulation of hydrogen peroxide generation in 
mouse skin.
t n-Hexane caused a stimulation of hydrogen peroxide 
generation in pre-irritated mouse skin, but a 
significant stimulation was not seen from application of 
the same dose to normal skin.
Since free radical generation appears to play a role 
in tumour promotion, and as n-tetradecane, n-decane, and 
n-octane have all been reported elsewhere to possess tumour 
promoting activity, these results here implicate n-hexane as 
possessing tumour promoting potential. As the lower alkanes, 
Cy and below, are not irritant on repeated application, any 
tumour promoting potential of these lower alkanes may remain 
latent unless evaporation is impeded or exposure is in 
combination with an irritant.
Elevation Of Catalase Activity From Oxygen Exposure/Incubation 
HYPOTHESIS;
5) The elevated catalase activity determined with in 
vivo PMA treated and subsequently cultured skin, 
is due to the unphysiological oxygen concentration 
used during incubation.
RESULTS:
• Total catalase in skin was found to be increased both, 
as an explant and iii vi v o , from exposure to increasing 
concentrations of oxygen.
These findings are consistent with the observations by 
Stevens and Autor (1977) of increased catalase in pulmonary 
macrophages during hyperoxic exposure. The dose dependency 
seen with the PMA treatment is likely due to the increase in 
macrophages in the skin; their increased presence is probably 
due to chemotactic factors triggered by increasing cutaneous 
dosing of PMA. However, a more direct interaction should not 
be ruled out.
Effects Of Free Radical Formation On Mouse Skin Mixed
Function Oxidase 
HYPOTHESIS;
6) Reactive oxygen generated by stimulation of
phagocytes may increase mixed function oxidase 
activity.
RESULTS;
• Current techniques for the assay of enzymic activities 
specific for cytochrome P-450 and cytochrome P-448 
failed to detect these in mouse skin. The presence of 
these activities in mouse hepatic tissue was 
demonstrated.
It is likely that the severity of the procedure 
necessary to prepare skin suspensions for assay causes loss 
of cytochrome activity. Cytochrome P-448 activity might be 
expected to be present in the skin since it is known to have 
a role in the activation of carcinogenic polycyclic aromatic 
hydrocarbons, and the mouse skin has been shown to be very 
responsive to tumour induction by this class of compounds. 
Applied Research Aspect
A practical application of the above findings is the 
use of PMA-stimulated oxygen consumption as a measure of 
degree of inflammatory cell response resulting from an 
applied material or physical agent.
Preliminary data has been presented in this thesis 
which shows this novel system to rank an alkane series in the 
same order as that determined by conventional irritation 
study. This technique may offer a more precise and 
convenient measure of irritancy than that provided by the 
currently used Draize test.
Alternate Measurements Of Free Radicals In Mouse Skin
(a) Chemiluminescence
Direct evidence for the stimulated production of free 
radicals by active phorbol esters is limited to the 
dose dependent generation of chemiluminescence in isolated 
mouse epidermal cells following PMA treatment (Fischer and 
Adams 1984)* Chemiluminescence is an index of both the 
generation of, and reactions mediated by, ( -^r and ^0 2 »
In the present thesis studies, direct measurement of 
free radicals by chemiluminescence was attempted. N-decane 
or commercial hexane or dimethyl sulpoxide were applied alone 
or in combination with an irritant 0.1 N sulphuric acid to 
the shaved dorsal backs of CD1 mice, and the luminescent 
measurements of singlet oxygen, dimolecular oxygen and all 
active oxygen species present were carried out 24 hours 
subsequently using a beta liquid scintillation counter. The 
results (Appendix 1) indicate comparable total luminescence 
for alkane, acid and acetone treatments but with an 
anticipated reduction in total luminescence for dimethyl 
sulphoxide, a free radical scavenger.
(b) Lipid Peroxidation
Reactive oxygen-dependent lipid peroxidation has been 
implicated in the action of epidermal tumour promoters. Both 
non-specific membrane peroxidation and stereo-specific lipid 
peroxidation can mediate the formation of highly reactive and 
diffusible aldehyde and carbonyl products which can 
themselves amplify these peroxidations and hence cellular 
damage and tumour promotion.
Although not attempted here, lipid peroxidation has 
been assessed by several methods including (1) the 
thiobarbituric acid reaction which measures malondialdehyde 
and peroxides, (2) diene conjugation for measurement of 
conjugated double bonds, (3) the measurement of fluorescent 
products formed by the interaction of peroxidized lipid and 
other tissue components, (4 ) the determination of pentane 
and/or ethane evolution, and (5 ) the formation of cholesterol 
epoxides.
The methodologies for measurement of chemiluminescence 
and lipid peroxidation could be beneficially used to confirm 
the findings of hydrogen peroxide, and hence free radical 
generation, in mouse skin iii vivo resulting from topical
application of either PMA or n-alkanes.
FUTURE RESEARCH DIRECTION
Experimental evidence is presented that endorses the 
concept of oxygen radical involvement in the tumour promoting 
activity of PMA and of members of the n-alkanes range 
(C5-C14) examined. Other materials should be included to 
determine any upper limit in carbon chain length for the
tumour promoting activity of the n-alkane series. A study of
members C^g - C24 would be relevant--to the petroleum industry 
product range as these materials occur in higher boiling 
solvents and gasoline fractions. A study of the branched 
chain counterparts would also be of relevance. All these 
materials cause a hyperplastic response on repeated 
application and hence the purely hyperplasia-causing agent 
ethylphenylpropiolate -should be included for comparative
purposes. The use of skin explants of selected inflammatory 
states in conjunction with topical application of the above 
alkane range may serve to provide further evidence for the 
role of macrophage infiltration in tumour promotion.
The elevation in catalase in response to hyperoxic 
conditions underlines the need for caution in interpreting 
biochemical responses of explant or isolate cell systems 
incubated with oxygen concentrations different from those 
that would be experienced iji vivo. It would be of interest 
to repeat the studies of Verma and Boutwell (1980) to 
determine whether the dramatic increase in ornithine 
decarboxylase seen with PMA treated mouse skin incubated in 
vitro under the 95% oxygen and 5% carbon dioxide, can still 
occur with 95% air and 5% carbon dioxide conditions used for 
the catalase studies reported here.
Pucci et al. (1983) have suggested that oxygen-oxidant 
mediated inactivation of key metabolic enzymes may serve a 
function in regulating cellular protein synthesis; Brown et 
a l . (1979) showed that exposure of Escherichia coli to 
hyperbaric oxygen resulted in inactivation of quinolate 
phosphoribosyl transferase which is an enzyme key to NAD + 
biosynthesis. Niacin, which enters the NAD+ biosynthetic 
pathway beyond this enzyme prevented oxygen-dependent 
toxicity in Escherichia coli; it also prevented hyperoxia- 
induced toxicity to alveolar macrophages (Pearl and Ruffin
1983)* Use of niacin addition to the skin explant system 
employed here, together with hyperoxic conditions, may help 
to elucidate whether the apparent catalase elevation is due 
to d_e novo protein synthesis or due to a reduction in
cutaneous hydrogen peroxide from inhibition of processes 
involving 'oxygen degradation.
In this thesis research, the tumour promoters 
investigated have been shown to change one of the cellular 
antioxidant defense enzymes namely catalase. Another 
antioxidant defense enzyme, superoxide dismutase is also 
depleted following treatment with PMA (Solanki (1981 ) 
et a l .).
Attempts to replace the native superoxide dismutase 
experimentally with a low molecular weight lipophilic copper 
complex, copper II (3»5 diisopropyl salicyclic acid)2 » which 
has superoxide dismutase-mimetic action have shown a 
substantial reduction in the tumour promoting activity of PMA 
(Kensler et al. 1983)* It would be worthwhile to investigate 
whether the catalase depletion seen with topical application 
of the n-alkane series is paralleled by a depletion in 
superoxide dismutase.
For the biochemical studies presented here, 
difficulties in preparing stable cytochrome - P450 
preparations prevented any free radical-mediated effects from 
being assessed. With improvement of isolation techniques, 
assessment of cutaneous free radical formation on cytochrome 
P-450 and cytochrome P-448 activities would be pertinent 
further research. It would also be interesting to 
investigate human skin and determine cutaneous activities of 
these cytochromes so that the appropriateness of the mouse 
skin as a model in this respect can be determined.
A practical application of some of the findings 
reported here is the use of PMA-induced oxygen consumption as
a measure of the degree of skin irritation caused by an 
applied material or physical agent. Further study is needed 
of this effect both in mouse skin and in rabbit skin with 
classes of compounds where skin irritation data is available 
on individual members. The optimal time course and 
conditions of this assay also need research and development 
in order to develop this technique as a possible quantitative 
replacement for the existing subjective. Draize skin 
irritation test.
APPENDIX
Chemiluminescent emission from isolated peripheral 
blood mononuclear cells is known to occur. The emission is 
believed to be due to the relaxation of electronically 
excited carbonyl groups during the oxidation by singlet 
oxygen of ingested materials. Incubation of phorbol 12,13 
myristate acetate (PMA) with isolated epithelial cells has 
shown a stimulated luminescent emission (Fischer and Adams,
1984)*' Direct measurement of free radicals by
chemiluminescence was attempted for dorsal excised skin which 
had previously received treatment with certain alkanes alone 
or in combination with an irritant.
Method
N-decane (0*1 ml) or commerical hexane (0.1 ml) or 
dimethylsulphoxide (0.1 ml) was applied to the shaved dorsal 
skin of two CD1 female mice either alone or immediately prior 
to treatment with 0.1 N sulphuric acid (0.1 ml). The tip of 
the automatic pipette was used to spread the sulphuric acid 
as evenly as possible across the treatment area since, being 
aqueous, the acid tended to bead on the skin.
Twenty-four hours subsequent to treatment, the animals 
were killed by cervical dislocature and the treated skin 
excised and placed in ice-cold phosphate buffered saline.
Each explant was placed in a polyethylene vial which had been 
stored overnight in total darkness and the volume made up to 
5 mis. with the saline. The luminescence of these vials, and
vials containing just the saline, and vials alone, was 
determined using an LKB Wallace 1216 Rack beta liquid 
scintillation counter.
DABCO (100 mM) was then added to each vial and the 
emission due to molecular oxygen species was determined. 
Finally, luminol (500 mM) was added. As the
chemiluminescence of luminol is dependent on the relaxation 
to its ground state of a 3-aminophthalate di-anion excited by 
free radicals, the emission is a measure of total active 
oxygen species.
Results
The luminescent emission (counts per milli-second) 
were recorded for all treatments and the appropriate blanks. 
Due to the increasing luminescence of the background blanks 
containing DABCO or luminol during the course of the 
determination, it was not possible.to correct appropriately 
for background chemiluminescence and hence neither 
dimolecular species nor all active oxygen species could be 
determined. Examination of the total luminescence showed 
comparable emissions for all treatments except with dimethyl 
sulphoxide where a reduction was noted. The combined 
acetone/sulphuric acid treatment produced a greater 
luminescence; it was noted that the acetone pretreatment 
prevented the beading of the acid solution.
Discussion
For total luminescence only, the alkane, sulphuric 
acid, and acetone treatments were found comparable after
appropriate background correction. As might be expected with 
a free radical scavenger, less total luminescence was 
measured from dimethyl sulphoxide treated skin.
The greater emission seen with acetone/sulphuric acid 
is possibly due to the acetone enhanced penetration of the 
irritant sulphuric acid into the skin; this was not seen in 
other combination treatments, but beading of the acid on the 
surface seemed to occur in these treatments. The results 
with DABCO or luminol additions suggest that these solutions 
were deteriorating over the course of the determinations; it 
was subsequently appreciated that the solutions should have 
been maintained on ice and in darkness during the 
experimental period.
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